Corona omicron indonesia

corona omicron indonesia

• New cases still at record levels in Malaysia, Singapore, South Korea, Thailand and Vietnam but have fallen sharply in India, Indonesia and the Philippines • China, despite ‘dynamic zero’ strategy to curb infections, has been tested by fast-spreading Omicron; Deaths have soared in Japan, South Korea and Hong Kong Virus Corona atau severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) adalah virus yang menyerang sistem pernapasan.

Penyakit akibat infeksi virus ini disebut COVID-19. Virus Corona bisa menyebabkan gangguan ringan pada sistem pernapasan, infeksi paru-paru yang berat, hingga kematian. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) atau yang lebih dikenal dengan nama virus Corona adalah jenis baru dari Coronavirus yang menular ke manusia.

Virus ini dapat menyerang siapa saja, mulai dari lansia (golongan usia lanjut), orang dewasa, anak-anak dan bayi, sampai ibu hamil dan ibu menyusui. Infeksi virus Corona yang disebut COVID-19 ( Corona Virus Disease 2019) pertama kali ditemukan di kota Wuhan, China pada akhir Desember 2019. Virus ini menular dengan sangat cepat dan menyebar ke hampir semua negara, termasuk Indonesia, hanya dalam waktu beberapa bulan.

Hal tersebut membuat beberapa negara memberlakukan kebijakan lockdown untuk mencegah virus Corona makin meluas. Di Indonesia, pemerintah menerapkan kebijakan Pemberlakuan Pembatasan Kegiatan Masyarakat (PPKM) untuk menekan penyebaran virus ini.

Coronavirus adalah kumpulan virus yang menginfeksi sistem pernapasan. Pada banyak kasus, virus ini hanya menyebabkan infeksi pernapasan ringan, seperti flu. Namun, virus ini juga bisa menyebabkan infeksi pernapasan berat, seperti infeksi paru-paru (pneumonia). Selain virus SARS-CoV-2 atau virus Corona, virus yang termasuk dalam kelompok Coronavirus adalah virus penyebab Severe Acute Respiratory Syndrome ( SARS) dan virus penyebab Middle-East Respiratory Syndrome ( MERS).

Meski disebabkan oleh virus dari kelompok yang sama, yakni Coronavirus, COVID-19 memiliki beberapa perbedaan dengan SARS dan MERS, antara lain dalam hal kecepatan penyebaran dan keparahan gejala.

Bila Corona omicron indonesia memerlukan pemeriksaan COVID-19, klik tautan di bawah ini agar Anda dapat diarahkan ke fasilitas kesehatan terdekat: • Rapid Test Antibodi • Swab Antigen (Rapid Test Antigen) • PCR Tingkat Kematian Akibat Virus Corona (COVID-19) Menurut data yang dirilis Gugus Tugas Percepatan Penanganan COVID-19, jumlah kasus terkonfirmasi positif hingga 15 Maret 2022 adalah 5.914.532 orang, dengan jumlah kematian 152.745 jiwa.

Dari angka tersebut, diketahui tingkat kematian ( case fatality rate) akibat COVID-19 adalah sekitar 2,6%. Jumlah ini menurun dari 3,4% pada bulan Januari 2022 lalu. Jika dilihat berdasarkan usia, kelompok usia >60 tahun memiliki persentase angka kematian yang lebih tinggi dibandingkan kelompok usia lainnya.

Sedangkan, bila dilihat dari jenis kelamin, 52,3 % penderita yang meninggal akibat COVID-19 adalah laki-laki dan 47,7% sisanya adalah perempuan. Meski jumlah kematian akibat COVID-19 tergolong tinggi, angka kesembuhan dari COVID-19 juga terus bertambah. Data terakhir menyebutkan, jumlah penyintas atau orang yang pernah terinfeksi virus Corona kemudian sembuh adalah 5.462.344 orang.

Gejala Virus Corona (COVID-19) Gejala awal infeksi virus Corona atau COVID-19 bisa menyerupai gejala flu, yaitu demam, pilek, batuk kering, sakit tenggorokan, dan sakit kepala. Setelah itu, gejala dapat hilang dan sembuh atau malah memberat. Penderita COVID-19 dengan gejala berat bisa mengalami demam tinggi, batuk berdahak corona omicron indonesia berdarah, sesak napas, atau nyeri dada.

Corona omicron indonesia tersebut muncul ketika tubuh bereaksi melawan virus Corona. Secara umum, ada tiga gejala umum yang bisa menandakan seseorang terinfeksi virus Corona, yaitu: • Demam (suhu tubuh di atas 38 derajat Celsius) • Batuk kering • Sesak napas Ada beberapa gejala lain yang juga bisa muncul pada infeksi virus Corona meskipun lebih jarang, yaitu: • Diare • Sakit kepala • Konjungtivitis • Hilangnya kemampuan mengecap rasa • Hilangnya kemampuan untuk mencium bau ( anosmia) • Ruam di kulit Gejala-gejala COVID-19 ini umumnya muncul dalam waktu 2 hari sampai 2 minggu setelah penderita terpapar virus Corona.

Sebagian pasien yang terinfeksi virus Corona bisa mengalami penurunan oksigen tanpa adanya gejala apa pun. Kondisi ini disebut happy hypoxia. Guna memastikan apakah gejala-gejala tersebut merupakan gejala dari virus Corona, diperlukan rapid test atau PCR. Untuk menemukan tempat melakukan rapid test atau PCR di sekitar rumah Anda, klik di sini.

Kapan harus ke dokter Segera lakukan isolasi mandiri jika Anda mengalami gejala infeksi virus Corona (COVID-19) seperti yang telah disebutkan di atas, terutama jika dalam 2 minggu terakhir Anda berada di daerah yang memiliki kasus COVID-19 atau kontak dengan penderita COVID-19. Setelah itu, hubungi hotline COVID-19 di 119 Ext. 9 untuk mendapatkan pengarahan lebih lanjut. Bila Anda menduga telah terpapar virus Corona tetapi tidak mengalami gejala apa pun atau bergejala ringan, tidak perlu memeriksakan diri ke rumah sakit.

Anda cukup isolasi mandiri di rumah selama 10 hari sejak munculnya gejala, ditambah dengan 3 hari bebas gejala demam dan gangguan pernapasan. Jika muncul gejala, baru lakukan isolasi mandiri dan tanyakan kepada dokter melalui telepon atau aplikasi mengenai tindakan yang perlu dilakukan dan obat yang perlu dikonsumsi.

Bila Anda memerlukan pemeriksaan langsung oleh dokter, jangan langsung ke rumah sakit, karena risiko Anda tertular atau menularkan virus Corona ke orang lain akan meningkat. Anda dapat membuat janji konsultasi dengan dokter di rumah sakit melalui aplikasi ALODOKTER agar bisa diarahkan ke dokter terdekat yang dapat membantu Anda. ALODOKTER juga memiliki fitur untuk membantu Anda memeriksa risiko tertular virus Corona dengan lebih mudah.

Untuk menggunakan fitur tersebut, silakan klik gambar di bawah ini. Penyebab Virus Corona (COVID-19) Infeksi virus Corona atau COVID-19 disebabkan oleh C oronavirus, yaitu kelompok virus yang menginfeksi sistem pernapasan. Pada sebagian besar kasus, C oronavirus hanya menyebabkan infeksi pernapasan ringan sampai sedang, seperti flu. Namun, virus ini juga bisa menyebabkan infeksi pernapasan berat, seperti pneumonia, Corona omicron indonesia ( Middle-East Respiratory Syndrome) dan SARS ( Severe Acute Respiratory Syndrome).

Ada dugaan bahwa virus Corona awalnya ditularkan dari hewan ke manusia. Namun, kemudian diketahui bahwa virus Corona juga menular dari manusia ke manusia. Seseorang dapat tertular COVID-19 melalui berbagai cara, yaitu: • Tidak sengaja menghirup percikan ludah (droplet) yang keluar saat penderita COVID-19 batuk atau bersin • Memegang mulut atau hidung tanpa mencuci tangan terlebih dahulu setelah menyentuh benda yang terkena cipratan ludah penderita COVID-19 • Melakukan corona omicron indonesia jarak dekat dengan penderita COVID-19 Virus Corona juga bisa menular melalui benda-benda yang sering disentuh, misalnya uang, gagang pintu, atau permukaan meja.

Virus Corona dapat menginfeksi siapa saja, tetapi efeknya akan lebih berbahaya atau bahkan fatal bila terjadi pada orang lanjut usia, ibu hamil, orang yang memiliki penyakit tertentu, perokok, atau orang yang daya tahan tubuhnya lemah, misalnya pada penderita kanker. Karena mudah menular, virus Corona juga berisiko tinggi menginfeksi para tenaga medis yang merawat pasien COVID-19.

Oleh sebab itu, para tenaga medis dan orang-orang yang sering kontak dengan pasien COVID-19 perlu corona omicron indonesia alat pelindung diri (APD). Berdasarkan data yang dikeluarkan oleh WHO, terdapat beberapa varian SARS-CoV-2 penyebab COVID-19.

Varian yang dimaksud dibagi menjadi dua jenis, yaitu variant of concern (VOC) dan variant of interest (VOI). VOC adalah varian virus SARS-CoV-2 yang dapat meningkatkan risiko penularan COVID-19 dengan cepat, memperparah gejala, dan mengurangi efektivitas terapi. Berikut ini adalah jenis variant of concern tersebut: • Varian Alfa (B.1.1.7) yang pertama kali ditemukan di Inggris pada September 2020.

• Varian Beta (B.1.351/B.1.351.2/B.1.351.3) yang pertama kali ditemukan di Afrika Selatan pada Mei 2020. • Varian Gamma (P.1/P.1.1/P.1.2) yang pertama kali ditemukan di Brazil pada November 2020.

• Varian Delta (B.1.617.2/AY.1/AY.2/AY.3) yang pertama kali ditemukan di India pada Oktober 2020. • Varian Omicron (B.1.1.529) yang pertama kali ditemukan di beberapa negara pada November 2021. Sementara itu, VOI adalah varian yang saat ini sedang diteliti karena dicurigai berpotensi menjadi VOC. Jenis varian tersebut adalah: • Varian Lamda (c.37) yang pertama kali ditemukan di Peru pada Desember 2020.

• Varian Mu (B.1621) yang pertama kali ditemukan di Kolombia pada Januari 2021. Diagnosis Virus Corona (COVID-19) Untuk menentukan apakah pasien terinfeksi virus Corona, dokter akan menanyakan gejala yang dialami pasien. Dokter juga akan bertanya apakah pasien tinggal di daerah atau baru saja bepergian corona omicron indonesia wilayah yang memiliki banyak kasus COVID-19, serta apakah pasien kontak dengan penderita atau orang yang diduga terinfeksi virus Corona sebelum gejala muncul.

Selanjutnya, guna memastikan diagnosis, dokter akan melakukan beberapa pemeriksaan berikut: • Rapid test, untuk mendeteksi antibodi (IgM dan IgG) yang diproduksi oleh tubuh dalam melawan virus Corona • Rapid test antigen, untuk mendeteksi antigen, yaitu protein yang ada di bagian terluar virus • Swab test atau tes PCR ( polymerase chain reaction), untuk mendeteksi virus Corona di dalam lapisan hidung • CT scan atau Rontgen dada, untuk mendeteksi infiltrat atau cairan di paru-paru • Tes darah lengkap, untuk memeriksa kadar sel darah putih dan C-reactive protein Hasil rapid test COVID-19 positif kemungkinan besar menunjukkan bahwa Anda memang sudah terinfeksi virus Corona, tetapi bisa juga berarti Anda terinfeksi kuman atau virus yang lain.

Sebaliknya, hasil rapid test COVID-19 negatif belum tentu menandakan bahwa Anda mutlak terbebas dari virus Corona. Pengobatan Virus Corona (COVID-19) Pada pasien bergejala ringan atau tanpa gejala, dokter akan menyarankan untuk isolasi mandiri di rumah, sambil tetap melakukan langkah-langkah pencegahan penyebaran infeksi virus Corona. Beberapa tindakan yang dapat dilakukan oleh dokter adalah: • Merujuk pasien dengan gejala berat untuk menjalani perawatan dan karantina di rumah sakit rujukan • Meresepkan obat pereda demam dan nyeri yang aman dan sesuai dengan kondisi pasien • Menganjurkan pasien untuk melakukan isolasi mandiri dan istirahat yang cukup • Menganjurkan pasien untuk banyak minum air putih untuk menjaga kadar cairan tubuh Sementara, pada pasien dengan gejala berat, dokter akan memberikan rujukan untuk menjalani karantina di rumah sakit rujukan.

Metode perawatan yang dapat diberikan antara lain: • Pemberian infus cairan agar tetap terhidrasi • Pemasangan ventilator atau alat bantu napas • Pemberian obat, seperti pengencer darah, antiperadangan, antiinterleukin-6 (IL-6), remdesivir, atau favipiravir Komplikasi Virus Corona (COVID-19) Pada kasus yang parah, infeksi virus Corona bisa menyebabkan beberapa komplikasi berikut ini: • Pneumonia(infeksi paru-paru) • Infeksi sekunder pada organ lain • Gagal ginjal • Acute cardiac injury • Acute respiratory distress syndrome • Kematian Di samping itu, ada pula istilah long haul COVID-19.

Istilah ini merujuk kepada seseorang yang sudah dinyatakan sembuh melalui hasil negatif pemeriksaan PCR, tetapi tetap mengalami keluhan, seperti lemas, batuk, nyeri sendi, nyeri dada, sulit berkonsentrasi, jantung berdebar, atau demam yang hilang corona omicron indonesia. Pencegahan Virus Corona (COVID-19) Saat ini, Indonesia sedang menjalankan program vaksinasi COVID-19 secara bertahap.

Hingga Maret 2022, data menunjukkan 92,89% penduduk telah menerima corona omicron indonesia dosis pertama dan sekitar 72,88% telah menerima vaksin dosis kedua. Tambahannya, sebanyak 6,67% penduduk sudah menerima vaksin booster. Vaksinasi COVID-19 bertujuan untuk membentuk kekebalan tubuh terhadap virus Corona. Selain itu, vaksinasi juga bertujuan untuk membentuk kekebalan kelompok atau herd immunity. Dengan begitu, masyarakat yang tidak dapat menjalani vaksin karena memiliki kondisi tertentu, seperti reaksi alergi berat terhadap vaksin, dapat terlindungi.

Untuk mencapai tujuan di atas, vaksin COVID-19 kini sudah dapat diberikan pada anak usia 6–18 tahun, ibu hamil, dan ibu menyusui. Sementara untuk orang yang memiliki riwayat penyakit atau menderita kondisi tertentu, vaksinasi bisa dilakukan, tetapi harus ada izin dari dokter.

Vaksinasi merupakan cara terbaik untuk mencegah COVID-19. Namun, Anda juga tetap harus menghindari faktor-faktor yang bisa menyebabkan Anda terinfeksi virus Corona, yaitu: • Terapkan physical distancing, yaitu menjaga jarak minimal 1 meter dari orang lain, dan jangan dulu ke luar rumah kecuali ada keperluan mendesak.

• Gunakan masker saat beraktivitas di tempat umum atau keramaian, termasuk saat pergi berbelanja bahan makanan atau mengikuti ibadah di hari raya. • Rutin mencuci tangan dengan air dan sabun atau hand sanitizer yang mengandung alkohol minimal 60%, terutama setelah beraktivitas di luar rumah atau di tempat umum. • Jangan menyentuh mata, mulut, dan hidung sebelum mencuci tangan.

• Tingkatkan daya tahan tubuh dengan menjalani pola hidup sehat, seperti mengonsumsi makanan bergizi, berolahraga secara rutin, beristirahat yang cukup, dan mencegah stres.

• Hindari kontak dengan penderita COVID-19, orang yang dicurigai positif terinfeksi virus Corona, atau orang yang sedang sakit demam, batuk, atau pilek. • Tutup mulut dan hidung dengan tisu saat batuk atau bersin, kemudian buang tisu ke tempat sampah.

• Jaga kebersihan lingkungan dan kebersihan rumah, termasuk benda-benda yang sering disentuh. Untuk orang yang diduga terkena COVID-19 (termasuk kategori suspek dan probable) yang sebelumnya disebut sebagai ODP (orang dalam pemantauan) maupun PDP (pasien dalam pengawasan), ada beberapa langkah yang bisa dilakukan agar tidak menularkan virus Corona ke orang lain, yaitu: • Lakukan isolasi mandiri dengan cara tinggal terpisah dari orang lain untuk sementara waktu.

Bila tidak memungkinkan, gunakan kamar tidur dan kamar mandi yang berbeda dengan yang digunakan orang lain. • Jangan keluar rumah, kecuali untuk mendapatkan pengobatan. • Hubungi pihak rumah sakit untuk menjemput bila gejala yang Anda alami bertambah berat. • Larang orang lain untuk mengunjungi atau menjenguk Anda sampai Anda benar-benar sembuh. • Sebisa mungkin jangan melakukan pertemuan dengan orang yang sedang sedang sakit.

• Hindari berbagi penggunaan alat makan dan minum, alat mandi, serta perlengkapan tidur dengan orang lain. • Pakai masker dan sarung tangan bila sedang berada di tempat umum atau sedang bersama orang lain. • Gunakan tisu untuk menutup mulut dan hidung bila batuk atau bersin, lalu segera buang tisu ke tempat sampah.

Perlu diketahui, kondisi-kondisi yang perlu ditangani langsung oleh dokter di rumah sakit, seperti melahirkan, operasi, cuci darah, atau vaksinasi anak, akan dilakukan dengan beberapa penyesuaian selama pandemi COVID-19. Tujuannya adalah agar Anda tidak tertular virus Corona selama di rumah sakit. Apabila Anda ingin mendapatkan lebih banyak informasi mengenai gejala, pencegahan, dan penanganan infeksi virus Corona, silakan download aplikasi ALODOKTER di Google Play atau App Store.

Melalui aplikasi ALODOKTER, Anda juga bisa chat langsung dengan dokter dan membuat janji konsultasi dengan dokter di rumah sakit.
Share on Pinterest David Paul Morris/Bloomberg via Getty Images • The coronavirus outbreak began in Wuhan, China, in December 2019. • Known as SARS-CoV-2, the virus has resulted in more than 453 million infections and over 6 million deaths.

• Keep up to date with the latest research and information about COVID-19 here. • The World Health Organization (WHO) is currently monitoring five variants of concern: Alpha, Beta, Gamma, Delta, and Omicron. 03/11/2022 09:01 GMT — Ayurvedic compound may serve as ‘starting point’ for COVID-19 treatment Researchers are investigating the bark of the neem tree as a potential COVID-19 treatment. They found that an extract from the tree’s bark may have antiviral benefits and help reduce symptoms.

The scientists believe Azadirachta indica may act as a pan-antiviral, capable of treating future emerging variants of SARS-CoV-2. Read more about the recent research here. 03/11/2022 08:52 GMT — Study joins search for variant-proof approach to SARS-CoV-2 treatment Rapidly mutating spike proteins in SARS-CoV-2 threaten to thwart mRNA vaccines and other COVID-19 medications.

However, researchers have identified other targets within the virus. A new study using a new screening methodology proposes a list of existing drugs worthy of further investigation. New research claims to have found the first solid evidence of an Omicron and Delta recombinant virus, and the World Health Organization (WHO) has said it will be “ tracking and discussing” the situation. The recombination was identified in three individuals in France, and estimates suggest that it has been circulating since early January 2022.

The researchers said that the hybrid version of the coronavirus combines the backbone of the Delta variant with the spike protein of the Omicron variant. Genetic recombination is a process in which two variants infect the same host cell. First reports about this recombination surfaced on virus research bulletin boards, which also indicated multiple cases in Europe.

It is too soon to know whether these “Deltamicron” infections will be very transmissible or cause severe disease, says Philippe Colson of IHU Mediterranee Infection in Marseille, France, and lead author of the study. Austria has suspended its COVID-19 vaccine mandate, which it had imposed before the highly contagious Omicron subvariant became the dominant strain. The mandate, which took effect in February, brought fines up to 3,600 euros, about $4,000, for corona omicron indonesia adults who refused to get vaccinated against COVID-19.

However, police enforcement of the measure was not scheduled to begin until March 15. Despite a high number of daily COVID-19 cases, Austria’s constitutional minister, Karoline Edtstadler, said that the vaccine mandate was “not proportionate” to the danger posed by Omicron, which seems to cause less severe symptoms and outcomes.

Austria was one of the first countries to issue a COVID-19 vaccine mandate. Many European countries have recently been lifting protective measures against COVID-19, with Germany and France expected to join others at the end of the month.

Read more about Omicron symptoms here. 03/10/2022 09:48 GMT — COVID-19 severity: Blood group may influence risk A recent study has identified a causal link between specific blood proteins and the risk of hospitalization, the need for respiratory support, or the risk of death from severe COVID-19. While certain blood proteins were associated with an increased risk of corona omicron indonesia COVID-19, others were protective.

Read Medical News Today’s coverage of the research here. 03/09/2022 16:15 GMT — WHO reverses position on booster doses In a recent statement, the World Health Organization (WHO) has announced that it “strongly supports urgent and broad access to current COVID-19 vaccines for primary series and booster doses,” as vaccines and boosters continue to protect against severe disease in the face of Omicron.

This represents a shift from the previous stance that the organization announced in September 2021, when it repeatedly warned against the widespread distribution of booster shots to people without any underlying health conditions.

At the time, WHO stressed the fact that rolling out boosters would accentuate inequities in vaccine access, and it prompted higher income countries to give the extra doses to countries with lower vaccination rates instead.

In the new statement, the WHO has also cautioned that “to ensure [that] COVID-19 vaccines provide optimal protection into the future, they may need to be updated,” as new variants emerge. Read the statement in full here. 03/09/2022 10:12 GMT — All US state mask mandates will be lifted by the end of March Hawaii, Oregon, and Washington are the only states with mask mandates still in effect. The mandates in both Oregon and Washington will end on Friday, March 11, at 11:59 p.m. Yesterday, David Ige, the governor of Hawaii, announced that they would lift the final U.S.

mask mandate before March 26. In his announcement, Ige said, “I do believe that we are the last community to release the mask mandate, because we care about each other, and we care about our community, and we are all willing to sacrifice to keep each other healthy and safe.” 03/08/2022 15:05 GMT — Pfizer will provide 10 million courses of Paxlovid in low and middle income countries Pfizer has committed to providing 10 million courses of the COVID-19 antiviral treatment known as Paxlovid to low and middle income countries this year.

Pfizer has also said it will cut the price of the drug in countries with a lower income, but it has corona omicron indonesia yet specified by how much, according to Reuters.

Nongovernmental organization activists say the 10 million doses are not enough to meet the demand for this drug in these countries. Read the full story here. 03/08/2022 14:50 GMT — Long COVID’s cardiovascular implications As millions of people across the globe are living with long COVID, Medical News Today delves into the topic by exploring a key aspect of the condition: the cardiovascular event known as postural orthostatic tachycardia syndrome (POTS). In the new “In Conversation” podcast, MNT spoke to three experts and an activist with long COVID about the cardiovascular complications of COVID-19.

Specifically, we asked: what is POTS, and what are its symptoms? What may cause this syndrome? Who is at risk, and what might be effective ways to treat it? Read the full MNT feature and listen to the podcast here. 03/07/2022 15:38 GMT — 4th shots and COVID-19 boosters: Why and when best to get it Studies indicate that immunity conferred by a past Omicron infection is not enough to prevent reinfection or protect against other variants. However, while real-world data show that a third dose is necessary for better protection against severe disease or hospitalization due to infection with this SARS-CoV-2 variant, receiving a fourth vaccine dose may not be required for everyone.

Read our in-depth explainer about additional vaccine boosters here. 03/07/2022 15:35 GMT — How ventilation, filtration, and humidity may prevent coronavirus transmission A recent study by researchers from the University of Oregon found that higher ventilation, filtration, and humidity levels decreased the amount of SARS-CoV-2 particles corona omicron indonesia the air.

The study, which appears in the journal Clinical Infectious Diseases, measured the amount of virus particles that 11 students with COVID-19 released during certain activities. “There are lots of mathematical models to estimate the effectiveness of indoor air disease transmission risk mitigation strategies, such as ventilation, filtration, and humidification, but to increase confidence, it is important to quantify these models in a physical setting,” explained senior author Dr.

Kevin Van Den Wymelenberg. Read our full coverage of this story here. 03/07/2022 15:25 GMT — Vaccinated less likely to develop long COVID A new study that has not yet undergone peer review has found an association between receiving two doses of a COVID-19 vaccine before a SARS-CoV-2 infection and reduced long COVID symptoms after 12 weeks. The study is based on data collected and analy zed by the UK Health Security Agency.

“This study provides good evidence that having preexisting immunity with vaccination before getting COVID-19 gives some protection from long COVID,” Dr. Davey Smith, professor of medicine at UC San Diego Health in La Jolla — who was not involved in this study — told Medical News Today.

Read this story in full here. 03/03/2022 10:32 GMT — President Biden announces National COVID-19 Preparedness Plan President Joe Biden has announced the White House’s National COVID-19 Preparedness Plan. It describes how they will continue to reduce the impact of COVID-19 while preparing for future variants. “We know how to keep our businesses and our schools open with the tools that we have at our disposal,” explains White House COVID-19 coordinator Jeff Zients.

In the plan, it reads, “We are not going to just ‘live with COVID.’ Because of our work, we are no longer going to let COVID-19 dictate how we live.” 03/03/2022 10:29 GMT — Vaccine protection wanes in adolescents 5 months after second dose Two doses of COVID-19 vaccine protect adolescents from severe disease and death. However, according to the latest data from the Centers for Disease Control and Prevention (CDC), vaccines are less effective against Omicron.

The data also show that protection wanes 5 months after the second dose. In the new report, the CDC concludes: “All eligible children and adolescents should remain up to date corona omicron indonesia recommended COVID-19 vaccinations, including a booster dose for those aged 12–17 years.” Find more live updates here.

03/02/2022 15:55 GMT — South African Omicron data offer renewed hope A recent study that appears in NEJM offers new hope that the worst of the pandemic may be winding down. Data from the Gauteng province of South Africa — where health experts first identified the Omicron variant in November 2021 — suggest that there have been significantly fewer hospitalizations and deaths from infections with this SARS-CoV-2 variant.

More importantly, the research showed that among younger and older populations — including the unvaccinated — corona omicron indonesia is a high percentage of antibodies to SARS-CoV-2, which may explain the lower rate of deaths and hospitalizations.

And among a high percentage of the population, the immunity to SARS-CoV-2 was “hybrid,” meaning that it was given partly by vaccines and partly from previous infection with the virus. “Our findings support the optimism expressed at the beginning of 2022 in South Africa that a turning point had been reached in the pandemic.

Many in high income countries dismissed this view as not applicable to their settings despite high vaccine coverage. But their experience has since generally aligned with South Africa’s,” wrote study author Prof. Shabir A. Madhi for The Conversation. 03/02/2022 15:30 GMT — Risk of vaccine-related inflammatory syndrome in children is 1 in 1 million A large recent study published in The Corona omicron indonesia has reviewed data on more than 21 million children corona omicron indonesia adolescents aged 12–20 years who received at least one dose of the COVID-19 vaccine over a period of 9 months.

The authors of the study found a total of 21 cases of multisystem inflammatory syndrome in children (MIS-C), suggesting that this rare complication occurred in 1 per 1 million vaccinated people. This rate is much lower than the rate at which unvaccinated individuals experience MIS-C if they contract SARS-CoV-2, which is 200 cases per 1 million.

“Our findings suggest that MIS-C after COVID-19 vaccination is rare,” conclude the study authors. Access the full paper here. 03/02/2022 11:00 GMT — Omicron subvariants BA.1 vs.

BA.2: What the latest data say Recent data indicate that the BA.2 subvariant of Omicron, or the “stealth” variant, has been outcompeting the previously dominant BA.1 subvariant in several countries. According to some new studies, BA.2 may be even more transmissible than BA.1, as well as slightly better at evading immunity.

Nevertheless, clinical data do not suggest a significant difference in the severity of disease caused by BA.2 versus BA.1. Read more about this in our dedicated article. 03/02/2022 10:47 GMT — England health workers no longer required to get vaccinated corona omicron indonesia March Secretary of State for Health and Social Care of the United Kingdom, Sajid Javid, has said that health and social care workers in England corona omicron indonesia no longer be required by law to receive a COVID-19 vaccine.

This decision is due to go into effect on March 15, amid worries that the vaccination requirement may leave the National Health Service (NHS) even shorter staffed. 03/01/2022 16:30 GMT — Hong Kong mortality rates among the highest in the world, New Zealand to expect peak cases, hospitalizations Mortality rates in Hong Kong are now among the highest in the world, with 117 new deaths recorded on Tuesday.

Ninety-one percent of these deaths were among people who had not received full vaccinations. According to Bloomberg, which used data from Johns Hopkins University, Hong Kong has the highest mortality rate among high income countries. Meanwhile, in New Zealand, Director-General of Health Dr. Ashley Bloomfield announced that there were almost 100,000 COVID-19 active cases across the motu, with peak cases and hospitalizations likely to occur in the next few days. “I know corona omicron indonesia such a high daily case number can be concerning for people to hear, and many of us will now have whānau members who now have COVID-19, but it’s important to remember that COVID-19 now is a very different foe to what it was at the beginning of the pandemic,” Dr.

Bloomfield said. Read more about these stories here and here. 03/01/2022 14:20 GMT — Pfizer vaccine only 12% effective in 5–11-year-old kids According to new data that Pfizer-BioNTech released, the COVID-19 vaccine is only 12% effective against Omicron infections in children aged 5–11 years. The protection wanes off more quickly and steeply than in children and adolescents aged 12–17 years, the data show.

The information appears as a study on the preprint server MedRXiv and has not yet undergone peer review. Specifically, between December 13, 2021, and January 30, 2022, the vaccine effectiveness dropped from 66% to 51% in 12–17-year-olds and from 68% to 12% in 5–11-year-olds. “However, vaccination of children 5–11 years was protective against severe disease and is recommended,” the preprint study concludes.

Read more about the study here. 02/28/2022 14:20 GMT — SARS-CoV-2 came from Wuhan market and not Chinese lab, twin studies say Two new studies ( 1, 2) are adding to evidence that SARS-CoV-2, the virus that sparked the COVID-19 pandemic, came from a market in Wuhan and not a Chinese government laboratory. Although the studies have not yet undergone peer review, they make it “extraordinarily clear” that the site of origin was Huanan Seafood Wholesale Market, according to Michael Worobey, an evolutionary biologist and co-author of both studies.

The research examines the geographical clusters of the earliest known COVID-19 cases and links them to genetic samples collected from the market and the first COVID-19 patients.

A joint study that China and the World Health Organization (WHO) conducted last year had already ruled out the theory that SARS-CoV-2 was engineered in a lab. Read MNT‘s previous coverage on the origins of SARS-CoV-2 here. 02/28/2022 11:30 GMT — COVID-19 and dementia: Is there a link? COVID-19 causes mild to moderate symptoms in most people, but in some individuals, the after-effects can linger for months.

Some of these effects are neurological, with possible symptoms including brain fog, anxiety, and difficulties with memory. This has led scientists to investigate whether COVID-19 could increase the risk of dementia. MNT explores the evidence so far. Read more here. 02/25/2022 15:10 GMT — Emergency room visits among teenage girls doubled during the pandemic Emergency rooms across the United States reported a significant increase in the number of visits from teenage girls dealing with eating disorders and other mental health conditions during the COVID-19 pandemic, according to the latest research from the Centers for Disease Control and Prevention (CDC).

The agency said that it observed this troubling trend among girls aged 12–17 years, which was worsened by pandemic-related stressors such as the “lack of structure in daily routine, emotional distress, and changes in food availability.” Corona omicron indonesia girls also made more visits for depression and obsessive-compulsive disorder in 2021, the data showed.

Read more here about how the pandemic has affected eating habits. 02/25/2022 09:04 GMT — COVID-19 and disordered eating: How the pandemic has impacted eating habits In a new feature, Medical News Today investigates whether the COVID-19 pandemic has adversely affected people’s eating patterns.

To explore this topic, we speak with two experts to help determine the relationship between disordered eating and the pandemic. Read the full feature here. 02/25/2022 09:03 GMT — Beyond Omicron: Corona omicron indonesia vaccines, transmission will shape the next variant In a recent article, Medical News Today spoke with experts about what the future of SARS-CoV-2 might hold. We ask whether the next variant will be weaker than Omicron, discuss endemicity, and corona omicron indonesia how vaccination might impact future variants.

Read more here. 02/25/2022 08:36 GMT — Sanofi and GSK seek approval for new COVID-19 vaccine Sanofi and GSK have announced positive results from late stage trials on their experimental COVID-19 vaccine. They plan to seek approval from the Food and Drug Administration (FDA) and the European Medicines Agency.

As the vaccine is protein-based rather than mRNA-based, it is easier corona omicron indonesia transport and store. According to the press release, in phase 3 efficacy trials, the vaccine was 100% effective against severe COVID-19 and hospitalization and 77% effective against moderate to severe disease.

However, it is worth noting that there were relatively few cases of severe Corona omicron indonesia among the trial participants. Once the trial is over later this year, the pharmaceutical companies plan to publish their data in a peer-reviewed journal. 02/24/2022 10:29 GMT — COVID-19 vaccines and blood clots: Two large studies investigate Two large studies have found a small increase in the absolute risk of rare blood clots called intracranial venous thromboses following a first dose of the AstraZeneca vaccine.

The authors stress, however, that the benefit of vaccination — its capacity to protect against severe COVID-19 — far corona omicron indonesia the risks. They found no evidence of increased risks following a first dose of the Pfizer-BioNTech vaccine.

Read more about the studies here. 02/24/2022 10:10 GMT — COVID-19 survivors: Increased risk of mental health issues A study tracking COVID-19 survivors found them more likely to develop mental health issues than other people over the year following diagnosis.

The researchers saw an increased risk even for those whose COVID-19 was mild enough that they did not require hospitalization. Read more about the study here. 02/24/2022 09:56 GMT — SARS-CoV-2 infection damages hamsters’ testicles In a recent study, scientists infected hamsters with SARS-CoV-2. They compared any changes in the hamsters’ testicles with those of hamsters infected by an influenza virus.

In the hamsters with SARS-CoV-2, the team identified a “varying degree of testicular inflammation, hemorrhage, and necrosis” and a reduced ability to produce sperm.

Although this was an animal study, the authors believe that “Long term follow-up of sperm count and sex hormone profile of convalescent COVID-19 males is warranted.” Find more live COVID-19 updates here. 02/23/2022 16:55 GMT — 3 doses of COVID-19 vaccine 99% effective against hospitalization with Omicron, Delta Three doses of Moderna’s COVID-19 vaccine were more than 99% effective against hospitalization with the Omicron or Delta variant, according to a new study in Nature Medicine.

However, while 3 doses were 75.5% effective against Omicron infection for people with a healthy immune system, this figure dropped to 29.4% for people with a compromised immune system. The study also showed that vaccine effectiveness against Omicron infection waned within 3 months of the second dose.

The researchers suggested a shorter interval between the second and third doses and follow-ups for people with a weakened immune system.

Read more COVID-19 updates here. 02/23/2022 10:18 GMT — UK to offer extra COVID-19 booster to most vulnerable people The United Kingdom’s Joint Committee on Vaccination and Immunisation (JCVI) has said it will start offering an additional dose of COVID-19 booster to people with a higher risk of severe disease this spring. Under the new plan, people aged 75 and above, residents in care homes for older adults, and those aged 12 or older who have weakened immune systems, or immunosuppression, will be eligible for the additional booster.

For older populations, this will be the fourth dose, and it will be the fifth for people with weakened immunity. The additional booster will be available 6 months after the most recent dose. The JCVI also said a further booster will likely be recommended for those at high risk in fall 2022. Read more corona omicron indonesia here. 02/23/2022 09:50 GMT — Corbevax COVID-19 vaccine gets emergency approval for 12–18 year-olds in India Corbevax, a protein subunit vaccine manufactured by Biological E., became India’s third COVID-19 vaccine to be approved for children aged 12–18.

The announcement came on Monday after the Health Ministry gave emergency use authorization (EUA) for the vaccine. Corbevax now joins Zydus Cadila’s ZyCoV-D and Bharat Biotech’s Covaxin vaccines that have EUA for use in children aged 12 and above. Corbevax had received EUA for use in adults in late December. Read more about globally authorized COVID-19 vaccines here. 02/23/2022 09:30 Corona omicron indonesia — Does Omicron infection protect against other variants? Since Omicron became so widespread worldwide, scientists have been trying to determine whether having an Omicron infection could protect against other variants.

Researchers from South Africa carried out a study and found that people who were vaccinated against COVID-19 and then contracted the Omicron variant had increased protection against both the Delta and Beta variants.

Meanwhile, those who were unvaccinated but had contracted Omicron mounted immunity only to Omicron infections. Read more of MNT‘s coverage of the study here. 02/22/2022 16:00 GMT — Can brain stimulation treat long COVID ‘brain fog’? Researchers at the SAVIR-Center in Magdeburg, Germany, tested the benefits of noninvasive brain stimulation for improving long COVID symptoms — such as “brain fog” and visual impairment — in two people. Both showed improvement in cognitive tests after treatment, as well as improvement in visual field loss.

Read MNT’s full coverage here. 02/22/2022 15:30 GMT — COVID-19 during pregnancy: How the placenta is involved Two new studies have examined the placentas of women who had COVID-19 while pregnant to understand the effect of the coronavirus on this organ and on maternal and birth outcomes after SARS-CoV-2 infection.

One of the studies documented cases of so-called placentitis — an inflammation of the placenta in pregnant mothers with COVID-19 — which led to stillbirths. The other study examined the “defense mechanisms” that the placenta puts into place to combat SARS-CoV-2 infection and prevent maternal-fetal transmission.

Read MNT’s full coverage of the two studies here. 02/22/2022 15:00 GMT — CDC: 2-dose vaccination during pregnancy 61% effective against hospitalization in infants The Centers for Disease Control and Prevention (CDC) have issued a report that explains the effectiveness of vaccination during pregnancy against hospitalizing infants with COVID-19.

The report uses case-control research conducted in 20 pediatric hospitals in 17 states during July 1, 2021 and January 17, 2022. The research involved 379 hospitalized infants younger than 6 months: 176 had COVID-19, and 203 did not, acting as controls.

The CDC report notes that maternal completion of 2 doses of an mRNA COVID-19 vaccine was corona omicron indonesia effective at preventing COVID-19 hospitalization among infants younger than 6 months. Completing the vaccination cycle early in the pregnancy yielded an effectiveness of 32% while completing it later in the pregnancy had an 80% effectiveness. Read the full report here. 02/21/2022 15:44 GMT — England will offer vaccine to 5–11-year-olds In England, the Joint Committee on Vaccination and Immunisation has concluded that, since a “very small number of children [experience] serious illness and hospitalization” with a SARS-CoV-2 infection, they would benefit from receiving a COVID-19 vaccine.

As a result, health services in England will soon offer low dose COVID-19 vaccines to children aged 5–11 years. Children whose parents decide to immunize them against SARS-CoV-2 will receive two 10 microgram doses of the Pfizer/BioNTech vaccine at an interval of at least 12 weeks. “The [National Health Services] will prepare to extend this nonurgent offer to all children during April, so parents can, if they want, take up the offer to increase protection against potential future waves of COVID-19 as we learn to live with this virus,” Health Secretary Sajid Javid corona omicron indonesia said.

02/21/2022 15:25 GMT — COVID-19: Why vitamin D levels may be key A recent study that appears in PLOS ONE suggests that people with low vitamin D levels prior to contracting SARS-CoV-2 may be more likely to develop severe COVID-19. The risk of severe disease for those with vitamin D deficiency is 14 times higher than that of their peers, the study indicates.

However, researchers not involved in this study point out that the way in which appropriate levels of vitamin D might help mitigate the risk of severe COVID-19 remains unclear. Read more about this study here. 02/21/2022 15:25 GMT — Italy recommends fourth shot corona omicron indonesia some On Sunday, February 20, Italy’s ministry of health announced that it will soon recommend a second mRNA vaccine booster dose — or a fourth shot — for people with weakened immune systems.

The guidance for the second booster indicates that it should be administered at least 120 days after the last COVID-19 vaccine dose. This news coincides with a report that Italy registered as many as 42,081 new COVID-19 cases on Sunday. 02/21/2022 13:37 GMT — UK to eliminate self-isolation requirement The United Kingdom’s prime minister, Boris Johnson, has announced that he intends to remove the requirement to self-isolate for people who test positive for SARS-CoV-2. This further easing of pandemic-related restrictions is set to occur this week.

Currently, people in the U.K. who have COVID-19 symptoms or test positive for a SARS-CoV-2 infection are required by law to self-isolate for at least 5 days.” Covid will not suddenly disappear, and we need to learn to live with this virus and continue to protect ourselves without restricting our freedoms,” Johnson states.

02/18/2022 11:25 GMT — COVID-19 case numbers declining but still high in the US The number of COVID-19 cases in corona omicron indonesia United States is dropping sharply. The U.S. is averaging roughly 140,000 new cases each week, which is a 64% reduction over the last 2 weeks. The number of deaths is dropping less sharply — roughly 2,300 corona omicron indonesia each day, a decline of 13% in 2 weeks.

Find information on the latest COVID-19 research here. 02/18/2022 09:18 GMT — UK: NHS Confederation speaks out against PM’s COVID-19 exit strategy Boris Johnson, the prime minister of the United Kingdom, is expected to scrap free tests and self-isolation rules on Monday.

The National Health Service (NHS) Confederation recently announced that, according to a survey, 75% of senior NHS staff in England do not want self-isolation rules to end. Discussing the survey’s results, the NHS Confederation writes that “Over 90% of more than 300 health leaders who responded showed strong support for the continued provision of free tests for key workers and the public, as well as retaining the use of masks in healthcare settings.” 02/18/2022 09:02 GMT — Long COVID: Risk factors and how to mitigate them After recovering from COVID-19, many people experience long-term symptoms.

This syndrome is known as long COVID. In a recent feature, Medical News Today spoke with three experts about the risk factors for this condition and whether people can help mitigate some of these risks. Read the full feature here. 02/17/2022 09:30 GMT — Can COVID-19 vaccines teach T cells to recognize Omicron? A recent study investigated whether T cells, which COVID-19 vaccines induce, recognize variants of the SARS-CoV-2 virus. T cells play a crucial role in the immune response against disease.

The results of the study suggest that SARS-CoV-2 variants of concern — including Delta and Omicron — are effectively recognized by T cells in the body. Read more about this study here. 02/17/2022 09:29 GMT — How does COVID-19 affect the heart? A new study, which appears corona omicron indonesia Nature Medicine, takes a close look at the incidence of heart conditions following COVID-19.

The researchers find evidence of a wide range of heart issues for up to 1 year after recovery. Read more about the research here. 02/16/2022 14:30 GMT — Vaccines reduce long COVID risk and may ease symptoms in unvaccinated people, UK data show A large review of 15 studies by the United Kingdom’s Health Security Agency has shown not only that people who have received one or more doses of a COVID-19 vaccine are less likely to develop long COVID but also that getting vaccinated can reduce symptoms among those previously unvaccinated.

In the studies on long COVID symptoms, fully vaccinated people were less likely than unvaccinated people to develop long-term symptoms, such as fatigue, muscle pain, shortness of breath, and loss of smell. The review also found that, on average, unvaccinated people living with long COVID saw an improvement in their symptoms after vaccination or had fewer symptoms overall than those who remained unvaccinated.

Scientists say that vaccines may achieve this by clearing the remaining viruses or viral particles in the body, and thereby reducing inflammation. However, some unvaccinated people with long COVID reported worsened symptoms after getting the vaccine. Read more about long COVID in the U.K. here. 02/16/2022 14:10 GMT — UK trial seeks volunteers for Omicron-specific vaccine A new vaccine trial in the United Kingdom is looking for around 3,000 volunteers to test a COVID-19 vaccine booster created specifically to target the Omicron variant.

Half of these volunteers will receive a dose of Moderna’s current booster, Spikevax, and the remaining participants will receive an updated formula containing genetic material that specifically fights the Omicron variant. Participants must not have tested positive for SARS-CoV-2 since November 2021 and must have had their last vaccine dose at least 3 months ago. The clinical trial will be led by a team at St George’s Hospital, in London, and it starts this week.

Moderna is currently conducting a similar trial in the United States. Pfizer is also expected to launch its trial for an Omicron-specific booster. Read more about the trial here. 02/16/2022 12:10 GMT — 3 doses of Pfizer–BioNTech COVID-19 vaccine more effective than 2 A new study has shown that a third dose of the Pfizer–BioNTech COVID-19 vaccine is much more effective in preventing infection and hospitalization compared with 2 doses alone, even months after being vaccinated.

The research, which appears in the journal The Lancet Regional Health – Americas, found that the effectiveness of 3 doses was 88% against infection corona omicron indonesia 97% against hospitalization within the first 3 months. Meanwhile, the effectiveness of 2 doses against infection declined from 85% to 49% up to 8 months following vaccination. The study adds to research showing the importance of boosters, especially for people aged 75 years or older and those with a compromised immune system.

Read more COVID-19 updates here. 02/16/2022 11:30 GMT — mRNA boosters after CoronaVac almost triple protection against COVID-19 A booster dose of the Pfizer-BioNTech COVID-19 vaccine administered 6 months after two doses of the CoronaVac vaccine greatly increases immunity, a study has found.

Inactivated virus vaccines are some of the world’s most widely used COVID-19 vaccines. However, studies have shown that the CoronaVac and Sinopharm vaccines have failed to retain high protection against infection with newer SARS-CoV-2 variants.

The researchers found that the third dose increased effectiveness against infection to 92.7%, up from 34% provided by 2 doses. The findings support administering an mRNA booster vaccine dose after two doses of CoronaVac, particularly for the elderly, as has been the case in countries like Brazil, Turkey, and Indonesia.

Read more about CoronaVac here. 02/15/2022 14:45 GMT — Two antibiotics may have an antiviral effect against COVID-19 A new, small study suggests that treating COVID-19 with a combination of either of two antibiotics plus one steroid may be as effective as standard care and cause fewer side effects.

The combination involved either the antibiotic ceftazidime or the antibiotic cefepime plus the steroid dexamethasone. By comparison, standard care may involve seven or more different drugs.

However, healthcare professionals and researchers continue to stress that antibiotics are rarely effective against corona omicron indonesia and highlight the dangers of overusing these drugs for antibiotic resistance. Read MNT’s full coverage of the new study here. 02/15/2022 12:30 GMT — Almost one-third of older adults develop new conditions after COVID-19 A new study finds that almost 1 in 3 older adults who received a COVID-19 diagnosis went on to develop new conditions in the long term, compared with one-fifth of older adults who never had COVID-19.

In older adults, COVID-19 raised the risk of conditions including respiratory failure, fatigue, high blood pressure, memory problems, kidney injury, mental health diagnoses, heart rhythm disorders, and hypercoagulability — which is when blood clots tend to form more easily.

The risk of these conditions, or sequelae, was much lower in people who had less severe disease. Head here for MNT’s full study coverage, which features interviews with the study author and other experts. 02/15/2022 12:20 GMT — Booster protection wanes after 4 months, CDC report finds A new report issued by the Centers for Disease Control and Prevention (CDC) has found that the effectiveness of mRNA vaccines was higher after the booster shot than after the second vaccine dose but that it started waning by the fourth month.

The report examined the effectiveness of mRNA vaccines against COVID-19-related emergency unit visits and hospitalizations in the period when Omicron was the predominant variant. The researchers found that in the first 2 months after the third, booster, dose, this effectiveness was at 87% for emergency care visits and 91% for hospitalizations. However, this dropped to 66% and 78%, respectively, by the fourth month.

Read the full CDC report here. 02/14/2022 12:37 GMT — How are COVID-19 deaths counted, and what does this mean? In slightly more than 2 years, authorities have recorded 5.75 million COVID-19 deaths worldwide. Some people believe that this is an overestimate of the actual mortality from the disease.

Others think COVID-19 has caused many more deaths than the official figures show. Most countries record every death and its cause, providing a permanent legal record. The doctor who records the death must note the primary cause and any contributing factors on the death certificate. Medical News Today has looked at the evidence and spoken with experts to uncover the truth behind the numbers.

“My view is that the current number of COVID-19 deaths is an undercounting simply because those deaths reflect the ones we know about, and not every death caused by this disease was recorded or diagnosed as such,” Dr. Arturo Casadevall, a distinguished professor and chair of molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, told MNT.

Read our Special Feature in full here. 02/14/2022 12:21 GMT — Sweden recommends second booster dose for older adults The Health Agency of Sweden now recommends that all adults aged 80 years and over receive a second booster dose of a COVID-19 vaccine, administered at least 4 months after the first.

For many, this would be the fourth dose to date. “A booster dose strengthens protection. Therefore we believe people 80 years or older will benefit from a second booster dose,” chief epidemiologist Anders Tegnell has said. Five COVID-19 vaccines currently have authorization in Sweden: Oxford-AstraZeneca’s Vaxzevria, Johnson & Johnson’s Janssen vaccine, Pfizer-BioNTech’s Comirnaty, Moderna’s Spikevax, and Novavax’s Nuvaxovid. 02/14/2022 11:50 GMT — Singapore grants interim authorization for Nuvaxovid On Monday, February 14, the Health Sciences Authority (HSA) of Singapore announced that it has granted interim authorization for the use of the Novavax COVID-19 vaccine, Corona omicron indonesia.

Nuvaxovid will be delivered to those aged 18 years and older, and according to the HSA, “The first batch of [vaccine doses] is expected to arrive in Singapore in the next few months.” Read about Nuvaxovid and its potential side effects here. 02/11/2022 09:22 GMT — Could antihistamines help treat long COVID? A recent paper describes the experiences of two corona omicron indonesia with long COVID whose symptoms improved after taking over-the-counter antihistamines.

According to the study, both experienced “significant improvement in symptoms and ability to perform activities of daily living.” The authors hope that others will run larger studies to investigate further. Find more live updates here. 02/11/2022 09:01 GMT — Household transmission: SARS-CoV-2 particles found outside of self-isolation rooms A recent study investigated whether airborne SARS-CoV-2 particles were present outside of isolation rooms in homes corona omicron indonesia one household member with a positive test result.

The researchers found that aerosols of small respiratory droplets containing airborne SARS-CoV-2 RNA were present both inside and outside of these rooms. Read MNT’s coverage of the research here. © 2004-2022 Healthline Media UK Ltd, Brighton, UK, a Red Ventures Company. All rights reserved. MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.

See additional information. © 2004-2022 Healthline Media UK Ltd, Brighton, UK, a Red Ventures Company. All rights reserved. MNT is the registered corona omicron indonesia mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.

See additional information. • Jika Anda pernah menderita COVID-19 dan memiliki gejala, isolasi setidaknya selama 5 hari. Untuk menghitung periode isolasi 5 hari Anda, hari 0 adalah hari pertama gejala Anda. • Jika Anda tidak lagi memiliki gejala corona omicron indonesia gejala Anda membaik setelah lima hari, Anda dapat meninggalkan tempat isolasi atau keluar dari rumah Anda.

• Tetap gunakan masker saat Anda bersama orang lain selama lima hari ke depan. • Hindari bepergian sampai 10 hari penuh setelah hari pertama mengalami gejala. Jika Anda harus bepergian pada hari ke 6-10, pakai masker yang ketat saat Anda berada di sekitar orang lain selama perjalanan. • Jika Anda demam, terus isolasi di rumah sampai demamnya hilang.
This article needs more medical references for verification or relies too heavily on primary sources.

Please review the contents of the article and add the appropriate references if you can. Unsourced or poorly sourced material may be challenged and removed. Find sources: "SARS-CoV-2 Omicron variant" – news · newspapers · books · scholar · JSTOR ( December 2021) • Asymptomatic infection [1] • Body ache [1] • Cough [1] • Fainting [2] • Fatigue [3] • Fever [4] • Headache [5] • Loss of smell or taste [6] [7] — less common • Nasal congestion or running nose [5] • Night sweats [8] — unique Omicron symptom • Upper respiratory tract infection [9] • Skin rash [10] • Sneezing [11] • Sore throat [2] Cases map 2019 2020 • January • responses • February • responses • March • responses • April • responses • May • responses • June • responses • July • responses • August • responses • September • responses • October • responses • November • responses • December • responses 2021 • January • responses • February • responses • March • responses • April • responses • May • responses • June • responses • July • responses • August • responses • September • responses • October • responses • November • responses • December • responses 2022 • January • responses • February • responses • March • responses • April • responses • May • responses • Disease testing • Breathalyzer • Development • Drug development • Drug repurposing • Public health mitigation Vaccines • History • Research • VITT • Deployment • Authorizations • Operation Warp Speed • Misinformation and hesitancy • US • Vaccine card • Vaccine passports Current vaccines • CoronaVac • Covaxin • Convidecia • Janssen • Medigen • Moderna • Novavax • Oxford–AstraZeneca • Pfizer–BioNTech • Sinopharm BIBP • Sputnik V • Arts and culture • Aviation • Cannabis • Cinema • films • Disney • Fashion • Financial markets • Food industry • Food security • Journalism • Music • Performing arts • Retail • Shipping • Television • US • sportscasting • programs • Tourism • Video games By country • Canada • India • Ireland • Malaysia • New Zealand • Russia • UK corona omicron indonesia US By sport • Association football • Baseball • Basketball • Combat sports • Cricket • Disc golf • Gaelic games • Gridirion football • Ice hockey • Motorsport • Rugby league • v • t • e The Omicron variant (B.1.1.529) is a variant of SARS-CoV-2 (the virus that causes COVID-19) that was first reported to the World Health Organization (WHO) from South Africa on 24 November 2021.

[12] [13] Omicron multiplies around 70 times faster than the Delta variant in the bronchi ( lung airways) but evidence suggests it is less severe than previous strains, especially compared to the Delta variant. [14] [15] Omicron might be less able to penetrate deep lung tissue. [16] Omicron infections are 91 percent less fatal than the delta variant, with 51 percent less risk of hospitalization.

[17] However, the estimated difference in the intrinsic risk of hospitalization largely decreases to 0–30 corona omicron indonesia when reinfections are excluded.

[18] Overall, the extremely high rate corona omicron indonesia spread, combined with its ability to evade both double vaccination and the body's immune system, means the total number of patients requiring hospital care at any given time is still of great concern. [16] Vaccines continue to provide protection against severe disease and hospitalisation especially after a third dose of an mRNA vaccine is given.

[19] [20] Early figures suggest that double vaccination offers 30 to 40 percent protection against infection and around 70 percent protection against hospitalization.

A recent third vaccine dose boosts effectiveness against infection to around 75 percent, and 88 percent for severe disease. [21] Contents • 1 Classification • 1.1 Nomenclature • 1.2 Mutations • 1.2.1 Sublineages and BA.2 subvariant • 1.2.1.1 Detection • 1.2.1.2 Affected countries and transmissibility • 1.2.1.3 Severity and immunity • 1.3 Possible consequences • 1.4 In non-human animals • 2 Signs and symptoms • 3 Characteristics • 3.1 Contagiousness • 3.1.1 Immune evasion • 3.2 Virulence • 4 Diagnosis • 4.1 PCR testing • 4.2 Rapid antigen testing • 5 Prevention • 6 Treatment • 7 Epidemiology • 8 Statistics • 9 History • 9.1 Reported cases • 9.2 Market reactions • 9.3 International response • corona omicron indonesia See also • 11 Notes • 12 References • 13 Further reading • 14 External links Omicron variant and other major or previous variants of concern of SARS-CoV-2 depicted in a tree scaled radially by genetic distance, derived from Nextstrain on 1 December 2021 Nomenclature On 26 November, the WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution declared PANGO lineage B.1.1.529 a variant of concern and designated it with the Greek letter omicron.

[12] [22] Greek letters are used to identify variants of SARS-CoV-2. The WHO skipped the preceding letters nu and xi in the Greek alphabet to avoid confusion with the similarities of the English word "new" and the Chinese surname Xi. [22] [23] [24] The previous designation was for the "variant of interest" Mu.

[25] [26] Possibly due to a lack of familiarity with the Greek alphabet among some English speakers and the relative frequency of the Latin prefix " omni" in other common speech, corona omicron indonesia name of the variant has also occasionally been mispronounced and misspelled as "Omnicron". [27] [28] The GISAID project has assigned it the clade identifier GR/484A, [29] and the Nextstrain project has assigned it the clade identifiers 21K and 21L, both belonging to a larger Omicron group 21M.

[30] The genomic sequence of the Omicron variant is pictured above. Defining mutations in the SARS-CoV-2 Omicron variant Gene Amino acid ORF1ab nsp3: K38R nsp3: V1069I nsp3: Δ1265 nsp3: L1266I nsp3: A1892T nsp4: T492I nsp5: P132H nsp6: Δ105-107 nsp6: A189V nsp12: P323L nsp14: I42V Spike A67V Δ69-70 T95I G142D, Δ143-145 Δ211 L212I ins214EPE G339D S371L S373P S375F K417N N440K G446S S477N T478K E484A Q493R G496S Q498R N501Y Y505H T547K D614G H655Y N679K P681H N764K D796Y N856K Q954H N969K L981F E T9I M D3G Q19E A63T N P13L Δ31-33 R203K G204R Sources: UK Health Security Agency [31] CoVariants [30] The variant has many mutations, some of which have concerned scientists.

[32] The Omicron variant has a total of 60 mutations compared to the reference / ancestral variant: 50 nonsynonymous mutations, 8 synonymous mutations, and 2 non-coding mutations. [33] Thirty-two mutations affect the spike protein, the main antigenic target of antibodies generated by infections and of many vaccines widely administered. Many of those mutations had not been observed in other strains. [34] [35] The variant is characterised by 30 amino acid changes, three small deletions, and one small insertion in the spike protein compared with the original virus, of which 15 are located in the receptor-binding domain (residues 319–541).

It also carries a number of changes and deletions in other genomic regions. Additionally, the variant has three mutations at the furin cleavage site. [36] The furin cleavage site increases SARS-CoV-2 infectivity. [37] The mutations by genomic region are the following: [38] [39] Illustration of the locations of the Omicron mutations in the spike protein, top view (left) and side view (right), showing amino acid substitutions (yellow), deletions (red), and insertions (green).

In this trimeric structure, two monomers (gray and light blue) have their receptor-binding domains in the "down" conformation while one (dark blue) is in the "up" or "open" conformation. Mutation data from WHO, [12] structure from PDB: 6VYB​.

[40] • Spike protein: A67V, Δ69-70, T95I, G142D, Δ143-145, Δ211, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F • Half (15) of these 30 changes are located in the receptor binding domain-RBD (residues 319–541) • ORF1ab • nsp3: K38R, V1069I, Δ1265, L1266I, A1892T • nsp4: T492I • nsp5: P132H • nsp6: Δ105-107, A189V • nsp12: P323L • nsp14: I42V • Envelope protein: T9I • Membrane protein: D3G, Q19E, A63T • Nucleocapsid protein: P13L, Δ31-33, R203K, Corona omicron indonesia A link with HIV infection may explain a large number of mutations in the sequence of the Omicron variant.

[41] [ unreliable medical source?] Indeed, in order to be affected by such a high number of mutations, the virus must have been able to evolve a long time without killing its corona omicron indonesia, nor being eliminated. One such situation occurs in people with a weakened immune system but receiving enough medical care to survive. [42] This is the case in HIV patients in South Africa, who represent more than 20% of the population. [43] Due to lack of access to clinics, fear of stigmatisation and disrupted healthcare, millions living with HIV in the region are not on effective HIV therapy.

HIV prevention could be key to reducing the risk of uncontrolled HIV driving the emergence of Covid variants. [44] In addition, it is believed that one of these many corona omicron indonesia, comprising a 9- nucleotide sequence, may have been acquired from another coronavirus (known as HCoV-229E), responsible for the common cold. [45] This is not entirely unexpected — at times, viruses within the body acquire and swap segments of genetic material from each other, and this is one common means of mutation.

[45] One hypothesis to explain the novel mutations is that SARS-CoV-2 was transmitted from humans to mice and mutated in a population of mice sometime between mid-2020 and late 2021 before reinfecting humans.

[46] Sublineages and BA.2 subvariant Researchers have established the existence of three sublineages of Omicron. The 'standard' sublineage is now referred to as BA.1 (or B.1.1.529.1), and the two other sublineages are known as BA.2 (or B.1.1.529.2) and BA.3 (or B.1.1.529.3).

[47] They share many mutations, but also significantly differ. In general, BA.1 and BA.2 share 32 mutations, but differ by 28. [48] This makes them as different as some other major variants, [49] and it has been suggested that BA.2 should receive its own Greek-letter name. [48] BA.1 has itself been divided in two, the original BA.1 and BA.1.1, where the main difference is that the latter has a R346K mutation. [50] [51] A laboratory study on hamsters and mice in Japan published as a non-peer-reviewed preprint in mid-February 2022 suggested that BA.2, is not only more transmissible than BA.1, but may cause more severe disease.

Therapeutic monoclonal antibodies used to treat people infected with COVID did not have much effect on BA.2, which was "almost completely resistant" to casirivimab and imdevimab, and 35 times more resistant to sotrovimab than the original B.1.1 virus. The researchers proposed that BA.2 should be recognised as a unique variant of concern, [52] [53] which would be given its own Greek letter.

Detection Ordinary COVID-19 tests, both PCR and rapid, can detect all Omicron subvariants as COVID-19, but further tests are necessary to distinguish the subvariants from each other and from other COVID-19 variants. [54] A notable difference between the 'standard' Omicron subvariant and BA.2 is that the latter lacks the characteristic S-gene target failure (SGTF)-causing deletion (Δ69-70) by which many qPCR tests are able to rapidly detect a case as an Omicron (or Alpha) variant, from the previously dominant Delta variant.

[55] [56] Thus, countries that primarily rely on SGTF for detection may overlook BA.2, [55] and British authorities consider SGTF alone as insufficient for monitoring the spread of Omicron. [57] This has resulted in it having been nicknamed 'Stealth Omicron'.

[57] Because BA.2 still can be separated from other variants through normal full sequencing, or checks of certain other mutations, the corona omicron indonesia is however inaccurate. [48] corona omicron indonesia Some countries, such as Denmark and Japan, use a variant corona omicron indonesia that tests for several mutations, including L452R.

[58] [59] It can also distinguish Delta, which has L452R, [60] and all Omicron sublineages, which do not have L452R. [61] [62] As Omicron became dominant and the Delta variant became rare, the SGTF mutation that had made Delta and BA.2 similar in qPCR tests could now be used for easily separating BA.1 and BA.2 from each other.

As a consequence, BA.2 could now be regarded as decidedly un-stealthy. [63] The third Omicron sublineage, BA.3, is very rare. It has the same SGTF deletion (Δ69-70) as BA.1. [64] [65] In April 2022 the WHO announced it was tracking BA.4 and BA.5 subvariants with BA.4 having been detected in South Africa, Botswana, Denmark, Scotland and England. [66]Early indications from data collected in South Africa suggested BA.4 and BA.5 have a significant growth advantage over BA.2.

[67] In addition, there were two new subvariants detected in the US state of New York, which are BA.2.12 and BA.2.12.1, [68] [69] both of which have a significant growth advantage of 23-27% over BA.2 and contributing to a rise in infections in central New York, centred on Syracuse and Lake Ontario. [70] Affected countries and transmissibility According to early research, BA.2 is roughly 30% to 60% more transmissible than BA.1. [71] [72] As a consequence, it may prolong a COVID-19 wave when it overtakes BA.1, [73] although it is difficult to assess what part is caused by the higher transmissibility of BA.2 in countries that simultaneously reduce restrictions (allowing easier transmission than in earlier periods with more restrictions).

[74] A new BA.1–BA.2 recombinant isolated from the UK in January 2022, dubbed the "XE" recombinant, was found by the WHO to be potentially 10% more transmissible than BA.2, making it about 43% to 76% to more transmissible than BA.1, and making the XE recombinant the most contagious variant identified. [75] [76] On 7 April 2022 Brazilian authorities announced the first detected case of a person infected with Omicron XE. [77] The first known sequence of BA.2 was in a sample from 15 November 2021.

[78] In mid-December 2021, BA.2 still appeared to be rare with relatively few sequences from half a dozen countries having been uploaded to GISAID, but subsequently numbers rapidly increased. As of 17 January 2022, BA.2 corona omicron indonesia been detected in at least 40 countries and in all continents except Antarctica. [62] [79] By 31 January, it had been detected in at least 57 countries. [80] In global samples collected from 4 February to 5 March and uploaded to GISAID, BA.2 accounted for c.

34%, compared to 41% for BA.1.1, 25% for BA.1 and less than 1% for BA.3. [81] In a review two weeks later, covering 16 February to 17 March, BA.2 had become the most frequent. [82] However, the data is geographically skewed due to sequencing rate and speed; for example, among the c. 205,000 COVID-19 sequences from March that had been uploaded to GISAID as of 22 March, United Kingdom and Denmark accounted for more than 3⁄ 4, and most of the remaining were from other European countries, Australia, Canada and the United States (altogether, c.

6,000 were from Africa, Asia and Latin America). [83] Based on GISAID corona omicron indonesia, BA.1 peaked in early January 2022, after which it was overtaken by both BA.1.1 and BA.2. [84] In North America, parts of Europe and parts of Asia, BA.1 was first outcompeted by BA.1.1. For example, in the United States, France and Japan, BA.1.1 became the dominant subvariant in January 2022. [85] [86] [87] By late December 2021/early January 2022, BA.2 appears to have become dominant in at least parts of India (already making up almost 80 percent in Kolkata in late December 2021 [88]) and the Philippines, had become frequent in Scandinavia, South Africa and Singapore, and was showing signs of growth corona omicron indonesia Germany and the United Kingdom.

[89] [90] [91] [92] In Japan, which has quarantine and detailed screening of all international travellers, as of 24 January, the vast majority of BA.2 had been detected in people that had arrived from India or the Philippines with cases going back at least to 1 December 2021 (far fewer BA.1 or other variants were detected among arrivals from the two countries in that period), but small numbers had also been detected in people arriving from other countries.

[59] [93] [94] In Denmark, the first BA.2 was in a sample collected on 5 December 2021 and extremely few were found in the directly following period. [95] By week fifty (13–19 December) it had started to increase, with BA.2 being at around 2 percent of sequenced cases compared to 46 percent BA.1 (remaining Delta). The frequency of both Omicron subvariants continued to increase throughout the last half of December; in week fifty-two (27 December–2 January), BA.2 had reached 20 percent and BA.1 peaked at 72 percent.

In January 2022, BA.1 began decreasing, whereas BA.2 continued its increase. By the second week (10–16 January) of 2022, the frequency of the two was almost equal, both being near 50 percent (around one percent was the rapidly disappearing Delta).

[95] In the following week, BA.2 became clearly dominant in Denmark with 65 percent of new cases being the BA.2 corona omicron indonesia. [96] Trends from the other Scandinavian countries, India, South Africa and the United Kingdom also showed that BA.2 was increasing in proportion to the original BA.1.

[97] [98] In early February 2022, it had become the dominant subvariant in South Africa, in late February it had become corona omicron indonesia in Germany and in early March it had become dominant in the United Kingdom. [99] [100] [101] In early March, BA.1.1 was still heavily dominant in the United States (having overtaken BA.1 in January), but BA.2 was increasing in frequency, later becoming dominant in the US by March 29.

[85] [102] Severity and immunity The risk of hospitalization is the same in BA.1 and BA.2 based on reviews from Denmark, India, South Africa and the United Kingdom. [57] [81] [96] [103] Norwegian studies show that the amount of virus in the upper airways is similar in those infected with BA.1 and BA.2.

[98] In general, Omicron (all subvariants) have a higher reinfection rate than other COVID-19 variants. Studies from Denmark and Qatar found that after an infection with BA.1, the vast majority of people were well-protected against a BA.2 infection, although it is unknown how long this protection lasts. [81] [104] [105] Laboratory studies also show that antibodies for BA.1 generally corona omicron indonesia against BA.2.

[105] In Denmark, preliminary data found breakthrough rates in people that had been vaccinated that were similar to the breakthrough rates seen for BA.1. [96] An initial study by the UK Health Security Agency found that vaccines afford similar levels of protection against symptomatic disease by BA.1 and BA.2, and in both it is considerably higher after two doses and a booster than two doses without booster. [106] [107] Because of the gradually waning effect of vaccines, further, booster vaccination may later be necessary.

[101] Possible consequences This section needs to be updated. Please help update this article to reflect recent events or newly available information. ( April 2022) The WHO is concerned that the large number of mutations in Omicron compared to earlier variants may reduce immunity in people who were previously infected and in vaccinated people. It is also possible the Omicron variant might be more infective in this regard than prior variants.

The effects of the mutations, if any, are unknown as of late November 2021. The WHO warns that health services could be overwhelmed especially in nations with low vaccination rates where mortality and morbidity rates are likely to be much higher, and urges all nations to increase COVID-19 vaccinations.

[108] Professor Paul Morgan, immunologist at Cardiff University, also recommends vaccination. Morgan said, "I think a blunting rather than a complete loss [of immunity] is the most likely outcome.

The virus can't possibly lose every single epitope on its surface, because if it did that spike protein couldn't work corona omicron indonesia more. So, while some of the antibodies and T cell clones made against earlier versions of the virus, or against corona omicron indonesia vaccines may not be effective, there will be others, which will remain effective.

(.) If half, or two-thirds, or whatever it is, of the immune response is not going to be effective, and you're left with the residual half, then the more boosted that is the better." [109] Professor Francois Balloux of the Genetics Corona omicron indonesia at University College London said, corona omicron indonesia what we have learned so far, we can be fairly confident that – compared with other variants – Omicron tends to be better able to reinfect people who have been previously infected and received some protection against COVID-19.

That is pretty clear and was anticipated from the mutational changes we have pinpointed in its protein structure. These make it more difficult for antibodies to neutralise the virus." [110] On 15 December 2021, the European Centre for Disease Prevention and Control assessed that, even if the variant turns out to be milder than Delta, its spread will very likely increase hospitalizations and fatalities due to the exponential corona omicron indonesia in cases caused by increased transmissibility.

[111] On 23 December 2021, Nature indicates that, though Omicron likely weakens vaccine protection, reasonable effectiveness against Omicron may be maintained with currently available vaccination and boosting approaches. [112] [113] In non-human animals In February 2022, the first confirmed case infecting a wild animal was confirmed by researchers at Pennsylvania State University in white-tailed deer in Staten Island, N.Y.

[114] Signs and symptoms Main article: Symptoms of COVID-19 A unique reported symptom of the Omicron variant is night sweats. [8] Also, loss of taste and smell seem to be uncommon compared to other strains. [6] [7] A study performed between 1 and 7 December by the Center for Disease Control found that: "The most commonly reported symptoms [were] cough, fatigue, and congestion or runny nose" making it difficult to distinguish from a less damaging variant or other virus.

[115] Research published in London on 25 December 2021 suggested the most frequent symptoms stated by users of the Zoe Covid app were "a running nose, headaches, fatigue, sneezing and sore throats." [11] Characteristics Many of the mutations to the spike protein are present in other variants of concern and are related to increased infectivity and antibody evasion.

Computational modeling suggests that the variant may also escape cell-mediated immunity. [35] On 26 November, the ECDC wrote that an evaluation of the neutralizing capacity of convalescent sera and of vaccines is urgently needed to assess possible immune escape, saying these data are expected within two to three weeks. [39] Although transmission via fomites is rare, preliminary data indicate that the variant lasts for 194 hours on plastic surfaces and 21 hours on skin, compared with just 56 and 7 hours, respectively, for the ancestral Wuhan strain.

[116] [117] Contagiousness It was not known in November 2021 how the variant would spread in populations with high levels of immunity. It was also not known if the Omicron variant causes a milder or more severe COVID-19 infection.

According to pharmaceutical companies, vaccines could be updated to combat the variant "in around 100 days" if necessary. [118] Relating to naturally acquired immunity, Anne von Gottberg, an expert at the South African National Institute for Communicable Diseases, believed at the beginning of December 2021 that immunity granted by previous variants would not protect against Corona omicron indonesia.

[119] On 15 December 2021, Jenny Harries, head of the UK Health Security Agency, told a parliamentary committee that the doubling time of COVID-19 in most corona omicron indonesia of the UK was now less than two days despite the country's high vaccination rate.

She said that the Omicron variant of COVID-19 is "probably the most significant threat since the start of the pandemic", and that the number of cases in the next few days would be "quite staggering compared to the rate of growth that we've seen in cases for previous variants".

[120] In January 2022, William Schaffner, professor of infectious diseases at Vanderbilt University Medical Center, compared the contagiousness of the Omicron variant to the contagiousness of the measles. [121] Immune evasion Further information: Viral strategies for immune response evasion A study suggests that mutations that promote breakthrough infections or antibody-resistance "like those in Omicron" could be a new mechanism for viral evolution success of SARS-CoV-2 and that such may become a dominating mechanism of its evolution.

[122] A preprint supports such an explanation of Omicron's spread, suggesting that it "primarily can be ascribed to the immune evasiveness rather than an inherent increase in the basic transmissibility".

[123] [124] Studies showed the variant corona omicron indonesia escape the majority of existing SARS-CoV-2 neutralizing antibodies, including of sera from vaccinated and convalescent individuals. [125] [126] [127] [128] Nevertheless, current vaccines are expected to protect against severe illness, hospitalizations, and deaths due to Omicron [129] and, on an individual level, the Omicron variant is milder than earlier variants that evolved when the antibody/vaccination share was lower than it was when Omicron emerged.

[15] Virulence Further information: Virulence As of 28 November 2021 [update] the World Health Organization's update states "There is currently no information to suggest that symptoms associated with Omicron are different from . other variants". Increased rates of hospitalization in South Africa may be due to a higher number of cases, rather than any specific feature of the Omicron variant.

[130] On 4 December 2021, the South African Medical Research Council reported that from 14 to 29 November 2021 at a hospital complex in Tshwane, inpatients were younger than in previous waves and the ICU and oxygen therapy rates were lower than in earlier waves. These observations are not definitive and the clinical profile could change over the following two weeks, allowing for more accurate conclusions about disease severity.

[131] Excess deaths nearly doubled in the week of 28 November, suggesting under-reporting, but the level was still much lower than that seen in the second wave in mid-January 2021. [132] On 12 December, director-general of the World Health Organization Tedros Adhanom asserted that it was wrong for people to consider Omicron as mild.

This is because high exposure to previous infections in South Africa likely affects the clinical course of the new infections. [133] On 20 December, a report by the Imperial College COVID-19 Response Team, based on data from England, found that hospitalisation and asymptomatic infection indicators were not significantly associated with Omicron infection, suggesting at most limited changes in severity compared with Delta.

[134] On 22 December, the team reported an approximately 41% (95% CI, 37– 45%) lower risk of a hospitalization requiring a stay of at least 1 night corona omicron indonesia to the Delta variant, and that the data suggest that recipients of 2 doses of the Pfizer–BioNTech, the Moderna or the Oxford–AstraZeneca vaccine remain substantially protected from hospitalization. [135] In January, the CDC confirmed that the variant causes less severe disease than previously dominant variants.

[136] The novel Omicron subtype 'BA.2' did not initially show an increase over this lower virulence, [137] [138] [139] albeit one preprint found that "infection experiments using hamsters show that BA.2 is more pathogenic than BA.1".

[140] In March, a study from Hong Kong indicated that BA.2 may be more severe for children, compared to other variants. [141] Nevertheless, in the U.S., the daily new COVID-19 deaths were higher during Omicron dominance than during Delta's during fall [142] and high volumes of hospitalizations corona omicron indonesia to the variant's other characteristics can cause indirect harm via local health care system strains, [136] beyond less severe but often non-mild disease effects.

[142] Diagnosis See also: COVID-19 testing PCR testing The FDA has published guidelines on how PCR tests will be affected by Omicron. [143] Tests that detect multiple gene targets will continue to identify the testee as positive for COVID-19. S-gene dropout or target failure has been proposed as a shorthand way of differentiating Omicron from Delta.

The variant can also be identified by sequencing and genotyping. [144] Rapid antigen testing In January 2022 the medicine and therapeutic regulatory agency Therapeutic Goods Administration (TGA) of the Australian Government found that only one of their 23 approved COVID-19 rapid antigen tests (RAT) stated that it detected Omicron. [145] Prevention See also: COVID-19 § Prevention As with other variants, the WHO recommended that people continue to keep enclosed spaces well ventilated, avoid crowding and close contact, wear well-fitting masks, clean hands frequently, and get vaccinated.

[12] [146] Response by vaccine producers On 26 November 2021, BioNTech said it would know in two weeks whether the current vaccine is effective against the variant and that an updated vaccine could be shipped in 100 days if necessary. AstraZeneca, Moderna and Johnson & Johnson were also studying the variant's impact on the effectiveness of their vaccines. [147] On the same day, Novavax stated that it was developing an updated vaccine requiring two doses for the Omicron variant, which the company expected to be ready for testing and manufacturing within a few weeks.

[148] [149] On 29 November 2021, The Gamaleya Institute said that Sputnik Light should be effective against the variant, that it would begin adapting Sputnik V, and that a modified version could be ready for mass production in 45 days.

[150] Sinovac said it could quickly mass-produce an inactivated vaccine against the variant and that it was monitoring studies and collecting samples of the variant to determine if a new vaccine is needed. [151] On 7 December 2021, at a symposium in Brazil with its partner Instituto Butantan, Sinovac said it would update its vaccine to the new variant and make it available in three months. [152] On December 2, the Finlay Institute was already developing a version of Soberana Plus against the variant.

[153] Pfizer hopes to have a vaccine targeted to immunize against Omicron ready by March 2022. [154] WHO On 29 November 2021, the WHO said cases and infections are expected among those vaccinated, albeit in a small and predictable proportion. [155] Vaccine efficacy In December, studies, some of which using large nationwide datasets from either Israel and Denmark, found that vaccine effectiveness of multiple common two-dosed COVID-19 vaccines is substantially lower against the Omicron variant than for other common variants including the Delta variant, and that a new (often a third) dose – a booster dose – is needed and effective, with it i.a.

substantially reducing deaths from the disease compared to cohorts who received no booster but two doses. [156] [157] [158] [159] [160] [161] On 7 December 2021, preliminary results from a laboratory test conducted at the Africa Health Research Institute in Durban with 12 people who received the Pfizer-BioNTech vaccine found a 41-fold reduction in neutralizing antibody activity against the variant in some of the samples.

This is a big reduction, but it does not mean that the variant can escape vaccines completely, so vaccination with current vaccines is still recommended. Neutralizing antibody activity against the variant was greater in those fully vaccinated after being infected about a year earlier. Effectiveness estimates will likely change as more data is collected, as antibodies generated by vaccination vary widely between individuals and the sample was small.

[162] [163] [164] On 8 December 2021, Pfizer and BioNTech reported that preliminary data indicated that a third dose of the vaccine would provide a similar level of neutralizing antibodies against the variant as seen against other variants after two doses.

[165] On 10 December 2021, the UK Health Security Agency reported that early data indicated a 20- to 40-fold reduction in corona omicron indonesia activity for Omicron by sera from Pfizer 2-dose vaccinees relative to earlier strains and a 20-fold reduction relative to Delta.

The reduction was greater in sera from AstraZeneca 2-dose vaccinees, falling below the detectable threshold. An mRNA booster dose produced a similar increase in neutralising activity regardless of the vaccine used for primary vaccination.

After a booster dose (usually with an mRNA vaccine), [166] vaccine effectiveness against symptomatic disease was at 70%–75%, and the effectiveness against severe disease was expected to be higher. [167] In January 2022, results from Israel suggested that a 4th dose of vaccine is only partially effective against the Omicron strain.

Many cases of infection broke through, albeit "a bit less than in the control group", even though trial participants had higher antibody levels after the 4th dose. [168] WHO recommendations for epidemiology On 26 November 2021, the WHO asked nations to do the following: corona omicron indonesia Enhance surveillance and sequencing efforts to better understand circulating SARS-CoV-2 variants.

• Submit complete genome sequences and associated metadata to a publicly available database, such as GISAID. • Report initial cases/clusters associated with virus-of-concern infection to WHO through the IHR mechanism. • Where capacity exists and in coordination with the international community, perform field investigations and laboratory assessments to improve understanding of the potential impacts of the virus of concern on COVID-19 epidemiology, severity, and the effectiveness of public health and social measures, diagnostic methods, immune responses, antibody neutralization, or other relevant characteristics.

[169] Treatment See also: Treatment and management of COVID-19 Corticosteroids such as dexamethasone and IL6 receptor blockers such as tocilizumab (Actemra) are known to be effective for managing patients with the earlier strains of severe COVID-19.

The impact on the effectiveness of other treatments was being assessed in 2021. [170] [171] Relating to monoclonal antibodies (mAbs) treatments, similar testing and research is ongoing. Preclinical data on in vitro pseudotyped virus data demonstrate that some mAbs designed to use highly conserved epitopes retain neutralizing activity against key mutations of Omicron substitutions. [172] Similar results are confirmed by cryo-electron microscopy and X-ray data, also providing the structural approach and molecular basis for the evasion of humoral immunity exhibited by Omicron antigenic shift as well as the importance of targeting conserved epitopes for vaccine and therapeutics design.

While 7 clinical mAbs or mAb cocktails experienced loss of neutralizing activity of 1-2 orders of magnitude or greater relative to the prototypic virus, the S309 mAb, the parent mAb of sotrovimab, neutralized Omicron with only 2-3-fold reduced potency. [173] Further data suggest Omicron would cause significant humoral immune evasion, while neutralizing antibodies targeting the sarbecovirus conserved region remain most effective.

[174] Indeed, most receptor-binding motif (RBM)-directed monoclonal antibodies lost in vitro neutralizing activity against Omicron, with only 3 out of 29 corona omicron indonesia examined in another study retaining unaltered potency.

Furthermore, corona omicron indonesia fraction of broadly neutralizing sarbecovirus mAbs neutralized Omicron through recognition of antigenic sites outside the RBM, including sotrovimab (VIR-7831), S2X259 and S2H97. [175] In particular, sotrovimab is not fully active against the BA.2 Omicron sublineage, and in early 2022 the office of the U.S.

ASPR stopped distributing the antibody treatment to states where BA.2 was dominant. [176] Epidemiology On 26 November 2021, the South African National Institute for Communicable Diseases announced that 30,904 COVID-tests (in one day) detected 2,828 new COVID infections (a 9.2% positivity rate).

[177] One week later, on 3 December 2021, the NICD announced that 65,990 COVID tests had found 16,055 new infections (5.7 times as many as seven days before; positive rate 24.3%) and that 72 percent of them were found in Gauteng. [178] [179] This province of South Africa is densely populated at about 850 inhabitants per km 2. Gauteng's capital Johannesburg is a megacity (about 5.5 million inhabitants in the city itself plus 9.5 million in the urban region).

In November 2021, the transmissibility of the Omicron variant, as compared to the Delta variant or other variants of the COVID-19 virus, was still uncertain. [180] Omicron is frequently able to infect previously Covid-positive people. [181] [182] It has been estimated the Omicron variant diverged in late September or early October 2021, based on Omicron genome comparisons. [183] Sequencing data suggests that Omicron corona omicron indonesia become the dominant variant in South Africa by November 2021, the same month where it had been first identified in the country.

[184] corona omicron indonesia Phylogeny suggests a recent emergence. Data from South Africa suggests that Omicron has a pronounced growth advantage there. However, this may be due to transmissibility or immune escape related, or both." [186] Also the serial interval plays a role in the growth. Detectable changes in levels of COVID-19 in wastewater samples from South Africa's Gauteng province were seen as early as 17–23 October (week 42).

[187] The National Institute for Communicable Diseases reports that children under the age of 2 make up 10% of total hospital admissions in the Omicron point of discovery Tshwane in South Africa.

[188] Data on the S gene target failure (SGTF) of sampled cases in South Africa indicates a growth of 21% per day relative to Delta, generating an increased reproduction number by a factor of 2.4. [a] Omicron became the majority strain in South Africa around 10 November. [189] [190] Another analysis showed 32% growth per day in Gauteng, South Africa, having become dominant there around 6 November. [191] In the UK, the logarithmic growth rate of Omicron-associated S gene target failure (SGTF) cases over S gene target positive (SGTP) cases was estimated at 0.37 per day, [b] which is exceptionally high.

[192] Furthermore, by 14 December it appears to have become the most dominant strain. [c] [193] Without presuming behavior change in response to the variant, a million infections per day by December 24 are projected for a 2.5 days doubling time.

[d] [144] In Denmark, the growth rate has been roughly similar with a doubling time of about 2–3 days, it having become the corona omicron indonesia prevalent strain on 17 December. [194] [195] [196] Switzerland is not far behind. [197] In Germany Omicron became the most prevalent variant on January 1. [198] In Scotland, Omicron apparently became the most prevalent variant on 17 December. [199] [200] In the Canadian province of Ontario it became the most prevalent strain on 13 December.

[201] In the US, the variant appears to have become the most prevalent corona omicron indonesia on December 18, growing at 0.24 per day. [202] In Portugal, Omicron had reached 61.5% of cases on 22 December. [203] In Belgium, the strain has become the most prevalent on 25 December, [204] and in the Netherlands on 28 December. [205] In Italy, it had reached 28% of cases on 20 December and was doubling every two days, [206] while it became the dominant variant in Norway on 25 December.

[207] In France, it made up about 15% of COVID-19 cases in mid-December, but around corona omicron indonesia December it had increased to more than 60%. [208] [209] Researchers recommend sampling at least 5% of COVID-19 patient samples in order to detect Omicron or other emerging variants. [210] During January 2022, in Denmark the BA.2 variant grew at ~0.10 per day (+11% per day) corona omicron indonesia a ratio to BA.1 (the legacy Omicron variant), and became the dominant strain in week 2, 2022.

[95] In the United Kingdom, the BA.2 variant was growing at ~0.11 per day (+12% per day) as a ratio to BA.1. [211] On 13 January 2022, the Corona omicron indonesia reported that the hospitalization rate was higher in the US and Canada than in Europe and South Africa.

This was attributed to a combination of a greater number of elderly people than in South Africa, greater prevalence of comorbidities such as hypertension and obesity than in Europe, higher indoor transmission due to the winter, lower vaccination rate in the US than in Europe and Canada, and a possible still high prevalence of the Delta variant, which more often leads to hospitalization.

[212] Statistics 0 The chance of detecting a case particularly depends on a country's sequencing rate. For example, South Africa sequences far more samples than any corona omicron indonesia country in Africa, but at a considerably lower rate than most Western nations. [213] [214] Furthermore, it can take up to two weeks to return a viral sequence in corona omicron indonesia with the technical capability, hence solid statistics on confirmed cases lag corona omicron indonesia actual situation.

[215] Denmark and Norway regard cases found corona omicron indonesia their variant qPCR test, which is relatively fast and checks several genes, [58] as sufficient for counting it as an Omicron, also before full sequencing.

[216] [217] Confirmed and suspected cases by country and territory • view • talk • edit Country/Territory Confirmed cases ( PANGOLIN) [218] as of 5 May Confirmed cases ( GISAID) [219] as of 5 May Confirmed cases (other sources) as of 11 February Suspected cases United Kingdom 998,552 1,127,212 246,780 [220] 600,041 [220] Denmark 196,746 216,559 66,563 [221] – United States 801,020 938,058 62,480 [222] – Japan 67,203 70,752 2,113 [223] – Canada 73,584 92,341 69,264 [224] – Germany 207,407 244,182 268,661 [225] – Norway 14,729 19,043 45,296 [216] – Austria 6,809 25,626 290,378 [226] [227] – France 83,564 110,439 5,591 [228] – Indonesia 9,761 10,823 3,779 [229] – Thailand 6,778 9,912 5,397 [230] – Singapore 4,543 4,873 4,322 [231] [232] [233] [234] – Estonia 1,982 2,518 3,857 [235] [236] corona omicron indonesia – Australia 33,905 46,119 11,071 [238] – India 37,542 56,081 8,209 [239] [240] – Israel 22,164 39,908 1,741 [241] [242] 861 [241] South Africa 9,631 12,749 1,095 [243] 19,070 [244] South Korea 7,731 9,493 1,318 [245] – Spain 24,607 31,992 51 [225] [246] – Belgium 26,448 30,865 121 [226] [246] – Sweden 38,397 42,525 28,583 [247] – Switzerland 30,034 32,635 19,269 [226] [248] corona omicron indonesia Argentina 2,228 2,583 455 [249] [250] 80 [251] Botswana 931 1,594 23 [252] – Netherlands 24,381 26,601 123 [253] [246] – Ireland 13,860 17,833 7,780 [254] – Gibraltar 112 122 24 [255] – Iceland – – 84 [256] – Italy 23,707 27,292 84 [257] – Chile 4,097 4,572 684 [258] [259] [260] – Portugal 7,683 8,870 69 [261] [246] 6 [262] [226] Morocco 128 138 76 [263] 246 [263] Zimbabwe 185 219 50 [264] – Ghana 441 605 33 [252] – Brazil 27,787 32,224 203 [265] – Finland 4,029 5,239 523 [266] [267] – Cyprus – – 31 [268] [269] – Kenya 1,653 2,329 27 [270] – Russia 1,273 1,738 8,239 [271] – Cayman Islands – – 44 [272] 59 [272] Uganda 12 38 25 [273] [274] – Mexico 12,736 13,678 1 [275] – New Zealand 3,169 3,739 116 [276] – Namibia 125 213 18 [277] – Hong Kong 1,432 3,526 102 [278] [279] – Senegal 14 229 3 [280] – Mozambique 133 176 2 [281] 2 [222] Greece 3,268 3,276 17 [226] [282] – Bermuda – 24 144 [283] [284] – Latvia 407 407 644 [285] [246] [286] – Romania 4,034 4,282 25 [287] [288] [289] – Malaysia 5,330 7,353 245 [290] – Zambia 141 365 11 [291] – Nigeria 827 1,638 6 [292] – Czech Republic 13,264 15,147 10 [226] [293] [246] – Kosovo 245 262 9 [294] – Slovenia 15,684 17,106 1,418 [295] [246] [296] [297] – Lebanon 85 107 433 [298] [299] 16 [298] Reunion 2,014 2,402 2 [300] – Mauritius – 763 7 [222] – Poland 31,766 33,327 1 [301] – Rwanda 70 178 corona omicron indonesia [301] – Turkey 9,135 10,239 6 [302] – Montenegro 142 211 5 [303] – Cambodia 950 974 31 [304] – Peru 4,429 4,720 2551 [305] – Jordan 83 83 832 [306] – China 89 96 4 [307] [308] [309] – Cuba – – 92 [310] [311] [312] – Croatia 10,379 11,742 3 [226] – Egypt 15 40 3 [301] – Malawi 133 166 3 [313] – Palestinian Territory corona omicron indonesia 9 126 [314] [315] – Taiwan 32 34 89 [316] – Lithuania 7,063 9,136 2 [317] – Colombia 1,629 3,816 3 [318] Slovakia 13,501 15,625 3 [319] – Trinidad and Tobago 291 499 1 [320] – Puerto Rico 3,166 3,558 1 [321] – Fiji – – 2 [322] – Nepal 255 349 2 [323] – Myanmar 25 28 4 [324] – Philippines 1,281 1,549 535 [325] [326] [327] [328] [329] [330] – Northern Cyprus – – 9 [331] – Bangladesh 690 998 10 [332] – Liechtenstein 246 736 1 [333] 3 [222] Hungary 28 28 61 [334] [246] [335] – Oman 71 85 2 [336] – Pakistan 359 463 75 [337] [338] – Sri Lanka 626 927 1 [339] – Georgia 718 822 600 [340] – Algeria 61 73 1 [301] – Bahrain – – 1 [341] – Ecuador 1,177 1,561 1 [342] – Kuwait 54 72 1 [343] – Luxembourg 4,031 11,149 1 [226] – Maldives – 281 5 [344] [345] – Corona omicron indonesia Leone – 1 1 [346] – Saudi Arabia 28 30 1 [347] – Tunisia 51 52 1 [348] – United Arab Emirates – 1 1 [349] – Iran 595 682 467 [350] – Ukraine 73 99 1 [351] – Panama 821 822 1 [352] – Costa Rica 1,430 1,529 1 [353] – Aruba 61 61 1 [354] – North Macedonia 46 47 9 [355] [356] corona omicron indonesia Vietnam 1,085 1,790 108 [357] – Brunei 1,163 1,253 8 [358] – Malta 138 162 2 [359] – Venezuela 60 62 7 [360] – French Guiana – 366 20 [361] – Republic of the Congo 50 78 1 [362] – Qatar 267 290 4 [363] – Paraguay 122 139 3 [364] – Burkina Faso – 17 2 [365] – Curacao 482 487 1 [366] – Saint Kitts and Nevis – 16 2 [367] – Libya – – 2 [368] – Albania 1 1 1 [369] – Barbados 1 7 1 [370] – Saint Vincent and the Grenadines – 62 1 [371] – Dominican Republic 69 73 1 [372] – Jamaica 443 622 1 [373] – Serbia 81 81 1 [374] – Tanzania 2 3 1 [375] – Togo – – 5 [376] – Belarus – 71 4 [377] – Bosnia and Herzegovina 118 122 10 [378] – Angola 25 corona omicron indonesia 16 [379] – Democratic Republic of the Congo 34 204 1 [380] – Bulgaria 2,516 2,520 12 [381] – Mayotte 123 130 1 [382] – Martinique – 593 1 [383] – Gambia 30 155 26 [384] – Seychelles – 235 – – Saint Martin 224 240 2 [385] – Laos – – 1 [386] – Iraq 36 103 5 [387] – Mauritania – – 14 [388] – South Sudan 28 28 41 [389] – Ivory Coast 41 60 78 [390] – Cape Verde – 152 corona omicron indonesia [391] – Antigua and Barbuda – 36 1 [392] – Gabon – – 1 [393] – Bolivia 2 7 1 [394] – Moldova 287 314 29 [395] – Kazakhstan 8 8 8 [396] – Guadeloupe 264 300 1 [397] – Azerbaijan 12 12 12 [398] – Suriname 81 96 – – Sint Maarten – 479 – – British Virgin Islands 20 26 – – Mali 1 2 – – Anguilla – 24 – – Bonaire – 400 – – Bhutan – – 14 [399] – Papua New Guinea 379 565 1 [400] – Mongolia 133 133 12 [401] – Antarctica – – 24 [402] – Uzbekistan corona omicron indonesia – 1 [403] – Saint Lucia 1 9 – – Burundi – 1 – – American Samoa – 35 – – Armenia 4 16 – – Guinea corona omicron indonesia 167 – – Guam 168 274 – – Belize 223 240 – – Eswatini 124 133 – – Djibouti 306 308 – – World total (170 countries and territories) 2,983,352 3,514,782 964,777 620,384 History On 26 November 2021, WHO designated B.1.1.529 as a variant of concern and named it "Omicron", after the fifteenth letter in the Greek alphabet.

[22] Omicron was first detected on 22 November 2021 in laboratories in Botswana and South Africa based on samples collected on 11–16 November.

[404] [405] The first known sample was collected in South Africa on 8 November. [185] [406] The first known case, outside of South Africa, was a person arriving in Hong Kong from South Africa via Qatar on 11 November, and another person who arrived in Belgium from Egypt via Turkey on the same date.

[407] [408] As of 7 January 2022, the variant has been confirmed in 135 countries. [409] Omicron has an unusually large number of mutations compared to previous variants. [410] [33] [46] [13] Several of the mutations are novel and involve changes to the spike protein reducing the ability for COVID-19 corona omicron indonesia to prevent symptomatic disease.

[20] A December 2021 article in Science [411] observes Omicron did not evolve from any other variant of note, but instead on a distinct track diverging in perhaps mid-2020. The article expounds on three theories that might explain this surprising genetic lineage: • The virus could have circulated and evolved in a population with little surveillance and sequencing.

• It could have gestated in a chronically infected COVID-19 patient. • It might have evolved in a nonhuman species, from which it recently spilled back into people. Reported cases See also: Timeline of the SARS-CoV-2 Omicron variant On 24 November 2021, the variant was first reported to the WHO from South Africa, [12] based on samples that had been collected from 14 to 16 November. [412] South African scientists were first alerted by samples from the very beginning of November where the PCR tests had S gene target failure (occurs in a few variants, but not in Delta which dominated in the country in October) and by a sudden increase of COVID-19 cases in Gauteng; sequencing revealed that more than 70 percent of samples collected in the province between 14 and 23 November were a new variant.

[413] [414] The first confirmed specimens of Omicron were collected on 8 November 2021 in South Africa, [185] [406] and on 9 November in Botswana. [35] Likely Omicron (SGTF) samples had occurred on 4 November 2021 in Pretoria, South Africa. [415] When WHO was alerted on 24 November, Hong Kong was the only place outside Africa that had confirmed a case of Omicron; one person who traveled from South Africa on 11 November, and another traveler who was cross-infected by this case while staying in the same quarantine hotel.

[414] [416] [417] On 25 November, one confirmed case was identified in Israel from a traveler returning from Malawi, [418] along with two who returned from South Africa and one from Madagascar. [419] Corona omicron indonesia four initial cases reported from Botswana occurred among fully vaccinated individuals.

[420] On 26 November, Belgium confirmed its first case; an unvaccinated person who had travelled from Egypt via Turkey on 11 November. [407] [421] [422] All three initial confirmed and suspected cases reported from Israel occurred among fully vaccinated individuals, [418] as did a single suspected case in Germany. [423] On 27 November, two cases were detected in the United Kingdom, another two in Munich, Germany and one in Milan, Italy.

[424] On 28 November, 13 cases were confirmed in the Netherlands among the 624 airline passengers who arrived from South Africa on 26 November. [425] Confirmation of corona omicron indonesia further 5 cases among these passengers followed later. [426] Entry into the Netherlands generally required having been vaccinated or PCR-tested, or having recovered. The passengers of these two flights had been tested upon arrival because of the newly imposed restrictions (which were set in place during their flight), after which 61 tested positive for SARS-CoV-2.

[427] A further two cases were detected in Australia. Both people landed in Sydney the previous day, and travelled from southern Africa to Sydney Airport via Doha Airport.

The two people, who were fully vaccinated, entered isolation; 12 other travellers from southern Africa also entered quarantine for fourteen days, while about 260 other passengers and crew on the flight have been directed to isolate.

[428] Two travellers from South Africa who landed in Denmark tested positive for COVID-19; it was confirmed on 28 November that both carried the Omicron variant. [429] [430] On the same day, Austria also confirmed its first Omicron case. [431] A detected Omicron case was reported in the Czech Republic, from a traveler who spent time in Namibia.

[432] Canada also reported its first Omicron cases, with two from travelers from Nigeria, therefore becoming the first North American country to report an Omicron case. [433] On 29 November, a positive case was recorded in Darwin, Australia. The person arrived in Darwin on a repatriation flight from Johannesburg, South Africa on 25 November, and was taken to a quarantine facility, where the positive test was recorded.

[434] Two more people who travelled to Sydney from southern Africa via Singapore tested positive. [435] Portugal reported 13 Omicron cases, all of them members of a soccer club.

[436] Sweden also confirmed their first case on 29 November, [437] as did Spain, when a traveler came from South Africa. [438] On 30 November, the Netherlands reported that Omicron cases corona omicron indonesia been detected in two samples dating back as early as 19 November.

[439] A positive case was recorded in Sydney corona omicron indonesia a traveller who had visited southern Africa before travel restrictions were imposed, and was subsequently active in the community. [440] Japan also confirmed its first case. [441] Two Israeli doctors have tested positive and have entered isolation.

Both of them had received three shots of the Pfizer vaccine prior to corona omicron indonesia positive. [442] In Brazil, three cases of the Omicron variant were confirmed in São Paulo. [443] Another five are under suspicion. [444] [445] A person in Leipzig, Germany with no travel history nor contact with travellers tested positive for Omicron. [446] On 1 December, the Omicron variant was detected in three samples in Nigeria that had been collected from travelers from South Africa within the last week.

[447] [448] On the same day, public health authorities in the United States announced the corona omicron indonesia first confirmed Omicron case. A resident of San Francisco who had been vaccinated returned from South Africa on 22 November, began showing mild symptoms on 25 November [449] and was confirmed to have a mild case of COVID-19 on 29 November.

[450] Ireland and South Korea also reported their first cases. [451] South Korea reported its cases from five travelers arriving in South Korea from Nigeria. [452] On 2 December, Dutch health authorities confirmed that all 14 passengers with confirmed Omicron infection on 26 November had been previously vaccinated.

[453] The same day, the Norwegian Institute of Public Health confirmed that 50 attendees of a company Christmas party held at a restaurant in Norway's capital, Oslo, were infected with the Omicron variant.

[454] France has confirmed only 25 cases of the new Omicron variant but officials say the number could jump significantly in the coming weeks. [455] By 6 December, Malaysia confirmed its first case of the variant. The case was a South African student entering to study at a private university. [456] In Namibia, 18 cases out of 19 positive COVID-19 samples that had been collected between 11 and 26 November were found to be Omicron, indicating a high level of prevalence in the country.

[457] Fiji also confirmed two positive cases of the variant. They travelled from Nigeria arriving corona omicron indonesia Fiji on November 25. [458] On 8 December, WHO announced the variant had been detected in 57 countries. [459] On 9 December, Richard Mihigo, coordinator of the World Health Organisation's Immunisation and Vaccine Development Programme for Africa, announced that Africa accounted for 46% of reported cases of the Omicron variant globally.

[460] On 13 December, the first death of a person with Omicron was reported in the UK. [461] On 16 December, New Zealand confirmed its first case of the Omicron variant, an individual who had traveled from Germany via Dubai.

[462] The first death of a person with Omicron was reported in Germany on 23 December [463] and in Australia on 27 December. [464] By Christmas 2021, the Omicron Strain became dominant in the US. [465] On 3 January 2022, South Korea reported the first two deaths of people who corona omicron indonesia positive post mortem for Omicron. [466] On 29 March 2022, Omicron subvariant BA.2 became the dominant strain in the U.S.

[467] [468] [469] Market reactions Main article: Financial market impact of the COVID-19 pandemic Worry about the potential economic impact of the Omicron variant led to a drop in global markets on 26 November, including the worst drop of the Dow Jones Industrial Average in 2021, led by travel-related stocks.

The price of Brent Corona omicron indonesia and West Texas Intermediate oil fell 10% and 11.7%, respectively. [470] Cryptocurrency markets were also routed. [471] [472] The South African rand has also hit an all-time low for 2021, trading corona omicron indonesia over 16 rand to the dollar, losing 6% of its value in November. [473] [474] [475] In early December 2021, the chairman of the Federal Reserve, Jerome Powell, testified before the U.S.

Senate Committee on Banking that "The recent rise in COVID-19 cases and the emergence of the Omicron variant pose downside risks to employment and economic activity and increased uncertainty for inflation." [476] International response On 26 November 2021, WHO advised countries not to impose new restrictions on travel, instead recommending a "risk-based and corona omicron indonesia approach to travel measures. [477] On the same day, the European Centre for Disease Prevention and Control (ECDC) reported modeling indicating that strict travel restrictions would delay the variant's impact on European countries by two weeks, possibly allowing countries to prepare for it.

[39] After the WHO announcement, on the same day, several countries announced travel bans from southern Africa in response to the identification of the variant, including the United States, which banned travel from eight African countries, [478] although it notably did not ban travel from any European countries, Israel, Canada, or Australia where cases were also detected at the time the bans were announced.

Other countries that also implemented travel bans include Japan, Canada, the European Union, Israel, Australia, the United Kingdom, Singapore, Malaysia, Indonesia, Morocco, and New Zealand. [479] [480] The Brazilian Health Regulatory Agency recommended flight restrictions regarding the new variant. [481] The state of New York declared a state of emergency ahead of a potential Omicron spike, although no cases had yet been detected in the state or the rest of the United States.

[482] On 27 November, Switzerland introduced obligatory tests and quarantine for all visitors arriving from countries where the variant was detected, which originally included Belgium and Israel.

[483] In response to the various travel bans, South African Minister of Health Joe Phaahla defended his country's handling of the pandemic and corona omicron indonesia that travel bans went against the "norms and standards" of the World Health Organization. [484] Some speculate that travel bans could have a significant impact on South Africa's economy by limiting tourism and could lead to other countries with economies that are reliant on tourism to hide the discovery of new variants of concern.

Low vaccine coverage in less-developed nations could create opportunities for the emergence of new variants, and these nations also struggle to gain intellectual property to develop and produce vaccines locally. [485] At the same time, inoculation has slowed in South Africa due to vaccine hesitancy and apathy, with a nationwide vaccination rate of only 35% as of November 2021.

[486] On 29 November, the WHO warned countries that the variant poses a very high global risk with severe consequences and that they should prepare by accelerating vaccination of high-priority groups and strengthening health systems.

WHO director-general Tedros Adhanom described the global situation as dangerous and precarious and called for a new agreement on the handling of pandemics, as the current system disincentivizes countries corona omicron indonesia alerting others to threats that will inevitably land on their shores. CEPI CEO Richard Hatchett said that the variant fulfilled predictions that transmission of the virus in low-vaccination areas would accelerate its evolution.

[155] In preparation for the Omicron variant arriving in the United States, President Joe Biden has stated that the variant is "cause for concern, not panic" and reiterated that the government is prepared for the variant and will have it under control. He also stated that large-scale lockdowns, similar to the ones in 2020 near the beginning of the pandemic, are "off the table for now." [487] In mid-December, multiple Canadian provinces reinstated restrictions on gatherings and events such as sports tournaments, and tightened enforcement of proof of vaccination corona omicron indonesia.

British Columbia expressly prohibited any non-seated "organized New Year's Eve event", [488] [489] [490] while Quebec announced a partial lockdown on 20 December, ordering the closure of all bars, casinos, gyms, schools, and theatres, as well as imposing restrictions on the capacity and operating hours of restaurants, and the prohibition of spectators at professional sporting events. [491] On 18 December, the Netherlands government announced a lockdown intended to prevent spread of the variant during the holiday period.

[492] In late December, some countries shortened the typical six-month interval for a booster dose of the vaccine to prepare for a wave of Omicron, as corona omicron indonesia doses are not enough to stop the infection. UK, South Korea and Thailand reduced to three months; Belgium, four months; France, Singapore, Taiwan, Italy and Australia, five months.

Finland reduced it to three corona omicron indonesia for risk groups. Other countries continued with a six-month booster schedule.

While antibody levels begin to drop at four months, a longer interval usually allows time for the immune system's response to mature. [493] See also • COVID-19 portal • Medicine portal • Viruses portal • Africa portal • Timeline of the SARS-CoV-2 Omicron variant • COVID-19 pandemic in Africa • COVID-19 vaccination in Africa • COVID-19 vaccination in Botswana • COVID-19 vaccination in South Africa • Variants of SARS-CoV-2 • Other variants of either interest or concern: Alpha, Beta, Gamma, Delta, Epsilon, Zeta, Eta, Theta, Iota, Kappa, Lambda, Mu Notes • ^ With a presumed identical person-to-person serial interval of log_e(2.4)/0.21 ~ 4.2 days, or a distribution thereof to the same effect.

• ^ Logarithmic growth rate of 0.37/day means that the log odds log e(SGTF/SGTP) is increasing by 0.37 in a day. So SGTF/SGTP was increasing by a multiplicative factor of exp(0.37) ~ 1.45. This is substantially higher than a naive increase to 100%+37%. The difference is mathematically due to compound growth within the day, which does not imply that epidemically people are already infectious within a day. Rather, simplified (non-delay) differential equations are used for convenience for the modeling.

This also indicates a doubling time of log_e(2)/(0.37/day) ~ 1. days for the Omicron to Delta prevalence ratio. • ^ Referring to ref 12 in the reference, where the x-axis is crossed at 14 December. • ^ A doubling time of 2.5 days corresponds to an exponential growth rate of ln(2)/(2.5 days) ~ 0.28/day. Direct comparison to the logistic growth rate needs to take the growth/decline of Delta into account.

References • ^ corona omicron indonesia b c Yadav PD, Gupta N, Potdar V, Mohandas S, Sahay RR, Sarkale P, et al. (January 2022). An in vitro and in vivo approach for the isolation of Omicron variant from human clinical specimens. pp. 2022–01.02.474750. doi: 10.1101/2022.01.02.474750. Archived from the original on 16 January 2022. Retrieved 16 January 2022. • ^ a b Padin, Malvika (17 Corona omicron indonesia 2022). "Feeling light-headed may be an early indication you have Omicron Covid variant".

mirror. Archived from the original on 28 January 2022. Retrieved 30 January 2022. • ^ Poudel S, Ishak A, Perez-Fernandez J, Garcia E, León-Figueroa DA, Romaní L, et al. (December 2021). "Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts – What is known so far?".

Travel Medicine and Infectious Disease. 45: corona omicron indonesia. doi: 10.1016/j.tmaid.2021.102234. PMC 8666662. PMID 34896326. • ^ "How Omicron Symptoms Compare with Corona omicron indonesia Variants". Healthline. 14 January 2022. Archived from the original on 21 January 2022.

Retrieved 30 January 2022. • ^ a b Omicron’s cold-like symptoms mean UK guidance ‘needs urgent update’ Archived 25 December 2021 at the Wayback Machine The Guardian • ^ a b "Omicron Symptoms: Here's How They Differ From Other Variants". NBC Chicago. Archived from the original on 24 January 2022. Retrieved 30 January 2022. • ^ a b Slater, Jack (23 January 2022). "Is a change to your taste or smell a sign of Omicron?". Metro. Archived from the original on 26 January 2022. Retrieved 30 January 2022.

• ^ a b Scribner H (21 December 2021). "Doctor reveals new nightly omicron variant symptom". Deseret News. Archived from the original on 2 January 2022. Retrieved 1 January 2022. • ^ "Does Omicron cause less damage to the lungs?".

www.medicalnewstoday.com. 14 January 2022. • ^ Murrison, Pip (18 January 2022). "Omicron symptoms: Three distinctive rashes to watch for". Express.co.uk. Archived from the original on 12 January 2022. Retrieved 30 January 2022. • ^ a b Omicron’s cold-like symptoms mean UK guidance ‘needs urgent update’ Archived 25 December 2021 at the Wayback Machine The Guardian • ^ a b c d e "Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern".

World Health Organization. 26 November 2021. Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ a b Gowrisankar A, Priyanka TM, Banerjee S (10 January 2022). "Omicron: a mysterious variant of concern". The European Physical Journal Plus. 137 (1): 100. Bibcode: 2022EPJP.137.100G. doi: 10.1140/epjp/s13360-021-02321-y. ISSN 2190-5444. PMC 8743750. PMID 35036269. • ^ Harvard Medical School (6 January 2022). "Coronavirus Resource Center – Harvard Health".

Harvard Health Publishing. Archived from the original on 11 January 2022. Retrieved 7 January 2022. Lab studies, animal studies, and epidemiological data all indicate that Omicron may cause less severe disease than previous variants. • ^ a b David Leonhardt (5 January 2022). "Omicron Is Milder". The New York Times. Archived from the original on 6 January 2022.

Retrieved 7 January 2022. A few weeks ago, many experts and journalists were warning that the initial evidence from South Africa — suggesting that Omicron was milder than other variants — might turn out to be a mirage. It has turned out to be real.

• ^ a b "Lung tissue study sheds light on fast Omicron spread". CIDRAP. Archived from the original on 16 December 2021. Retrieved 25 December 2021. • ^ Lewnard, Joseph A.; Hong, Vennis X.; Patel, Manish M.; Kahn, Rebecca; Lipsitch, Marc; Tartof, Sara Y. (11 January 2022). "Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California": 2022.01.11.22269045.

doi: 10.1101/2022.01.11.22269045. S2CID 245851556. Archived from the original on 16 January 2022. Retrieved 17 January 2022. {{ cite journal}}: Cite journal requires -journal= ( help) • ^ "Some reduction in hospitalisation for Omicron v Delta in England: early analysis".

Imperial College London. Archived from the original on 22 January 2022. Retrieved 22 January 2022. • ^ Ahmed SF, Quadeer AA, McKay MR (January 2022). "SARS-CoV-2 T Cell Corona omicron indonesia Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron". Viruses. 14 (1): 79. doi: 10.3390/v14010079. PMC 8781795.

PMID 35062283. • ^ a b Al Jurdi A, Gassen RB, Borges TD, Lape IT, Morena L, Efe O, et al. (6 January 2022).

"Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients": 2022.01.03.22268649.

doi: 10.1101/2022.01.03.22268649. S2CID 245739956. Archived from the original on 11 January 2022. Retrieved 16 January 2022. {{ cite journal}}: Cite journal requires -journal= ( help) • ^ "How Effective Are COVID-19 Vaccines Against Omicron?". Healthline. 7 January 2022. Archived from the original on 16 January 2022. Retrieved 17 January 2022.

• ^ a b c Parekh M, Platt P, Barnes J, et al. (Global Health Security Team) (26 November 2021). "Coronavirus latest news: EU suspends all flights to southern Africa over omicron Covid variant fears".

The Telegraph. ISSN 0307-1235. Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ Patel V (27 November 2021). "How Omicron, the New Covid-19 Variant, Got Its Name". The New York Times. ISSN 0362-4331. Archived from the original on 28 November 2021. Retrieved 28 November 2021. • ^ "There are corona omicron indonesia COVID-19 variants you haven't heard of". NewsNation Now. 27 November 2021. Archived from the original on 27 November 2021.

Retrieved 27 November 2021. • ^ "Tracking SARS-CoV-2 variants". World Health Organization. Archived from the original on 18 June 2021. Retrieved 13 December 2021. • ^ "Countries are scrambling to stop a new covid variant".

The Economist. 26 November 2021. Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ Tcholakian D (15 December 2021).

" 'Omni is everywhere': why do so many people struggle to say Omicron?". The Guardian. Archived from the original on 23 December 2021. Retrieved 23 December 2021. • ^ Zimmer B (2 December 2021). " 'Omicron': Greek's 'Little O' Will Loom Larger Now". Wall Street Journal. ISSN 0099-9660. Archived from the original on 3 December 2021.

Corona omicron indonesia 23 December 2021. President Joe Biden stumbled over the pronunciation in a press conference on Monday, calling the variant “omnicron” with an extra “n” sound.

It has also been frequently misspelled that way online. The confusion is understandable, since we’re more familiar with words that have the Latin prefix “omni-” meaning “all,” as in “omnipresent” or “omnivore.” • ^ "In focus". gisaid.org. GISAID. 28 November 2021. Archived from the original on 21 January 2021. Retrieved 28 November 2021. The unique mix of spike amino acid changes in Omicron GR/484A (B.1.1.529) is of interest as it comprises several that were previously known to affect receptor binding and antibody escape.

• ^ a b "Variant: 21K (Omicron)". covariants.org. CoVariants. 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021. Variant 21K (Omicron) appears to have arisen in November 2021, possibly in South Africa. • ^ "SARS-CoV-2 variants of concern and variants under investigation in England – Technical briefing 29" (PDF).

gov.uk. UK Health Security Agency. 26 November 2021. p. 18. Archived (PDF) from the original on 27 November 2021 corona omicron indonesia. Retrieved 10 December 2021. • ^ Hurst L (26 November 2021). "What we know so far about the B.1.1.529 'Omicron' COVID variant causing concern".

Euronews. Archived from the original on corona omicron indonesia November 2021. Retrieved 26 November 2021. • ^ a b William A. Haseltine (2 December 2021). "Omicron Origins". Forbes. Archived from the original on 3 December 2021. Retrieved 4 December 2021. • ^ Cookson C, Barnes O (26 November 2021). "What we know about Omicron variant that has sparked global alarm". Financial Times.

Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ a b c Callaway E (December 2021). "Heavily mutated Omicron variant puts scientists on alert". Nature. 600 (7887): 21. Bibcode: 2021Natur.600.21C.

doi: 10.1038/d41586-021-03552-w. PMID 34824381. S2CID 244660616. Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ Zimmer C (26 November 2021). "New Virus Variant Stokes Concern but Vaccines Still Likely to Work". The New York Times. Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ Zhang L, Mann M, Syed ZA, Reynolds HM, Tian E, Samara NL, et al.

(November 2021). "Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation". Proceedings of the National Academy of Sciences of the United States of America. 118 (47): e2109905118. doi: 10.1073/pnas.2109905118. PMC 8617502. PMID 34732583. S2CID 242937417. • ^ SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 29 (PDF) (Briefing).

Public Health England. 26 November 2021. GOV-10481. Archived (PDF) from the original on 27 November 2021. Retrieved 26 November 2021. • ^ a b c "Implications of the emergence and spread of the SARS-CoV-2 B.1.1.529 variant of concern (Omicron) for the EU/EEA" (PDF). ecdc.europa.eu. Archived (PDF) from the original on 26 November 2021.

Retrieved 26 November 2021. • ^ Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (April 2020). "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein".

Cell. 181 (2): 281–292.e6. doi: 10.1016/j.cell.2020.02.058. PMC 7102599. PMID 32155444. • ^ "The birth of Omicron: Did HIV play a role?". www.medicalnewstoday.com. 6 December 2021. Archived from the original on 15 December 2021. Retrieved 11 December 2021. • ^ "The mystery of where omicron came from — and why it matters". NPR. 1 December 2021. Archived from the original on 9 December 2021. Retrieved 8 December 2021.

• ^ "HIV and AIDS in South Africa". Avert. 21 July 2015. Archived from the original on 16 October 2015. Retrieved 8 December 2021. • ^ Sample I (11 December 2021). "Why uncontrolled HIV may be behind the emergence of Omicron". The Guardian. Archived from the original on 20 December 2021. Retrieved 12 December 2021. • ^ a b "Fact Check-Omicron is not the common cold 'rebranded' ". Reuters. 10 December 2021. Archived from the original on 21 December 2021.

Retrieved 25 December 2021 – via www.reuters.com. • ^ a b Wei C, Shan KJ, Wang W, Zhang S, Huan Q, Qian W (December 2021). "Evidence for a mouse origin of the SARS-CoV-2 Omicron variant". Journal of Genetics and Genomics = Yi Chuan Xue Bao.

48 (12): 1111–1121. doi: 10.1016/j.jgg.2021.12.003. PMC 8702434. PMID 34954396. • ^ "Lineage B.1.1.529". PANGOLIN. 19 December 2021. Archived from the original on 20 December 2021. Retrieved 19 December 2021. • ^ a b c McGregor G (21 January 2022). "What is 'stealth Omicron'? The rise of the subvariant is alarming some scientists who say it needs its own Greek letter".

Fortune. Archived from the original on 23 January 2022. Retrieved 23 January 2022. • ^ "En subvariant af omikron, BA.2, udgør nu knap halvdelen af alle danske omikrontilfælde" [A subvariant of Omicron, BA.2., now comprises almost half of all Danish Omicron cases] (in Danish). Statens Serum Institut. 19 January 2022. Archived from the original on 20 January 2022. Retrieved 20 January 2022. • ^ "Statement on Omicron sublineage BA.2".

World Health Organization. 22 February 2022. Retrieved 12 March 2022. • ^ "Research identifies differences between Omicron lineages BA.1 and BA.2". News Medical Life Sciences. 16 February 2022.

Retrieved 12 March 2022. • ^ Yamasoba, Daichi; Kimura, Izumi; Nasser, Hesham; Morioka, Yuhei; Nao, Naganori; Ito, Jumpei; Uriu, Keiya; Tsuda, Masumi; Zahradnik, Jiri; Shirakawa, Kotaro; Suzuki, Rigel; Kishimoto, Mai; Kosugi, Yusuke; Kobiyama, Kouji; Hara, Teppei; Toyoda, Mako; Tanaka, Yuri L; Butlertanaka, Erika P; Shimizu, Ryo; Ito, Hayato; Wang, Lei; Oda, Yoshitaka; Orba, Yasuko; Sasaki, Michihito; Nagata, Kayoko; Yoshimatsu, Kumiko; Asakura, Hiroyuki; Nagashima, Mami; Sadamasu, Kenji; Yoshimura, Kazuhisa; Kuramochi, Jin; Seki, Motoaki; Fujiki, Ryoji; Kaneda, Atsushi; Shimada, Tadanaga; Nakada, Taka-aki; Sakao, Seiichiro; Suzuki, Takuji; Ueno, Takamasa; Takaori-Kondo, Akifumi; Ishii, Ken J; Schreiber, Gideon; Sawa, Hirofumi; Saito, Akatsuki; Irie, Takashi; Tanaka, Shinya; Matsuno, Keita; Fukuhara, Takasuke; Ikeda, Terumasa; Sato, Kei (15 February 2022), Virological characteristics of SARS-CoV-2 BA.2 variant, Cold Spring Harbor Laboratory, doi: 10.1101/2022.02.14.480335, S2CID 246905491 • ^ Ellis, Ralph (18 February 2022).

"Subvariant May Be More Dangerous Than Omicron: Study". Medscape. Retrieved 4 April 2022. • ^ a b Rajeshuni, N (26 January 2022). "Scientists monitoring new omicron subvariant BA.2". ABC News. Archived from the original on 1 February 2022. Retrieved 2 February 2022. • ^ a b Sample I, Walker P (7 December 2021). "Scientists find 'stealth' version of Omicron that may be harder to track". www.theguardian.com. Archived from the original on 7 December 2021.

Retrieved 7 December 2021. • ^ "Stealth Omicron: What is The Fast Spreading Omicron BA.2 Sub-Variant That Can Escape RT-PCR Test?".

india.com. 23 January 2022. Archived from the original on 23 January 2022. Retrieved 23 January 2022. • ^ a b c Parker C (21 January 2022). "Government scientists monitoring new BA.2 variant of Omicron".

Yahoo News. Archived from the original on 21 January 2022. Retrieved 21 January 2022. • ^ a b "Variant-PCR-testen (tidl. Delta-PCR-testen)" (in Danish).

Statens Serum Institut. 21 December 2021. Archived from the original on 7 February 2021. Retrieved 17 January 2022. • ^ a b "SARS-CoV-2の変異株B.1.1.529系統(オミクロン株)について(第6報)" (in Japanese). National Institute of Infectious Diseases (Japan). 14 January 2022. Archived from the original on 20 January 2022. Retrieved 24 January 2022. • ^ "Delta Variant Report". outbreak.info ( Scripps Research). 13 December 2021.

Archived from the original on 19 December 2021. Retrieved 13 December 2021. • ^ "BA.1 Lineage Report". outbreak.info ( Scripps Research). 19 December 2021. Archived from the original on 16 December 2021. Retrieved 19 December 2021. • ^ a b "BA.2 Lineage Report". outbreak.info ( Scripps Research).

21 January 2022. Archived from the original on 13 December 2021. Retrieved 21 January 2022. • ^ Zimmer C, Lyons, PJ (24 February 2022). "Is the BA.2 version of Omicron worse? Here's what you need to know". New York Times. Retrieved 12 March 2022. corona omicron indonesia ^ "Lineage BA.3". PANGOLIN. 25 January 2022. Archived from the original on 27 January 2022. Retrieved 25 January 2022. • ^ "BA.3 Lineage Report".

outbreak.info ( Scripps Research). 19 December 2021. Archived from the original on 20 December 2021. Retrieved 19 December 2021. • ^ "WHO monitoring 2 more Omicron sub-variants known as BA.4 and BA.5". Corona omicron indonesia Broadcasting Corporation. corona omicron indonesia April 2022. Retrieved 13 April 2022. • ^ @Tuliodna (11 April 2022). "New Omicron BA.4 & BA.5 detected in South Africa, Botswana, Belgium, Germany, Denmark, and U.K.

Early indications that these new sublineages are increasing as a share of genomically confirmed cases in SA" (Tweet) – via Twitter. • ^ Lee, Bruce Y. "New BA.2.12.1 Omicron Subvariant Is Even More Contagious, Fueling Covid-19 Upswing In New York State". Forbes. Retrieved corona omicron indonesia April 2022. • ^ Doucleff, Michaeleen (14 April 2022). "2 new omicron variants are spreading in N.Y. and elsewhere. Corona omicron indonesia what we know".

NPR. Retrieved 15 April 2022. • ^ "New, highly transmissible forms of omicron may pose latest covid threat". Washington Post. ISSN 0190-8286. Retrieved 16 April 2022. • ^ Rong-Gong Lin II; Luke Money (24 March 2022).

"The Omicron subvariant BA.2 is on the rise. We need to take it seriously, experts say". Los Angeles Times. Retrieved 25 March 2022. • ^ Goodman B (24 February 2022). "New studies bring BA.2 variant into sharper focus". CNN. p. 1. • ^ Sample I (10 March 2022). "UK Covid cases rising among those aged 55 and over". The Guardian. Retrieved 12 March 2022. • ^ Henley J (22 March 2022).

"WHO blames rising Covid cases in Europe on curbs lifted too soon". The Guardian. Retrieved 24 March 2022. • ^ Tom Tapp (31 March 2022). "New Mutant "XE" Omicron Variant May Be The Most Transmissible Version Of Covid Yet, According To WHO". Deadline. Retrieved 4 April 2022. • ^ "XE Variant: New COVID Strain May be More Contagious Than BA.2 Subvariant, WHO Says". NBC Chicago. 3 April 2022. Retrieved 4 April 2022. • ^ Peixoto, Roberto (7 April 2022).

"Entenda o que é a ômicron XE, que teve o primeiro caso confirmado no Brasil" [Understand what is omicron XE, which had its first case confirmed in Brazil]. G1 (in Brazilian Portuguese). Retrieved 8 April 2022. • ^ "BA.2 Lineage Report, India". outbreak.info ( Scripps Research). 4 February 2022. Retrieved 5 February 2022. • ^ "COVID-19 variants identified in the UK". UK Health Security Agency. 21 January 2022. Archived from the original on 23 January 2022.

Retrieved 21 January 2022. • ^ "COVID-19 Weekly Epidemiological Update, Edition 77" (PDF). World Health Organization. 1 February 2022. Archived (PDF) from the original on 3 February 2022. Retrieved 2 February 2022. • ^ a b c "COVID-19 Weekly Epidemiological Update, Edition 82". World Health Organization.

8 March 2022. Retrieved 12 March 2022. corona omicron indonesia ^ "COVID-19 Weekly Epidemiological Update, Edition 84". World Health Organization. 22 March 2022. Retrieved 25 March 2022. • ^ Keating D, Dong M, Shin Y corona omicron indonesia March 2022). "How fast omicron's BA.2 variant is spreading around the world". Washington Post. Retrieved 24 March 2022. • ^ "COVID-19 Weekly Epidemiological Update, Edition 80".

World Health Organization. 22 February 2022. Retrieved 12 March 2022. • ^ a b "Variant Proportions". Centers for Disease Control and Prevention. 28 March 2020. Retrieved 12 March 2022. • ^ Carassio J (7 February 2022). "BA.1.1, un nouveau sous-variant d'Omicron déjà très répandu en France".

Le Progrès. Retrieved 12 March 2022. • ^ "BA.1.1 Lineage Report, United States, France and Japan". outbreak.info ( Scripps Research). 12 March 2022. Retrieved 12 March 2022. • ^ Yengkhom S (11 January 2022). "BA.2 'stealth' variant makes up 80% of Kolkata's Omicron infections". The Times of India.

Archived from the original on 16 January 2022. Retrieved 17 January 2022. • ^ "Omicron 'sub-lineage' BA.2 designated as COVID variant under investigation, says UKHSA". Sky News. 21 January 2022. Archived from the original on 21 January 2022. Retrieved 21 January 2022. • ^ "SARS-CoV-2 Sequencing Update 14 January 2022" (PDF).

corona omicron indonesia

Network for Genomic Surveillance in South Africa. 14 January 2022. Archived (PDF) from the original on 17 January 2022.

Retrieved 17 January 2022. • ^ "Omicron sub-variant BA.2 'under investigation' by UK health officials". The Independent. 23 January 2022. Archived from the original on 23 January 2022. Retrieved 23 January 2022. • ^ Österman H (11 January 2022). "Undergrupp av omikron ökar: "Kan vara ännu mer smittsam" " (in Swedish). Aftonbladet. Archived from the original on 11 January 2022. Retrieved 17 January 2022.

• ^ "新型コロナウイルス感染症(変異株)の患者等の発生について(空港検疫))" (in Japanese). National Institute of Infectious Diseases (Japan). 20 January 2022. Archived from the original on 20 January 2022.

Retrieved 24 January 2022. • ^ "新型コロナウイルス感染症(変異株)の患者等の発生について(空港検疫)" (in Japanese). National Institute of Infectious Diseases (Japan). 24 January 2022. Archived from the original on 24 January 2022.

Retrieved 24 January 2022. • ^ a b c "Genomic overview of SARS-CoV-2 in Denmark". Danish Covid-19 Genome Consortium. 29 January 2022. Archived from the original on 20 December 2021. Retrieved 29 January 2022. • ^ a b c Bernstein L (25 January 2022). "There's a new version of omicron but so far it doesn't appear to be more dangerous". Washington Post. Archived from the original on 25 January 2022. Retrieved 25 January 2022. • ^ "Enhancing response to Omicron SARS-CoV-2 variant: Technical brief and priority actions for Member States" (PDF).

World Health Organization. 21 January 2022. Corona omicron indonesia (PDF) from the original on 27 January 2022. Retrieved 24 January 2022. • ^ a b "COVID-19 Ukerapport – uke 2" (PDF) (in Norwegian). Norwegian Institute of Public Health. 19 January 2022. Archived (PDF) from the original on 27 January 2022. Retrieved 25 January 2022. • ^ "Omicron BA.2 sub-variant dominant in S.Africa, says CDC". Reuters. 10 February 2022.

Retrieved 12 March 2022. • ^ "Wöchentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19)" (PDF). Robert Koch Institute. 10 March 2022. Retrieved corona omicron indonesia March 2022. • ^ a b "Covid infections rising again across UK - ONS".

BBC News. 11 March 2022. Retrieved 12 March 2022. • ^ Reuters. "BA.2 version of omicron is now dominant coronavirus variant in U.S., CDC says". www.nbcnews.com.

Retrieved 30 March 2022. • ^ Larsen JA (21 January 2022). "Ny Omikron-variant tager over i Danmark – det ved vi om den" (in Danish). TV2. Archived from the original on 22 January 2022.

Retrieved 21 January 2022. • ^ "Reinfections with Omicron subvariants are rare, Danish study finds". Reuters. 22 February 2022. Retrieved 12 March 2022. • ^ a b "Had Omicron? You're unlikely to catch its rising variant". Nature. 25 February 2022. Retrieved 12 March 2022. • ^ "Boosters increase protection against death from Omicron in over-50s to 95% – UKHSA". The Guardian. 27 January 2022.

Archived from the original on 29 January 2022. Retrieved 27 January 2022. • ^ "COVID-19 vaccine surveillance report Week corona omicron indonesia (PDF). UK Health Security Agency. 27 January 2022. Archived (PDF) from the original on 27 January 2022.

Retrieved 27 January 2022. • ^ Gregory A (29 November 2021). "Omicron Covid variant poses very high global risk, says WHO". The Guardian. London. Archived from the original on 29 November 2021. Retrieved 29 November 2021.

• ^ Geddes L (29 November 2021). "What does appearance of Omicron variant mean for the double-vaccinated?". The Guardian. London. Archived from the original on 29 November 2021. Retrieved 29 November 2021. • ^ Omicron: what do we know about the new Covid variant? Archived 5 December 2021 at the Wayback Machine The Guardian • ^ Assessment of the further emergence corona omicron indonesia potential impact of the SARS-CoV-2 Omicron variant of concern in the context of ongoing transmission of the Delta variant of concern in the EU/EEA, 18th update (Technical report).

Stockholm: European Centre for Disease Prevention and Control. 15 December 2021. Archived from the original on 20 December 2021. Retrieved 16 December 2021. • ^ Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H, et al.

(COMMIT-KZN Team) (December 2021). "Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization". Nature. 602 (7898): 654–656. doi: 10.1038/s41586-021-04387-1. PMC 8866126. PMID 35016196. S2CID 245879254. • ^ Callaway E (December 2021).

"Omicron likely to weaken COVID vaccine protection". Nature. 600 (7889): 367–368. Bibcode: 2021Natur.600.367C. doi: 10.1038/d41586-021-03672-3. PMID 34880488. S2CID 245007078.

Archived from the original on 21 December 2021. Retrieved 4 January 2022. • ^ "Why Omicron-infected white-tailed deer pose an especially big risk to humans".

Fortune. • ^ CDC COVID-19 Response Team (December 2021). "SARS-CoV-2 B.1.1.529 (Omicron) Variant – United States, December 1-8, 2021". MMWR. Morbidity and Mortality Weekly Report.

Center for Disease Control. 70 (50): 1731–1734. doi: 10.15585/mmwr.mm7050e1. PMC 8675659. PMID 34914670. S2CID 245071514. Archived from the original on 20 December 2021. Retrieved 17 December 2021. • ^ "Omicron survives longer on plastic, skin than prior variants; nose swabbing found best for rapid tests". Reuters. 24 January 2022. Archived from the original on 28 January 2022. Retrieved 28 January 2022. • ^ Hirose R, Itoh Y, Ikegaya H, Miyazaki H, Watanabe N, Yoshida T, et al.

(19 January 2022). "Differences in environmental stability among SARS-CoV-2 variants of concern: Omicron has higher stability". bioRxiv 10.1101/2022.01.18.476607. • ^ New Covid variant: Will new measures against Omicron work? Archived 28 November 2021 at the Wayback Machine BBC • ^ AFP (2 December 2021).

"S. Africa expert: Previous infection doesn't protect against Omicron, but shots do". The Times of Israel. Archived from the original on 2 December 2021. Retrieved 2 December 2021. • ^ "LIVE – Covid: 'Staggering' Omicron case numbers expected – top health official".

BBC News. 15 December 2021. Archived from the original on 22 December 2021. Retrieved 15 December 2021. See entry for 10:05 • ^ Rozsa M, Karlis N (28 January 2022). "Omicron variant of COVID-19 may be the most contagious virus to ever exist". Salon. Archived from the original on 28 January 2022.

Retrieved 30 January 2022. • ^ Wang, Rui; Chen, Jiahui; Wei, Guo-Wei (16 December 2021). "Mechanisms of SARS-CoV-2 Evolution Revealing Vaccine-Resistant Mutations in Europe and America" (PDF). The Journal of Physical Chemistry Letters. 12 (49): 11850–11857. doi: 10.1021/acs.jpclett.1c03380. PMC 8672435. PMID 34873910. Archived (PDF) from the original on 18 December 2021. Retrieved 27 January 2022. • ^ "Study findings suggest spread of Omicron can be ascribed to immune evasiveness rather than an increase in transmissibility".

News-Medical.net. 5 January 2022. Archived from the original on 21 January 2022. Retrieved 17 January 2022. • ^ Lyngse, Frederik Plesner; Mortensen, Laust Hvas; Denwood, Matthew J.; Christiansen, Lasse Engbo; Møller, Camilla Holten; Skov, Robert Leo; Spiess, Katja; Fomsgaard, Anders; Lassaunière, Maria Magdalena; Rasmussen, Morten; Stegger, Marc; Nielsen, Claus; Sieber, Raphael Niklaus; Cohen, Arieh Sierra; Møller, Frederik Trier; Overvad, Maria; Mølbak, Kåre; Krause, Tyra Grove; Kirkeby, Carsten Thure (27 December 2021).

"SARS-CoV-2 Omicron VOC Transmission in Danish Households": 2021.12.27.21268278. doi: 10.1101/2021.12.27.21268278. S2CID 245536365. Archived from the original on 26 January 2022. Retrieved 27 January 2022. {{ cite journal}}: Cite journal requires -journal= ( help) • ^ Yunlong Cao et al. (23 December 2021). "Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies". Nature. doi: 10.1038/d41586-021-03796-6. S2CID 245455422. {{ cite journal}}: CS1 maint: uses authors parameter ( link) • ^ Wilhelm, Alexander; Widera, Marek; Grikscheit, Katharina; Toptan, Tuna; Schenk, Barbara; Pallas, Christiane; Metzler, Melinda; Kohmer, Niko; Hoehl, Sebastian; Helfritz, Corona omicron indonesia A.; Wolf, Timo; Goetsch, Udo; Ciesek, Sandra (8 December 2021).

"Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and Monoclonal Antibodies". doi: 10.1101/2021.12.07.21267432.

S2CID 244950946. {{ cite journal}}: Cite journal requires -journal= ( help) • ^ Liu, Lihong; Iketani, Sho; Guo, Yicheng; Chan, Jasper F-W.; Wang, Maple; Liu, Liyuan; Luo, Yang; Chu, Hin; Huang, Yiming; Nair, Manoj S.; Yu, Jian; Chik, Kenn K-H.; Yuen, Terrence T-T.; Corona omicron indonesia, Chaemin; To, Kelvin K-W.; Chen, Honglin; Yin, Michael T.; Sobieszczyk, Magdalena E.; Huang, Yaoxing; Wang, Harris H.; Sheng, Zizhang; Yuen, Kwok-Yung; Ho, David D.

(23 December 2021). "Striking Antibody Evasion Manifested by the Omicron Variant of SARS-CoV-2". Nature. 602 (7898): 676–681. doi: 10.1038/d41586-021-03826-3. PMID 35016198. S2CID 245462866. • ^ Rössler, Annika; Riepler, Lydia; Bante, David; Laer, Dorothee von; Kimpel, Janine (11 December 2021). "SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals".

doi: 10.1101/2021.12.08.21267491. S2CID 245019954. {{ cite journal}}: Cite journal requires -journal= ( help) • ^ "Omicron Variant: What You Need to Know". Centers for Disease Control and Prevention. 20 December 2021. Archived from the original on 27 January 2022. Retrieved 27 January 2022. • ^ "Update on Omicron". World Health Organization. 28 November 2021. Archived from the original on 30 November 2021.

Retrieved 30 November 2021. • ^ Abdullah F (4 December 2021). "Tshwane District Omicron Variant Patient Profile – Early Features". South African Medical Research Council. Archived from the original on 7 December 2021. Retrieved 7 December 2021. • ^ "Omicron Wave Sees South Africa's Weekly Excess Deaths Almost Double". Bloomberg. 8 December 2021. Archived from the original on 19 December 2021.

Retrieved 11 December 2021. • ^ "South Africa: previous infections may explain Omicron hospitalisation rate". The Guardian. 14 December 2021. Archived from the original on 20 December 2021. Retrieved 14 December 2021. • ^ Ferguson N, Ghani A, Cori A, Hogan A, Hinsley W, Volz E (20 December 2021). Growth, population distribution and immune escape of the Omicron in England (Technical report). WHO Collaborating Centre for Infectious Disease Modelling, MRC Centre for Global Infectious Disease Analysis.

Imperial College London. doi: 10.25561/93038. Report 49. Archived (PDF) from the original on 20 December 2021. • ^ Ferguson N, Ghani A, Hinsley W, Volz E (22 December 2021). Hospitalisation risk for Omicron cases in England (Technical report). WHO Collaborating Centre for Infectious Disease Modelling, MRC Centre for Global Infectious Disease Analysis.

Imperial College London. doi: 10.25561/93035. Report 50. Archived (PDF) from the original on 23 December 2021. • ^ a b Iuliano, A. Danielle (2022). "Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–January 2022". MMWR. Morbidity and Mortality Weekly Report. 71 (4): 146–152. doi: 10.15585/mmwr.mm7104e4. ISSN 0149-2195.

PMID 35085225. S2CID 246332966. • ^ "What to know about BA.2, the newest Covid omicron variant". NBC News. Retrieved 14 February 2022.

• ^ "Omicron BA.2: What we know about the Covid sub-variant". BBC News. 2 February 2022. Retrieved 14 February 2022. • ^ "There's a new version of omicron but so far it doesn't appear to be more dangerous". Washington Post. Retrieved 14 February 2022. • ^ Yamasoba, Daichi; Kimura, Izumi; Nasser, Hesham; Morioka, Yuhei; Nao, Naganori; Ito, Jumpei; Uriu, Keiya; Tsuda, Masumi; Zahradnik, Jiri; Shirakawa, Kotaro; Suzuki, Rigel; Kishimoto, Mai; Kosugi, Yusuke; Kobiyama, Kouji; Hara, Teppei; Toyoda, Mako; Tanaka, Yuri L.; Butlertanaka, Erika P.; Shimizu, Ryo; Ito, Hayato; Wang, Lei; Oda, Yoshitaka; Orba, Yasuko; Sasaki, Michihito; Nagata, Kayoko; Yoshimatsu, Kumiko; Asakura, Hiroyuki; Nagashima, Mami; Sadamasu, Kenji; Yoshimura, Kazuhisa; Kuramochi, Jin; Corona omicron indonesia, Motoaki; Fujiki, Ryoji; Kaneda, Atsushi; Shimada, Tadanaga; Nakada, Taka-aki; Sakao, Seiichiro; Suzuki, Takuji; Ueno, Takamasa; Takaori-Kondo, Akifumi; Ishii, Ken J.; Schreiber, Gideon; Consortium, The Genotype to Phenotype Japan (G2P-Japan); Sawa, Hirofumi; Saito, Akatsuki; Irie, Takashi; Tanaka, Shinya; Matsuno, Keita; Fukuhara, Takasuke; Ikeda, Terumasa; Sato, Kei (15 February 2022).

"Virological characteristics of SARS-CoV-2 BA.2 variant": 2022.02.14.480335. doi: 10.1101/2022.02.14.480335. S2CID 246905491. {{ cite journal}}: Cite journal requires -journal= ( help) • ^ Brenda Goodman (25 March 2022). "BA.2 more severe for children, Hong Kong study finds, though serious outcomes uncommon".

Cable News Network. Retrieved 25 March 2022. • ^ a b Johnson, Carla K. "Omicron drives US deaths higher than in fall's delta wave". medicalxpress.com. Retrieved 14 February 2022. • ^ "SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests". FDA. 16 December 2021. Archived from the original on 21 December 2021. Retrieved 16 December 2021. • ^ a b "SARS-CoV-2 variants of concern and variants under investigation in England" (PDF).

Archived (PDF) from the original on 18 December 2021. Retrieved 10 December 2021. • ^ "Only one approved rapid test in Australia explicitly states it detects Omicron". the Guardian. 27 January 2022. Archived from the original on 30 January 2022. Retrieved 30 January 2022. • ^ Nebehay S, Winning A (26 November 2021). "WHO names new COVID variant omicron, cautions against travel measures".

Reuters. Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ "BioNTech says it could tweak Covid vaccine in 100 days if needed".

The Guardian. 26 November 2021. Archived from the original on 27 November 2021. Retrieved 27 November 2021. • ^ "Novavax developing vaccine that targets new COVID-19 variant". CBS Baltimore Staff. 30 November 2021. Archived from the original on 2 December 2021.

Retrieved 4 December 2021. • ^ Maddipatla M, Roy M (26 November 2021). "Maryland-Based Vaccine Manufacturer Developing COVID-19 Vaccine That Targets Omicron Variant". Reuters. Archived from the original on 28 November 2021. Retrieved 30 November 2021. • ^ "Sputnik V maker: Vaccine could be adapted to fight omicron". ABC News. Moscow. Associated Press. 29 November 2021. Archived from the original on 2 December 2021.

Retrieved 29 November 2021. • ^ "Sinovac and world's Covid-19 vaccine makers 'ready' to produce Omicron jab". South China Morning Post. 29 November 2021. Archived from the original on 30 November 2021. Retrieved 29 November 2021. • ^ "Sinovac prevê atualização da Coronavac para variante Ômicron em até três meses" [Sinovac plans to update Coronavac to the Omicron variant within three months].

CNN Brazil (in Portuguese). 7 December 2021. Archived from the original on 9 December 2021. Retrieved 9 December 2021. • ^ "Cuba to update domestic vaccine to battle Omicron". Al Jazeera. 2 December 2021. Archived from the original on 20 December 2021.

Retrieved 20 December 2021. • ^ Spencer K (10 January 2022). "Pfizer CEO says omicron vaccine will be ready in March".

CNBC. Archived from the original on 26 January 2022 corona omicron indonesia. Retrieved 27 January 2022. • ^ a b "Omicron poses very high global risk, world must prepare -WHO". Reuters. Geneva. 29 November 2021. Archived from the original on 30 November 2021. Retrieved 30 November 2021.

• ^ Arbel, Ronen; Hammerman, Ariel; Sergienko, Ruslan; Friger, Michael; Peretz, Alon; Netzer, Doron; Yaron, Shlomit (8 December 2021). "BNT162b2 Vaccine Booster and Mortality Due to Covid-19". New England Journal of Medicine. 385 (26): 2413–2420. doi: 10.1056/NEJMoa2115624. PMC 8728797. PMID 34879190. • ^ Khoury, David S.; Steain, Megan; Triccas, James A.; Sigal, Alex; Davenport, Miles P.; Cromer, Deborah (17 December 2021).

"A meta-analysis of Early Results to predict Vaccine efficacy against Omicron": 2021.12.13.21267748. doi: 10.1101/2021.12.13.21267748. S2CID 245130598. Archived from the original on 29 January 2022. Retrieved 28 January 2022. {{ cite journal}}: Cite journal requires -journal= ( help) • ^ Garcia-Beltran, Wilfredo F.; Denis, Kerri J. St; Hoelzemer, Angelique; Lam, Evan C.; Nitido, Adam D.; Sheehan, Maegan L.; Berrios, Cristhian; Ofoman, Onosereme; Chang, Christina C.; Hauser, Blake M.; Feldman, Jared; Gregory, David J.; Poznansky, Mark C.; Schmidt, Aaron G.; Iafrate, A.

John; Naranbhai, Vivek; Balazs, Alejandro B. (14 December 2021). "mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant". medRxiv : The Preprint Server for Health Sciences: 2021.12.14.21267755. doi: 10.1101/2021.12.14.21267755.

PMC 8687472. PMID 34931201. Archived from the original on 29 January 2022. Retrieved 28 January 2022. • ^ Nicole A. Doria-Rose, Xiaoying Shen et al. (20 December 2021). "Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization". medRxiv : The Preprint Server for Health Sciences: 2021.12.15.21267805.

doi: 10.1101/2021.12.15.21267805. PMC 8687471. PMID 34931200. Archived corona omicron indonesia the original on 29 January 2022. Retrieved 28 January 2022. {{ cite journal}}: CS1 maint: uses authors parameter ( link) • ^ Hansen, Christian Holm; Schelde, Astrid Blicher; Moustsen-Helm, Ida Rask; Emborg, Hanne-Dorthe; Corona omicron indonesia, Tyra Grove; Mølbak, Kåre; Valentiner-Branth, Palle; Institut, on behalf of the Infectious Disease Preparedness Group at Statens Serum (23 December 2021).

"Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study": 2021.12.20.21267966. doi: 10.1101/2021.12.20.21267966. S2CID 245352810. Archived from the original on 29 January 2022.

Retrieved 28 January 2022. {{ cite journal}}: Cite journal requires -journal= ( help) • ^ Bar-On, Yinon M.; Goldberg, Yair; Mandel, Micha; Bodenheimer, Omri; Freedman, Laurence; Alroy-Preis, Sharon; Ash, Nachman; Huppert, Amit; Milo, Ron (23 December 2021). "Protection against Covid-19 by BNT162b2 Booster across Age Groups". New England Journal of Medicine.

385 (26): 2421–2430. doi: 10.1056/NEJMoa2115926. ISSN 0028-4793. PMC 8728796. PMID 34879188. • ^ "Pfizer shot provides partial omicron corona omicron indonesia, study finds". The Japan Times. Bloomberg. 8 December 2021. Archived from the original on 8 December 2021. Retrieved 8 December 2021. • ^ "Early Lab Test Shows Omicron Weakening Vaccine Effectiveness".

The Wall Street Journal. 7 December 2021. Archived from the original on 7 December 2021. Retrieved 7 December 2021.

• ^ "Omicron coronavirus variant partly evades Pfizer vaccine's protection, study shows". CNN. 7 December 2021. Archived from the original on 8 December 2021.

Retrieved 7 December 2021. • ^ "Pfizer And BioNTech Provide Update On Omicron Variant" (Press release). New York City and Mainz: Pfizer. 8 December 2021. Archived from the original on 21 December 2021. Retrieved 8 December 2021. • ^ "Coronavirus (COVID-19) booster vaccine". NHS. Government Digital Service. 17 September 2021. Archived from the original on 22 December 2021.

Retrieved 11 December 2021. • ^ SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 31 (PDF) (Briefing). Public Health England. 10 December 2021. pp. 3–5, 20–22. GOV-10645. Archived (PDF) from the original on 18 December 2021. Retrieved 10 December 2021. • ^ "Israeli trial, world's first, finds 4th dose 'not good enough' against Omicron". www.timesofisrael.com. 18 January 2022 corona omicron indonesia. Retrieved 11 April 2022. • ^ "Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern".

WHO. 26 November 2021. Archived from the original on 26 November 2021. • ^ "Update on Omicron". World Health Organization. 28 November 2021. Archived from the original on 30 November 2021. corona omicron indonesia ^ Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, Arabi YM, et al. (April 2021). "Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19".

The New England Journal of Medicine. 384 (16): 1491–1502. doi: 10.1056/NEJMoa2100433. PMC 7953461. PMID 33631065. • ^ Cathcart AL, Havenar-Daughton C, Lempp FA, Ma D, Schmid M, Agostini ML, et al. (2021). "The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2".

bioRxiv 10.1101/2021.03.09.434607. • ^ McCallum M, Czudnochowski N, Rosen LE, Zepeda SK, Bowen JE, Dillen JR, et corona omicron indonesia. (2021). "Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement". bioRxiv 10.1101/2021.12.28.474380. • ^ Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. (December 2021). "Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies". Nature. 602 (7898): 657–663. doi: 10.1038/d41586-021-03796-6.

PMC 8866119. PMID 35016194. S2CID 245455422. • ^ Cameroni E, Saliba C, Bowen JE, Rosen LE, Culap K, Pinto D, et al. (December 2021). "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift". bioRxiv. doi: 10.1038/d41586-021-03825-4. PMC 8687478. PMID 34931194. Archived from the original on 24 December 2021. Retrieved 23 December 2021. • ^ "March 25, 2022 - Important Update - HHS/ASPR".

aspr.hhs.gov. Retrieved 6 April 2022. • ^ Latest confirmed cases of COVID-19 in South Africa (26 November 2021) Archived 4 December 2021 at the Wayback Machine www.nicd.ac.za • ^ Latest confirmed cases of COVID-19 in South Africa (3 December 2021) Archived 4 December 2021 at the Wayback Machine www.nicd.ac.za • ^ see also GIS dashboard Archived 8 September 2021 at the Wayback Machine (statistical data) www.nicd.ac.za • ^ "Update on Omicron".

World Health Organization. 28 November 2021. Archived from the original on 30 November 2021. Retrieved 30 November 2021. • ^ Pulliam JR, van Schalkwyk C, Govender N, von Gottberg A, Cohen C, Groome MJ, et al. (January 2021). "SARS-CoV-2 reinfection trends in South Africa: analysis of routine surveillance data".

medRxiv. doi: 10.1101/2021.11.11.21266068. S2CID 243983860. • ^ "Omicron seems to carry higher Covid reinfection corona omicron indonesia, says South Africa". The Guardian. 2 December 2021. Archived from the original on 3 December 2021. Retrieved 3 December 2021. • ^ " 'Patience is crucial': Why we won't know for weeks how dangerous Omicron is".

www.science.org. Archived from the original on 30 November 2021. Retrieved 30 November 2021. • ^ Network for Genomic Surveillance in South Africa (26 November 2021). "Proportion and number of clades by epiweek in South Africa, 2021" (PDF). Archived (PDF) from the original on 2 December 2021. Retrieved 2 December 2021. • ^ a b c "Omicron becomes dominant variant in South Africa". The Guardian.

2 December 2021. Archived from the original on 2 December 2021. Retrieved 2 December 2021. • ^ "Risk assessment for SARS-CoV-2 variant: Omicron VOC-21NOV-01 (B.1.1.529): 3 December 2021" (PDF). GOV.UK. Archived (PDF) from the original on 4 December 2021. Retrieved 4 December 2021. • ^ McCarthy K, Rachida S, Yousif M, Ndlovu N, Iwu-Jaja C, Howard W, et al. "Wastewater-based epidemiology for SARS-CoV-2 in South Africa" (PDF). National Institute for Communicable Diseases.

Archived (PDF) from the original on 9 November 2021. Retrieved 30 November 2021. • ^ "COVID-19: Toddlers make up 10% of hospital cases in South Africa's Omicron epicentre". gulfnews.com. Archived from the original on 2 December 2021. Retrieved 2 December 2021.

• ^ "Omicron Spread in South Africa". p. 6. Archived from the original on 4 December 2021. Retrieved 4 December 2021. • ^ Mandavilli A (4 December 2021). "Omicron Variant Spreading Twice as Quickly as Delta in South Africa". The New York Times. ISSN 0362-4331.

Archived from the original on 4 December 2021. Corona omicron indonesia 4 December 2021. • ^ The SARS-CoV-2 variant Omicron: a snapshot of where we are – 08.12.2021, 5 PM CET., archived from the original on 21 December 2021retrieved 10 December 2021 • ^ "Prof. Albertsen deliberations". Twitter. Archived from the original on 14 December 2021.

Retrieved 11 December 2021. • ^ "SARS-CoV-2 variants of concern and variants under investigation in England – Technical briefing 33" (PDF). gov.uk. UK Health Security Agency. 23 December 2021. Archived (PDF) from the original on 2 January 2022. Retrieved 15 January 2022. • ^ Covid-19 Rapport om omikronvarianten [Status of the SARS-CoV-2 variant Corona omicron indonesia in Denmark] (PDF) (Report) (in Danish). Statens Serum Institut. 20 December 2021.

Archived (PDF) from the original on 21 December 2021. Retrieved 21 December 2021. • ^ Ekspertrapport den 17. december 2021 – Corona omicron indonesia for smittetal og nyindlæggelser med omikronvarianten [Expert report 17 December 2021 – Scenarios for infection numbers and new hospitalizations with the Omicron-variant] (PDF) (Report) (in Danish).

Statens Serum Institut. 18 December 2021. Archived (PDF) from the original on 19 December 2021. Retrieved 18 December 2021. • ^ "Variant-PCR svar fra 27. nov. og frem, Testcenter Danmark" (in Danish). Archived from the original on 27 December 2021. Retrieved 27 December 2021. • ^ "Schweiz sitrep". Twitter.

10 December 2021. Archived from the original on 12 December 2021. Retrieved 10 December 2021. • ^ "RKI – Coronavirus SARS-CoV-2 – Corona omicron indonesia vom 13.1.2022" (PDF).

www.rki.de. Archived (PDF) from the original on 13 January 2022. Retrieved 13 January 2022. • ^ "Omicron in Scotland – evidence paper". www.gov.scot. Archived from the original on 20 December 2021. Retrieved 11 December 2021. • ^ Wenseleers T (22 December 2021), tomwenseleers/newcovid_belgium, archived from the original on 22 December 2021retrieved 22 December 2021 • ^ "Ontario Dashboard".

Ontario COVID-19 Science Advisory Table. Archived from the original on 17 March 2021. Retrieved 12 December 2021. • ^ "COVID Data Tracker". Centers for Disease Control and Prevention. 28 March 2020. Archived from the original on 22 May 2021. Retrieved 21 December 2021. • ^ "Portugal says Omicron dominant, infections rising". NewsNine. 25 December 2021. Archived from the original on 28 December 2021.

Retrieved 28 December 2021. • ^ Wenseleers T (20 December 2021), tomwenseleers/newcovid_belgium, archived from the original corona omicron indonesia 22 December 2021retrieved 21 December 2021 • ^ "Variants of the coronavirus SARS-CoV-2 in the Netherlands". Archived from the original on 11 January 2022. Retrieved 14 January 2022. • ^ "COVID: Omicron accountts for 28% of cases in Italy, will soon be dominant". ANSA.en.

23 December 2021. Archived from the original on 24 December 2021. Retrieved 28 December 2021. • ^ Oppdatert P. "Statistikk over meldte tilfeller av virusvarianten omikron" (in Norwegian).

Folkehelseinstituttet. Archived from the original on 28 December 2021 corona omicron indonesia. Retrieved 29 December 2021. • ^ "Covid-19: Omicron is now the dominant variant in France". France24. 31 December 2021. Archived from the original on 3 January 2022. Retrieved 31 December 2021. • ^ "Omicron is now the dominant variant in France". CNN. 31 December 2021. Archived from the original on 31 December 2021.

Retrieved 31 December 2021. • ^ Maxmen A (December 2021). "Omicron blindspots: why it's hard to track coronavirus variants". Nature. 600 (7890): 579.

Bibcode: 2021Natur.600.579M. doi: 10.1038/d41586-021-03698-7. PMID 34916668. S2CID 245262198. Archived from the original on 19 December 2021. Retrieved 20 December 2021. • ^ "SARS-CoV-2 variants of concern and variants under investigation in England, Technical briefing 38" (PDF).

assets.publishing.service.gov.uk. Retrieved 3 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "The puzzle of America's record Covid hospital rate". BBC News. 13 January 2022.

Archived from the original on 14 January 2022. Retrieved 14 January 2022. • ^ Berger M (28 November 2021). "South Africa, which found the omicron variant first, leads Africa in coronavirus sequencing". Washington Post. Archived from the original on 2 December 2021. Retrieved 2 December 2021. • ^ "Sequencing by country". GISAID. 2 December 2021. Archived from the original on 2 December 2021.

Retrieved 2 December 2021. • ^ Geddes L (15 December 2021). "How big is the risk of Omicron in the UK and how do we know?". The Guardian. Archived from the original on 21 December 2021.

Retrieved 15 December 2021. • ^ a b Oppdatert, Publisert. "Statistikk over meldte tilfeller av virusvarianten omikron".

Folkehelseinstituttet (in Norwegian). Retrieved 22 December 2021. • ^ "Status på omikron-varianten (B.1.1.529) pr. 05.12.21" [Status of the Omicron variant (B.1.1.529) per 05.12.21] (in Danish). Statens Serum Institut.

Archived from the original on 7 December 2021. Retrieved 18 December 2021. • ^ "Cov-Lineages". cov-lineages.org. Retrieved 15 January 2022. {{ cite web}}: CS1 maint: url-status ( link) Updated frequently. • ^ "Tracking of Variants". GISAID. Archived from the original on 23 June 2021.

Retrieved 12 January 2022. Updated frequently. • ^ a b "UK Corona omicron indonesia Security Agency Omicron daily overview: 31 December 2021" (PDF). {{ cite web}}: CS1 maint: url-status ( link) • ^ "Omikron (B.1.1.529)" [Omicron (B.1.1.529)] (in Danish). Statens Serum Institut. Retrieved 21 December 2021. • ^ a b c d "Newsnodes - Omicron tracker". newsnodes.com. Retrieved 24 December 2021. • ^ "オミクロン株の国内発生状況について". www.mhlw.go.jp (in Japanese). Retrieved 9 January 2022. • ^ "Tracking variants of the novel coronavirus in Canada".

CTV News. 4 February 2021. Retrieved 11 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ a b "Wochenberichte zu COVID-19" (in German). Robert Koch Institute. 16 December 2021. Retrieved 19 December 2021. • ^ a b c d e f g h "Omicron in Europe: Where has the new COVID variant been detected?". euronews. 13 December 2021. Retrieved 20 December 2021. • ^ "SARS-CoV-2-Varianten in Österreich". AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit (in German).

Retrieved 20 December 2021. • ^ "Coronavirus : chiffres clés et évolution de la COVID-19 en France et dans le Monde". www.santepubliquefrance.fr (in French). Retrieved 19 December 2021. • ^ "Indonesia Laporkan 3.779 Kasus Omicron". CNNIndonesia.com (in Indonesian). 8 February corona omicron indonesia. Retrieved 8 February 2022. • ^ "Country Has 5,397 Omicron Corona omicron indonesia. สำนักข่าวไทย อสมท (in Thai). 10 January 2022. Retrieved 10 January 2022. • ^ "Singapore reports 24 confirmed Omicron cases as at Thursday".

www.thesundaily.my. Retrieved 18 December 2021. • ^ Auto, Hermes (22 December 2021). "More Omicron cases picked up in Singapore; community spread a matter of time: MOH - The Straits Times".

www.straitstimes.com. Retrieved 22 December 2021. • ^ Acharya, Ashutosh (29 December 2021). "Omicron most transmissible COVID-19 variant corona omicron indonesia not threatening Singapore: Experts". The Federal. Retrieved 29 December 2021. • ^ "MOH - News Highlights". www.moh.gov.sg. Retrieved 1 January 2022.

• ^ "Tänahommikuse seisuga on haiglas 274 koroonaviirusega nakatunud patsienti" [As of this morning, the hospital has 274 patients infected with the coronavirus].

terviseamet.ee (in Estonian). 13 December 2021. Retrieved 13 December 2021. Eestis on tuvastatud kokku 26 koroonapositiivset, kelle puhul viitab genotüpiseerimine omikron tüvele, nendest kuus on kinnitatud sekveneerimise käigus.

A total of 26 corona-positive cases have been identified in Estonia, in which case genotyping indicates an omicron strain, six of which have been confirmed during sequencing. • ^ "Tänahommikuse seisuga on haiglas 220 koroonaviirusega nakatunud patsienti - Terviseamet".

www.terviseamet.ee (in Estonian). Retrieved 22 December 2021. • ^ "Tänahommikuse seisuga on haiglas 231 koroonaviirusega nakatunud patsienti - Terviseamet". www.terviseamet.ee (in Estonian). Retrieved 31 December 2021. • ^ "Variants of concern". CDGN. Retrieved 7 January 2022. • ^ India, COVID19. "INDIA WE WILL FIGHT IT TOGETHER". COVID19 India.

Retrieved 30 December 2021. • ^ "Omicron Cases in India - Coronavirus Cases in India". NDTV.com. Retrieved 10 January 2022. • ^ a b @IsraelMOH (25 December 2021). "היום, 25/12/2021 זוהו 591 מאומתים חדשים" (Tweet) (in Hebrew) – via Twitter.

• ^ staff, T. O. I.; Schneider, Tal. "In Israel's first suspected Omicron death, vaccinated woman succumbs to virus". www.timesofisrael.com. Retrieved 29 December 2021.

• ^ "Lineage B.1.1.529". cov-lineages.org. Cov-Lineages. Retrieved 19 December 2021. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Omicron variant more resistant to vaccine but causes less severe covid, major South African study concludes". Washington Post. ISSN 0190-8286. Retrieved 16 December 2021. Later information provided by a Discovery Health spokeswoman put the number of total cases at 78,173, of which 19,070 tests were positive during the "omicron period" from Nov.

15 to Dec. 7. • ^ 고병준 (3 January 2022). "(2nd LD) Daily virus cases stay below 4,000 for 2nd straight day amid tighter antivirus corona omicron indonesia. Yonhap Corona omicron indonesia Agency. Retrieved 4 January 2022. • ^ a b c d e f g h "Epidemiological update: Omicron variant of concern (VOC) – data as of 16 December 2021 (12:00)".

European Centre for Disease Prevention and Control. 16 December 2021. Retrieved 20 December 2021. • ^ "Statistik om SARS-CoV-2 virusvarianter av särskild betydelse — Folkhälsomyndigheten". www.folkhalsomyndigheten.se (in Swedish). Retrieved 5 January 2022. • ^ "COVID-⁠19 Switzerland - Coronavirus - Dashboard". www.covid19.admin.ch. Retrieved 29 December 2021.

• ^ "Ómicron: the Ministry of Health confirmed the first case in Argentina". MRT. 6 December 2021. Archived from the original on 6 December 2021. Retrieved 6 December 2021.

• ^ "Córdoba confirmó 454 casos de la variante Ómicron de coronavirus" [Córdoba confirmed 454 cases of the Omicron variant of coronavirus] (in Spanish). Télam. 19 December 2021. Retrieved 19 December 2021. • ^ "Hay más de 80 casos posibles de Ómicron en Argentina" [There are more than 80 possible cases of Ómicron in Argentina] (in Spanish).

13 December 2021. Retrieved 13 December 2021. • ^ a b "Table 1. Confirmed cases of SARS-CoV-2 Omicron VOC reported by public sources, as of 10 December 2021 (12:00)". ecdc.europa.eu. European Centre for Disease Prevention and Control (ECDC). 10 December 2021. Retrieved 16 December 2021. • ^ "Omikronvariant B.1.1.529". National Institute for Public Health and the Environment. Retrieved 15 December 2021. • ^ "Summary of COVID-19 virus variants in Ireland – HPSC".

HSE Health Protection Surveillance Centre (HPSC). 28 January 2022. p. 7. Retrieved 1 February 2022. • ^ "Travel restrictions tightened as Rock confirms 24 Omicron cases". 17 December 2021. Retrieved 20 December 2021. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Kári spáir omíkron-bylgju í janúar". ruv.is (in Icelandic). 18 December 2021. Retrieved 19 December 2021.

• ^ "Covid-19: sulla piattaforma ICoGen 84 sequenze della variante Omicron" [Covid-19: 84 sequences of the Omicron variant on the ICoGen platform] (in Italian).

18 December 2021. Archived from the original on 20 December 2021. Retrieved 20 December 2021. • ^ "ISP confirmó 30 casos de la nueva variante Ómicron a nivel nacional". CNN Chile (in Spanish). 16 December 2021. Archived from the original on 16 December 2021. Retrieved 19 December 2021. • ^ "Autoridad sanitaria informa 73 casos confirmados con variante Ómicron en Chile". La Tercera. 20 December 2021. Retrieved 21 December 2021. • ^ Ministerio de Salud [@ministeriosalud] (3 January 2022).

" 'Tenemos 684 casos #ómicron en todo el país.

corona omicron indonesia

De ellos, 661 corresponden a viajeros, 14 casos positivos con nexo de viajeros y 9 son los casos comunitarios, estos últimos, todos en la región Metropolitana' " ['We have 684 #omicron cases nationwide. Of these, 661 correspond to travelers, 14 positive cases connected to travelers and 9 are community cases, the latter, all in the Metropolitan region.'] (Tweet) (in Spanish). Retrieved 4 January 2022 – via Twitter. • ^ "Portugal tem 38 casos da variante ómicron. Cuidados intensivos com "tendência fortemente crescente" " [Portugal has 38 cases of the omicron variant.

Intensive care shows "strongly increasing trend"]. Público. 3 December 2021. Archived from the original on 4 December corona omicron indonesia. Retrieved 4 December 2021. • ^ "Monitorização das linhas vermelhas para a COVID-19" [Monitoring of red lines for COVID-19] (PDF).

INSA (in Portuguese). National Health Service of Portugal. 3 December 2021. p. 14. Archived (PDF) from the original on 4 December 2021. Retrieved 7 December 2021. • ^ a b MATIN, S. BaLE. "Le Matin - Omicron : 76 cas enregistrés au Maroc corona omicron indonesia une personne admise en réanimation".

Le Matin (in French). Retrieved 29 December 2021. • ^ "Zimbabwe says country has identified 50 cases of Omicron".

corona omicron indonesia

Reuters. Johannesburg. 3 December 2021. Archived from the original on 3 December 2021. Retrieved 3 December 2021. • ^ "Ômicron: incidência já é de 31,7% em oito estados do Brasil, mostra levantamento inédito" (in Brazilian Portuguese).

Editora Globo S/A. 29 December 2021. Retrieved 31 December 2021. • ^ "THL ja STM: Etelä-Suomessa lähes kaikki corona omicron indonesia omikronia". Yle Uutiset (in Finnish). 5 January 2022. Retrieved 6 January 2022. • ^ "53,600 COVID infections diagnosed in 1 week, 140 deaths in 2 weeks". clickittefaq.

13 January 2022. Retrieved 13 January 2022. The total number of cases of the Omicron variant was 523 until Wednesday. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Cyprus detects first cases of COVID-19 Omicron variant". news.trust.org. Reuters. Retrieved 10 December 2021. • ^ "Coronavirus: 28 more people found positive for Omicron - Cyprus Mail". cyprus-mail.com. Retrieved 19 December 2021. {{ cite web}}: CS1 maint: url-status ( link) • ^ @MOH_Kenya (18 December 2021). "Twenty-seven sequences (77%) were confirmed to belong to the newly identified Omicron variant of concern" (Tweet).

Retrieved 20 December 2021 – via Twitter. • ^ "В России выявили более 250 случаев заболевания подвидом омикрон-штамма ВA.2". TASS. 2 February 2022. Retrieved 2 February 2022. • ^ a b "COVID-19 Update - 24 December". www.gov.ky. Retrieved 26 December 2021. • ^ Ministry of Health - Uganda [@@MinofHealthUG] (18 December 2021). "PRESS RELEASE: Update on Omicron Variant in #Uganda" (Tweet).

Uganda. Retrieved 19 December 2021 – via Twitter. • ^ "Omicron confirmed in nine African countries, say officials". ABC News. Corona omicron indonesia from the original on 7 December 2021.

Retrieved 7 December 2021. • ^ Guillén, Beatriz (3 December 2021). "México confirma el primer caso de ómicron en el país" [Mexico confirms the first omicron case in the country]. El País (in Spanish). Mexico. Retrieved 3 December 2021. • ^ "MidCentral hits 90% fully vaccinated milestone; 69 community cases; 62 in hospital; 7 in ICU".

Ministry of Health NZ. Retrieved 20 December 2021. • ^ "Namibia detects Omicron coronavirus variant in 18 of 19 samples". Reuters. 6 December 2021. Archived from the original on 6 December 2021. Retrieved 7 December 2021. • ^ corona omicron indonesia reports 7 imported virus cases".

Hong Kong's Information Services Department (in Chinese (Hong Kong)). Retrieved 24 December 2021. • ^ "14 imported virus cases found". Hong Kong's Information Services Department (in Chinese (Hong Kong)) .

corona omicron indonesia

Retrieved 30 December 2021. • ^ "Senegal records first Omicron case in tourist who attended demonstration". Reuters. 5 December 2021. Archived from the original on 5 December 2021. Retrieved 5 December 2021. • ^ "Omicron in southern Africa: Mozambique is worried for its economy, especially tourism".

Bahrain News Agency. 10 December 2021. Retrieved 10 December 2021. • ^ Newsroom. "Όμικρον: corona omicron indonesia κρούσματα στην Ελλάδα - Η ΚΑΘΗΜΕΡΙΝΗ". www.kathimerini.gr. Retrieved 20 December 2021. • ^ Bell, Jonathan (21 December 2021). "Omicron cases surge from one to more than 100 in two weeks". www.royalgazette.com. Retrieved 24 December 2021. • ^ Bell, Jonathan (24 December 2021). "Two in hospital as Bermuda passes 6,000 Covid-19 cases".

www.royalgazette.com. Retrieved 26 December 2021. • ^ "Latvia gets its first two Omicron cases". Public Broadcasting of Latvia.

corona omicron indonesia

Reuters. 6 December 2021. Archived from the original on 6 December 2021. Retrieved 6 December 2021. • ^ "Pagājušajā nedēļā par trešdaļu pieaudzis Covid-19 inficēto skaits - Slimību profilakses un kontroles centrs". www.spkc.gov.lv (in Latvian). Retrieved 4 January 2022. • ^ "Comunicate de presa" [Press Releases].

ms.ro (in Romanian). Ministerul Sănătăţii (Health Ministry Romania). 12 December 2021. Retrieved 13 December 2021. So far, 8 corona omicron indonesia with the Omicron variant of the SARS-Cov-2 virus have been confirmed in Romania. • ^ "MS: Încă două cazuri de infectare cu varianta Omicron au fost confirmate în România".

www.digi24.ro (in Romanian). Retrieved 18 December 2021. Până în prezent, în România au fost confirmate 13 cazuri cu varianta OMICRON a virusului SARS-Cov-2. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Au fost descoperite încă 9 cazuri de infectare cu varianta Omicron în România".

www.digi24.ro (in Romanian). Retrieved 24 December 2021. • ^ "Covid-19: 245 Omicron cases detected so far, 157 among umrah returnees, corona omicron indonesia Khairy". The Star. 6 January 2022. Retrieved 6 January 2022. • ^ "Zambia reports more Omicron variant COVID-19 cases". Xinhuanet.com.

11 December 2021. Retrieved 13 December 2021. • ^ Adetifa, Dr Ifedayo (7 December 2021). "Three Additional Cases of Omicron Variant Confirmed". ncdc.gov.ng. Nigeria Centre for Disease Control (NCDC). Retrieved 11 December 2021.

In addition to the three cases announced earlier on 1st December 2021, this brings the total number of confirmed cases of the Omicron variant detected in Nigeria to six (6). • ^ "Koronavirus ONLINE: Válek smetl povinné očkování 60+. A 5982 případů za sobotu v ČR". Blesk.cz (in Czech). Archived from the original on 20 December 2021. Retrieved 20 December 2021. • ^ "Kosovo reports first cases of COVID-19 Omicron". Reuters. Pristina. 26 December 2021.

Retrieved 28 December 2021. Kosovo's health ministry said corona omicron indonesia Sunday it had registered its first nine cases of the Omicron coronavirus variant in the Balkan country. • ^ "First cases of the omicron variant of coronavirus confirmed in Slovenia". GOV.SI. 14 December 2021. Retrieved 15 December 2021. • ^ W3bStudio (21 December 2021). "Omicron confirmed in all Slovenian regions but one". Slovenia Times. Retrieved 22 December 2021. • ^ "Omicron estimated to represent 40% of all coronavirus cases in Slovenia".

Slovenia Times. 30 December 2021. Retrieved 1 January 2022. The National Laboratory of Health, Environment and Food said today it had confirmed 981 omicron cases with PCR tests. {{ cite web}}: CS1 maint: url-status ( link) • ^ a b "Cases of Omicron variant rise to 8 in Lebanon". www.news.cn.

Retrieved 19 December 2021. • ^ "Lebanon's total Omicron cases rise to 433". ANI News. Xinhua. Retrieved 26 December 2021. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Covid-19 à La Réunion : identification d'un 2ème cas positif au variant « Omicron »" [Covid-19 in Reunion Island: identification of a 2nd positive case for the "Omicron" variant]. reunion.gouv.fr (in French).

Les services de l'État à La Réunion. 3 December 2021. Retrieved 9 December 2021. • ^ a b c d "В России впервые с октября выявили менее 200 тыс. случаев ковида за неделю". ТАСС. Retrieved 20 December 2021.

• ^ "Six cases of Omicron variant detected in Turkey – minister". Reuters. 11 December 2021. Retrieved 11 December 2021. • ^ "Laboratorije Odjeljenja za molekularnu dijagnostiku potvrdile 5 slučajeva infekcije Omicron sojem". Institut za javno zdravlje Crne Gore. 16 December 2021.

Retrieved 17 December 2021. • ^ "Cambodia confirms 1st case of Omicron COVID-19 variant". Xinhua News Agency. 15 December 2021. Retrieved 15 December 2021. • ^ "Distribución de casos por las VOC delta - ómicron" [Distribution of cases by VOC Delta - Omicron]. Instituto Nacional de Salud del Perú (in Spanish).

corona omicron indonesia March 2022. Retrieved 9 March 2022. • ^ الأردنية (بترا), وكالة الأنباء. "تسجيل 30 إصابة جديدة بمتحور أوميكرون في المملكة". بترا -وكالة الأنباء الأردنية. Retrieved 5 January 2022.

• ^ 畅, 刘 (13 December 2021). "天津从入境人员中检出奥密克戎变异株,为中国内地首次检出" [The Omicron mutant strain was detected in Tianjin from immigrants, which is the first detection in Mainland China]. The Beijing News. Retrieved 13 December 2021. • ^ "Guangzhou reports China's second case of Omicron variant". South China Morning Post. 14 December 2021. Retrieved 17 December 2021. • ^ "湖南长沙从入境人员中检出2例新冠病毒奥密克戎变异株感染者" [2 cases of coronavirus Omicron variant detected from incoming persons in Changsha, Hunan Province].

18 December 2021. • ^ MINSAP, Redacción (15 December 2021). "Nota informativa del Ministerio de Salud Pública". Sitio oficial de gobierno del Ministerio de Salud Pública en Cuba (in European Spanish). Retrieved 20 December 2021. • ^ "Ascienden a 44 los casos de Ómicron en Cuba". Cubita Now. Retrieved 30 December 2021. • ^ "Ascienden a 92 los corona omicron indonesia de ómicron confirmados en Cuba" [Confirmed omicron cases in Cuba amount to 92].

Cubita Now. 4 January 2022. Retrieved 9 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Malawi confirms 3 Omicron cases, issues strict traveling restrictions". www.news.cn. Retrieved 10 December 2021. • ^ "First case of Omicron coronavirus variant detected in Gaza". The Times of Israel. 26 December 2021. • ^ "الناطق باسم corona omicron indonesia الصحة د.

كمال. - وزارة الصحة الفلسطينية - Facebook". Facebook. Retrieved 30 December 2021. • ^ Chang, Ming-hsuan; Liu, Kay (1 January 2022). "Taiwan reports 21 new COVID-19 cases, confirms 2 Omicron infections". Central News Agency of the Republic of China. Focus Taiwan. Retrieved 2 January 2022. • ^ "Lithuania confirms two Omicron infections". Lithuanian National Radio and Television. 15 December 2021. Retrieved 15 December 2021. • ^ @MinSaludCol (20 December 2021). "¡ATENCIÓN!

Se confirma la presencia de la variante Ómicron en Colombia" (Tweet). Retrieved 21 December 2021 – via Twitter. • ^ "First Omicron cases confirmed in Slovakia". The Slovak Spectator. 11 December 2021. Retrieved 12 December 2021.

First three Omicron cases have been confirmed in Slovakia. • ^ Lindo, Paula (13 December 2021). "Health Ministry: Trinidad and Tobago's first omicron case breached travel protocols". Trinidad and Tobago Newsday. Retrieved 16 December 2021. TT's first recorded case of the omicron variant is an imported one. • ^ "Confirman primer caso positivo de variante ómicron en Puerto Rico". CNN en Español (in Spanish). 14 December 2021. Retrieved 14 December 2021.

• ^ "Two confirmed cases of Omicron variant in quarantine". Fiji Broadcasting Corporation. Archived from the original on 6 December 2021.

Retrieved 6 December 2021. • ^ "Nepal detects first two cases of Omicron variant – health ministry". Reuters. 6 December 2021. Retrieved 6 December 2021. • ^ "Myanmar confirms four cases of Omicron variant of COVID-19". ANI News. Retrieved 2 January 2022. • ^ "Philippines detects Omicron variant from 2 international travelers".

GMA News. 15 December 2021. Retrieved 15 December 2021. • ^ Magsambol, Bonz (20 December 2021). "Philippines detects one more case of Omicron, total now at 3". Rappler. Retrieved 22 December 2021. • ^ "PH detects 4th imported Omicron case". CNN Philippines. 27 December 2021. • ^ "Philippines detects 10 new Omicron cases, including 3 local". GMA News.

31 December 2021. Retrieved 2 January 2022. • ^ "Philippines detects 29 more cases of COVID-19 omicron variant". ABS-CBN News. 6 January 2022. Retrieved 7 January 2022. • ^ "Philippines detects 492 new Omicron cases, total at 535". GMA News. 19 January 2022. Retrieved 24 January 2022. • ^ " 'Omicron variant' detected in two people in TRNC!". KIBRIS POSTASI (in Turkish).

Retrieved 22 December 2021. • ^ "Bangladesh reports first Omicron cases". Business Standard. 11 December 2021. Retrieved 12 December 2021. • ^ "Epidemiological update: Omicron variant of concern (VOC) – data as of 8 December 2021 (12.00)".

ecdc.europa.eu. ECDC. 8 December 2021. Retrieved 9 December 2021. • ^ "Müller Cecília: megjött Magyarországra az omikron variáns" [Cecília Müller: the omicron variant has arrived in Hungary]. Infostart. 13 December 2021. Retrieved 13 December 2021. • ^ "További 46 omikronos esetet azonosítottak". koronavirus.gov.hu (in Hungarian).

23 December 2021. Retrieved 24 December 2021. • ^ "Recording the First Cases Of Omicron Variant #OmanVSCovid19". Twitter. Retrieved 14 December 2021. • ^ "Coronavirus: Pakistan reports first case of Omicron variant".

www.geo.tv. 9 December 2021. Retrieved 9 December 2021. • ^ "Important Public Service Information". Twitter. Retrieved 29 December 2021. • ^ "Sri Lanka reports first corona omicron indonesia of Omicron variant". The Economic Times .

corona omicron indonesia

Retrieved 3 December 2021. • ^ "Omicron Cases Rise to 600 in Georgia". bm.ge. 7 January corona omicron indonesia. Retrieved 8 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "The Kingdom of Bahrain detects a case of the Omicron variant in an incoming traveller with no local contact". Bahrain News Agency.

11 December 2021. Retrieved 13 December 2021. • ^ "Ecuador confirma primer caso de Ómicron". Ministerio de Salud Pública. 14 December 2021. Retrieved 15 December 2021. • ^ Coronavirus: Kuwait reports first case of Omicron variant 8 December 2021 • ^ "First case of Omicron detected in Corona omicron indonesia. ANI News. Retrieved 9 December 2021. • ^ "Maldives reports 4 new Omicron cases". The Times of Addu. 15 December 2021. Retrieved 30 December 2021.

• ^ "Public Health National Emergency Operations Center, Sierra Leone". www.facebook.com. Retrieved 10 December 2021. • ^ "Saudi Arabia detects first case of COVID-19 Omicron variant in Kingdom". Al Arabiya English. December 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ "Tunisia records first case of omicron variant". Arab News. 3 December 2021.

Archived from the original on 8 December 2021. Retrieved 5 December 2021. • ^ Mukherjee, Promit; Hunnicutt, Trevor (1 December 2021). "Omicron rapidly dominating in South Africa; U.S. reports first case". Reuters. Archived from the original on 2 December 2021. Retrieved 2 December 2021. • ^ "افزایش مبتلایان به اُمیکرون در کشور به ۴۶۷ مورد". ایسنا (in Persian). 7 January 2022. Retrieved 10 January 2022.

• ^ "В Україні виявили штам "Омікрон" " [Omicron strain found in Ukraine]. Ukrainian Ministry of Health (in Ukrainian). 18 December 2021. Archived from the original on 20 December 2021. Retrieved 20 December 2021. • ^ "Panama detects first case of COVID-19 Omicron variant". Reuters. 20 December 2021. Retrieved 21 December 2021. • ^ "Costa Rica Announces First Case of Omicron Variant". The Tico Times. 20 December 2021. Retrieved 21 December 2021. • ^ "First Omicron cases in Aruba". The Daily Herald.

Retrieved 21 December 2021. • ^ "В Северной Македонии выявили первый случай заражения омикрон-штаммом". ТАСС. Retrieved 26 December 2021. • ^ Макфакс (5 January 2022). "Пораст на бројот на заразени од коронаворус, во Македонија активни 5.667 случаи" [Increase in the number of coronavirus infected, 5,667 active cases in Macedonia]. МАКФАКС (in Macedonian). Retrieved 9 January 2022. Во Македонија вчера беа детектирани corona omicron indonesia случаи на омикрон, од кои 8 од Скопје и едно лице од Кочани.

(Nine cases of Omicron were detected in Macedonia yesterday, of which 8 were from Skopje and one person from Kocani.) {{ cite web}}: CS1 maint: url-status ( link) • ^ "Ngày 19/1: Có 15.959 ca COVID-19, Hà Nội vẫn nhiều nhất; Đã ghi nhận 108 ca nhiễm biến chủng Omicron" (in Vietnamese). Retrieved 19 January 2022. • ^ "Brunei detects another 7 Omicron cases".

The Star (Malaysia). 28 December 2021. Retrieved 28 December 2021. Another seven new Omicron cases have been detected in the Sultanate following the first case found on Dec 22.

• ^ Farrugia, Claire (3 January 2022). "Authorities keep silent on cases of Omicron". Times of Malta. Retrieved 7 January 2022. Nothing said after the announcement that the first two cases had been detected. • ^ Sequera, Vivian (23 December 2021).

"Venezuela's Maduro says seven Omicron cases detected". Reuters. Retrieved 7 January 2022. • ^ "Covid-19 : la circulation du variant Omicron désormais avérée en Guyane, une vingtaine de cas détectés" [Covid-19: the circulation of the Omicron variant now proven in Guyana, around twenty cases detected].

Guyane la 1ère (in French). 29 December 2021. Retrieved 7 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "(COVID-19) La République du Corona omicron indonesia enregistre une flambée des nouvelles contaminations (officiel)_French.news.cn" [(COVID-19) Republic of Congo records outbreak of new contamination (official)]. french.news.cn (in French). 5 January 2022.

Retrieved 7 January 2022. corona omicron indonesia également pour la première fois la circulation du variant Omicron en République du Congo (.also confirming for the first time the circulation of the Omicron variant in the Republic of Congo). {{ cite web}}: CS1 maint: url-status ( link) • ^ "MOPH Confirms Detection of Four Cases of Omicron COVID-19 Variant in Qatar".

corona omicron indonesia

news.qna.org.qa. 17 December 2021. Retrieved 2 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Se confirman tres casos de Ómicron en viajeros provenientes de Cancún" [Three cases of Omicron confirmed in travellers from Cancun]. corona omicron indonesia. 27 December 2021. Retrieved 2 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Burkina Faso com dois casos de variante de covid-19 Omicron" [Burkina Faso with two cases of COVID-19 Omicron variant].

ANGOP. 18 December 2021. Retrieved 2 January 2022. • ^ "Omikron-variant officieel op Curaçao" [Omicron variant officially in Curacao]. Paradise FM. 24 December 2021. Retrieved 2 January 2022. • ^ Byron, Anglina (1 January 2022). "Dr Laws confirms two cases of Omicron variant in St Kitts and Nevis". Associates Times a Caribbean News website. Retrieved 2 January 2022. • ^ "Libya reports first Omicron cases". The Libya Observer. 30 December 2021. Retrieved 2 January 2022. • ^ "First Case of 'Omicron' Variant Confirmed in Albania".

Albanian Daily News. 23 December 2021. Retrieved 2 January 2022. • ^ Rollock, Melissa (30 December 2021). "Chief Medical Officer: Omicron Is Here". GIS. Retrieved 2 January 2022. • ^ "One Imported Omicron Case". www.gov.vc. 27 December 2021. Retrieved 2 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ Sorto, Marlon (25 December 2021). "República Dominicana confirma primer caso de variante ómicron de covid-19" [Dominican Republic confirms first case of Omicron variant of COVID-19].

CNN Espanol. Retrieved 2 January 2022. • ^ "Jamaica On Alert For Omicron Variant – Jamaica Information Service". jis.gov.jm. 22 December 2021. Retrieved 2 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Omikron soj stigao u Srbiju, potvrdila dr Tanja Jovanović" [Omicron strain has arrived in Serbia, Dr. Tanja Jovanović confirmed.]. Klinka. 23 December 2021.

Retrieved 2 January 2022. • ^ "Tanzanian president confirms spreading of Omicron variant-Xinhua". english.news.cn. 1 January 2022. Retrieved 2 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Le Togo enregistre ses premiers cas du variant Omicron" [Togo records its first cases of the Omicron variant].

Le Courrier. Retrieved 2 January 2022. Au moins cinq cas du nouveau variant Omicron ont été identifiés au Togo. (At least five cases of the new Omicron variant have been identified in Togo). • ^ "В Беларусь пришел новый вариант коронавируса – омикрон" [New variant of coronavirus arrives in Belarus - Omicron]. minzdrav.gov.by (in Russian). 29 December 2021. Retrieved 2 January 2022. Новый штамм выявлен у четырех минчан.

(The new strain was identified in four residents of Minsk.) {{ cite web}}: CS1 maint: url-status ( link) • ^ "Omikron stigao i u Bosnu i Hercegovinu, novi soj potvrđen kod 10 osoba" [Omicron has also arrived in Bosnia and Herzegovina, the new strain has been confirmed in 10 people]. www.klix.ba (in Croatian). 29 December 2021. Retrieved 2 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Covid-19: Angola confirms Omicron's circulation". Angola Press News Agency. 24 December 2021.

Retrieved 2 January 2022. • ^ "COVID-19 : Dr Muyembe révèle corona omicron indonesia le variant Omicron représente 29% soit 11% d'écart avec le variant Delta en RDC" [COVID-19: Dr Muyembe reveals that the Omicron variant represents 29% or 11% difference from the Delta variant in the DRC]. Politico.cd (in French). 15 December 2021. Retrieved 2 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Covid-19 in Bulgaria: Omicron variant found in 12 samples sequenced by NCIPD".

The Sofia Globe. 2 January 2022. Retrieved 3 January 2022. • ^ "Covid-19 : Un premier cas de variant Omicron confirmé à Mayotte" [Covid-19: First case of the Omicron variant confirmed in Mayotte]. Mayotte la 1ère (in French). 22 December 2021. Retrieved 7 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Covid-19 : un premier cas de variant Omicron détecté en Martinique" [Covid-19: First case of the Omicron variant detected in Martinique]. Martinique la 1ère (in French).

24 December 2022. Retrieved 7 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ Ceesay, Landing (7 January 2022). "Covid-19 Update: Gambia Registers 26 Omicron Variant Cases".

Gambia.com. Retrieved 7 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Covid -19 : premiers cas de variant Omicron détectés en Guadeloupe et à Saint-Martin". LEFIGARO (in French). 18 December 2021. Retrieved 9 January 2022. Un autre cas a été confirmé, à Saint-Martin, sur une personne en provenance du Canada, indique la même source. (Another case has been confirmed in Saint-Martin, on a person from Canada, indicating the same source.) {{ cite web}}: CS1 maint: url-status ( link) • ^ "Laos has detected first case corona omicron indonesia Covid-19 Omicron Variant".

Laotiantimes.com. 7 January 2022. Retrieved 7 January 2022. • ^ Reuters (6 January 2022). "Iraq reports first cases of Omicron variant". Reuters. Retrieved 9 January 2022. Iraq has identified more than five cases of the Omicron coronavirus variant. • ^ "AMI - Des membres du gouvernement commentent les résultats du conseil des ministres".

fr.ami.mr. 30 December 2021. Retrieved 9 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "South Sudan confirms omicron variant in the country". Juba echo. 2 January 2022. Retrieved 9 January 2022. • ^ "Covid-19 Omicron: Des cas positifs de ce variant "plus transmissible mais moins virulent" enregistres en Côte d'Ivoire". gouv.ci. 4 Corona omicron indonesia 2022. Retrieved 9 January 2022. .on a eu 78 échantillons positifs pour le variant Omicron.

• ^ "Covid 19: INSP confirma que 87% das amostras enviadas ao Instituto Pasteur revelaram presença da ómicron" [Covid 19: INSP confirms that 87% of samples sent to the Pasteur Institute revealed the presence of the omicron]. inforpress.cv. 4 January 2022. Retrieved 9 January 2022. Há menos de uma semana, foram enviadas para esse laboratório, cerca de trezentas amostras, das quais foram processadas 202 que confirmaram a presença da variante ómicron em 87% das amostras processadas”, avançou a mesma fonte.

{{ cite web}}: CS1 maint: url-status ( link) • ^ McLeod, Sheri-Kae (7 January 2022). "Antigua Confirms First Case of Omicron". Corona omicron indonesia News. Retrieved 9 January 2022. • ^ "Gabon: le variant Omicron représente de 20 à 25% des personnes contrôlées positives au Covid-19". RFI (in French). 6 January 2022. Retrieved 9 January 2022. • ^ "Ministerio de Salud confirma presencia de variante ómicron en Bolivia". La Nación (in Spanish).

7 January 2022. Retrieved 9 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ corona omicron indonesia "Omicron" a pus stăpânire pe Iaşi: 29 la 0!

La ATI sunt numai nevaccinati" ["Omicron" took over Laşi: 29 to 0! At ATI they are only unvaccinated]. www.ziaruldeiasi.ro. Retrieved 10 January 2022. 29 din 29 confirmaţi. (29 out of corona omicron indonesia confirmed.) {{ cite web}}: CS1 maint: url-status ( link) • ^ "First 8 Omicron Cases Detected in Kazakhstan". see.news. 6 January 2022. Retrieved 10 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Variant Omicron: premiers cas détectés en Guadeloupe et à Saint-Martin" [Omicron variant: first cases detected in Guadeloupe and Saint-Martin].

SudOuest (in French). 18 December 2021. ISSN 1760-6454. Retrieved 10 January 2022. • ^ "Azerbaijan detects COVID-19 Omicron variant". AzerNews.az. 10 January 2022. Retrieved 10 January 2022. Twelve people have tested positive for the COVID-19 Omicron variant in Azerbaijan. {{ cite web}}: CS1 maint: url-status ( link) • ^ "Bhutan reports first cases of Omicron coronavirus variant". The Economic Times. 14 January 2021. Retrieved 19 January 2022.

• ^ "Papua New Guinea reports first Omicron cases, amid fears over low vaccination rate". the Guardian. 19 January 2022. Retrieved 19 January 2022. • ^ "12 cases of Omicron variant confirmed in Mongolia".

MONTSAME News Agency. 17 January 2022. Retrieved 19 January 2022. {{ cite web}}: CS1 maint: url-status ( link) • ^ Página12 (22 January 2022). "Covid-19 en la Antártida: Ómicron se propagó en la Base Esperanza y evacuaron corona omicron indonesia 9 personas - Se registraron 24 contagios" [Covid-19 in Antarctica: Omicron has spread at the Esperanza Base and 9 people were evacuated]. PAGINA12. Retrieved 28 January 2022. La variante Ómicron de coronavirus llegó a la Antártida, donde se detectaron 24 casos de covid-19 en la Base Esperanza.

• ^ "Uzbekistan reports first Omicron case, tightens pandemic restrictions-Xinhua". www.xinhuanet.com. Retrieved 10 February 2022.

• ^ Schrieber M (16 December 2021). "The scientist in Botswana who identified omicron was saddened by the world's reaction". Goats and Soda. NPR. Archived from the original on 21 December 2021. Retrieved 17 December 2021. • ^ "Inside the South African lab that discovered Omicron".

Africanews. 9 December 2021. Archived from the original on 17 December 2021. Retrieved 17 December 2021. • ^ a b "SARS-CoV-2 Sequencing Update 1 December 2021" (PDF). South African National Institute for Communicable Diseases. Archived (PDF) from the original on 1 December 2021.

Retrieved 2 December 2021. • ^ a b Lambrecht P (29 November 2021). "Wat weten we al over de nieuwe coronavariant, de omikron?" [What do we already know about the new coronavirus variant, Omicron?]. De Tijd (in Dutch). Belgium. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ Philip Whiteside (30 November 2021). "COVID-19: how the spread of Omicron went from patient zero to all around the globe".

Sky News. Archived from the original on 30 November 2021. Retrieved 17 December 2021. • ^ "Enhancing Readiness for Omicron (B.1.1.529): Technical Brief and Priority Actions for Member States". WHO. 17 December 2021. Archived from the original on 29 November 2021. Retrieved 19 December 2021. • ^ Torjesen I (November 2021). "Covid-19: Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear". BMJ. 375: n2943. doi: 10.1136/bmj.n2943. PMID 34845008.

S2CID 244715303. Archived from the original on 2 December 2021. Retrieved 2 December 2021. • ^ "Where did 'weird' Omicron come from?". www.science.org. Archived from the original on 22 December 2021. Retrieved 27 December 2021. • ^ Vaughan A (27 November 2021). "Omicron: How dangerous is the new variant first found in South Africa?".

NewScientist. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ Cowan K (29 November 2021). "Inside Corona omicron indonesia leg of Omicron variant discovery: A single test result, a missing gene, and an email". News24. Archived from the original on 2 December 2021.

Retrieved 2 December 2021. • ^ a b Whiteside P (30 November 2021). "COVID-19: How the spread of Omicron went from patient zero to all around the globe". SkyNews. Archived from the original on 30 November 2021. Retrieved 1 December 2021. • ^ van Vliet K (3 December 2021). "Waarom Zuid-Afrika zoveel virusvarianten ontdekt". Trouw (in Dutch). Archived from the original on 22 December 2021 corona omicron indonesia.

Retrieved 9 December 2021. • ^ Covid: New heavily mutated variant B.1.1.529 in South Africa raises concern Archived 26 November 2021 corona omicron indonesia the Wayback Machine, 25 November 2021, BBC News, accessed 25 November 2021 • ^ Tracking SARS-CoV-2 variants Archived 18 June 2021 at the Wayback Machine (Tables: Currently designated Variants Under Monitoring -describes 529 variant as present in 'Multiple countries'- and 'Formerly monitored variants'- B.1.523 & B.1.619 Reclassified Nov 2021).

www.who.int, accessed 25 November 2021 • ^ a b @BNODesk (26 November 2021). "Statement from Israel's health ministry reporting 1 confirmed case of new coronavirus variant B.1.1.529" (Tweet). Retrieved 26 November 2021 corona omicron indonesia via Twitter. • ^ "מחוסנת ב-3 מנות ואישה שנסעה לאילת באוטובוס: המאומתים לזן החדשt". m.ynet.co.il (in Hebrew). 26 November 2021. Archived from the original on 27 November 2021.

Retrieved 28 November 2021. "4 מאומתים לווריאנט החדש התגלו בארץ, רה"מ יקיים מסיבת עיתונאים ב-14:30" translated: "4 verified for the new variant were discovered in the country, the prime minister will hold a press conference at 14:30 • ^ Four cases of the new COVID-19 variant recorded in Botswana Archived 26 November 2021 at the Wayback Machine, 25 November 2021, Mmegi Online, accessed 26 November 2021 • ^ "Al meer dan veertig omikron-gevallen vastgesteld in Europa" [More than 40 omicron cases identified in Europe].

De Standaard (in Dutch). Belgium. 30 November 2021. Archived from the original on 30 November 2021. Retrieved 1 December 2021. • ^ "Belgium detects first case of new COVID-19 corona omicron indonesia in Europe". Reuters. 26 November 2021.

Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ Kesselgruber K (27 November 2021). "Flughafen Frankfurt: Person mit Omikron-Verdacht war vollständig geimpft" [Frankfurt airport: Person suspected to be infected with Omicron Variant was fully vaccinated].

Frankfurter Rundschau (in German). Archived from the original on 27 November 2021. Retrieved 27 November 2021. • ^ "UK, Germany and Italy detect Omicron coronavirus variant cases". Reuters. 27 November 2021. Archived from the original on 27 November 2021. Retrieved 27 November 2021. • ^ "Coronavirus variant Omicron found in 13 positive tests so far - RIVM".

www.rivm.nl. Archived from the original on 6 December 2021. Retrieved 6 December 2021. • ^ "Actuele informatie over COVID-19 - RIVM" [Current information about COVID-19 - RIVM].

www.rivm.nl (in Dutch). 4 December 2021. Archived from the original on 6 April 2020. Retrieved 6 December 2021. • ^ "61 travellers from South Africa in Netherlands positive for COVID-19 – authorities".

Reuters. Amsterdam. 27 November 2021. Archived from the original on 26 November 2021. Retrieved 27 November 2021. • ^ "Travellers test positive to Omicron COVID-19 strain after arriving in Sydney from southern Africa, NSW Health says". ABC News. 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021. • ^ "To personer er indrejst i Danmark med coronavarianten Omikron" [Two people have entered Denmark with the corona variant Omicron].

www.bt.dk (in Danish). 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021. • ^ Af Ritzau (28 November 2021). "Nu er det bekræftet: To corona omicron indonesia smittet med Omikron rejst ind i Danmark" [Now it has been confirmed: Two people infected with Omicron traveled into Denmark]. ekstrabladet.dk (in Danish). Archived from the original on 28 November 2021. Retrieved 28 November 2021. • ^ "Austria detects suspect Omicron case as Europe battles virus surge".

WION. Archived from the original on 28 November 2021. Retrieved 28 November 2021. • ^ "Omicron variant found in UK, Germany, Czech Republic". New York Post. 28 November 2021. Archived from the original on 27 November 2021. Retrieved 28 November 2021.

• ^ "Canada, Netherland, Australia latest countries reporting cases of omicron COVID-19 variant". ABC13. 28 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021. • ^ Perera A (29 November 2021). "COVID-positive repatriation flight arrival to the Northern Territory tests positive to Omicron variant".

ABC News. Archived from the original on 29 November 2021. Retrieved 29 November 2021. • ^ Nguyen K corona omicron indonesia November 2021). "NSW Health confirms two more Omicron COVID-19 cases in travellers from southern Africa". ABC News. Archived from the original on 29 November 2021. Retrieved 29 November 2021. • ^ "Live updates: Omicron variant".

Cable News Network. 29 November 2021. Archived from the original on 30 November 2021. Retrieved 29 Corona omicron indonesia 2021. • ^ "Första fallet av omikron upptäckt i Sverige" [The first case of omicron detection in Corona omicron indonesia. www.aftonbladet.se (in Swedish). 29 November 2021. Archived from the original on 30 November 2021.

Retrieved 29 November 2021. • ^ "Spain detects first Omicron case, COVID-19 infections rise". Reuters. 29 November 2021. Archived from the original on 30 November 2021. Retrieved 30 November 2021. • ^ "Omicron variant found in two previous test samples - RIVM". www.rivm.nl. Archived from the original on 4 December 2021.

Retrieved corona omicron indonesia December 2021. • ^ "NSW records fifth case of Omicron COVID-19 variant as two more potential infections investigated". ABC News. 30 November 2021. Archived from the original on 30 November 2021.

Retrieved 30 November 2021. • corona omicron indonesia "Japan's first Omicron case may help portray PM Kishida as decisive". Reuters. 30 November 2021.

Archived from the original on 30 November 2021. Retrieved 30 November 2021. • ^ "Two Israeli doctors test positive for Omicron COVID variant". The Jerusalem Post. Archived from the original on 31 December 2021.

Retrieved 30 November 2021. • ^ "SP confirma terceiro caso da variante ômicron" [SP confirms third case of ômicron variant]. g1 (in Brazilian Portuguese). 1 December 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ "O que se sabe sobre os primeiros casos confirmados da variante Ômicron no Brasil" [What is known about the first confirmed cases of the Ômicron variant in Brazil]. CNN Brasil (in Brazilian Portuguese).

30 November 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ "Passa para 6 o número de casos suspeitos da variante Ômicron investigados no Brasil" [The number of corona omicron indonesia cases of the Ômicron variant investigated in Brazil goes to 6]. CNN Brasil (in Brazilian Portuguese).

30 November 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ "Germany: Leipzig reports first Omicron variant case with no travel history". Free Press Journal. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ Dahir A, Ezeamalu B, Pérez-Peña R (1 December 2021). "Ghana and Nigeria are the latest African countries to detect the Omicron variant".

corona omicron indonesia

The New York Times. Archived from the original on 2 December 2021. Retrieved 2 December 2021. • ^ "Nigeria confirms first cases of Omicron among travellers from South Africa". Reuters. 1 December 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ Graff A (1 December 2021). "First case of omicron in US identified in San Francisco".

San Francisco Chronicle. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ Stark K, Rodriguez JF, Dillon RM (1 December 2021). "First U.S. Case of Omicron Variant Found in San Francisco Resident".

San Francisco: KQED. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ O'Donnell D (1 December 2021). "Case of Omicron variant confirmed in Ireland". RTÉ News and Current Affairs. Archived from the original on 3 December 2021. Retrieved 12 December 2021. • ^ "South Korea reports five Omicron cases on flight from Nigeria".

Reuters. 1 December 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ "Dutch say 14 air passengers from S.

Africa with Omicron were vaccinated". Reuters. 2 December 2021. Archived from the original on 2 December 2021. Retrieved 2 December 2021. • ^ "Number of confirmed omicron cases as of 3 December". Folkehelseinstituttet. 4 December 2021. Archived from the original on 4 December 2021. Retrieved 4 December 2021. • ^ "France now has 25 Omicron Covid variant cases – minister". Reuters. 6 December 2021. Archived from the original on 6 December 2021.

Retrieved 7 December 2021. • ^ "Omicron sudah sampai ke Malaysia". Malaysiakini. 3 December 2021. Archived from the original on 3 December 2021. Retrieved corona omicron indonesia December 2021. • ^ "Namibia detects Omicron coronavirus variant in 18 of 19 samples". Reuters. 6 December 2021. Archived from the original on 6 December 2021. Retrieved 7 December 2021.

• ^ "Fijians test positive for Omicron variant – Govt". RNZ. 7 December 2021. Archived from the original on 6 December 2021. Retrieved 8 December 2021. • ^ "New omicron variant detected in 57 countries: WHO". www.aa.com.tr. Archived from the original on 8 December 2021.

Retrieved 8 December 2021. • ^ "Africa accounts corona omicron indonesia 46% of reported cases of Omicron, WHO official says". Reuters. 9 December 2021. Archived from the original on 10 December 2021. Retrieved 9 December 2021. • ^ "Covid: First UK death recorded with Omicron variant". BBC News. 13 December 2021.

Archived from the original on 20 December 2021. Retrieved 13 December 2021. • ^ "First Omicron case detected in New Zealand". Ministry of Healfh. 16 December 2021. Archived from the original on 20 December 2021.

Retrieved 16 December 2021. • ^ "COVID: Germany records first death from omicron variant". DW. 23 December 2021. Archived from the original on 24 December 2021. Retrieved 23 December 2021. • ^ "Australia: Omicron death, false negative COVID results". Al Jazeera. 27 December 2021. Archived from the original on 27 December 2021. Retrieved 27 December 2021. • ^ Reuters (28 December 2021).

"U.S. CDC estimates Omicron variant to be 58.6% of cases, revises projection". Reuters. Retrieved 15 April 2022. • ^ Reuters (3 January 2022). "S.Korea reports first deaths linked to Omicron coronavirus variant – Yonhap". Reuters. Archived from the original on 3 January 2022. Retrieved 3 January 2022. • ^ Goodman, Brenda. "Omicron subvariant BA.2 is now the dominant strain of Covid-19 in the US, CDC says". CNN. Retrieved 29 March 2022.

• ^ McDade, Aaron (29 March 2022). "Omicron BA.2 sub-variant now dominant in U.S., CDC says". Newsweek. Retrieved 29 March 2022. • ^ CDC (28 March 2020). "COVID Data Tracker". Centers for Disease Control and Prevention. Retrieved 29 March 2022.

• ^ Gregg A (26 November 2021). "Dow plunges more than 900 points as new coronavirus variant sends global markets reeling". Washington Post. Archived from the original on 26 November 2021.

Retrieved 26 November 2021. • ^ " 'Omicron' cryptocurrency soars on new variant". www.msn.com. Archived from the original on 1 December 2021.

Retrieved 1 December 2021. • ^ Davies P (26 November 2021). "Bitcoin's price has slumped after a new COVID variant was found. Why?". euronews. Archived from the original on 27 November 2021.

Retrieved 27 November 2021. • ^ "South African markets sink on new Covid-19 variant". Moneyweb. 26 November 2021. Archived from the original on 27 November 2021. Retrieved 29 November 2021. • ^ "Rand tanks as UK red lists South Africa again amid new Covid variant". Archived from the original on 26 November 2021. Retrieved 29 November 2021. • ^ "New variant sees Rand plummet - eNCA".

www.enca.com. Archived from the original on 26 November 2021. Retrieved 29 November 2021. • ^ "Omicron raises uncertainty around inflation, says Powell". BBC News. 2 December 2021. Archived from the original on 1 December 2021. Retrieved 1 December 2021. • ^ "WHO cautions against imposing corona omicron indonesia restrictions due to new variant".

Reuters. Geneva. 26 November 2021. Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ "Covid live updates today: Omicron variant, symptoms, vaccines efficacy, restrictions." en.as. 28 November 2021.

Archived from the original on 28 November 2021. Retrieved 28 November 2021. • ^ "World closing its doors to African countries due to omicron". aa.com. 30 November 2011. Archived from the original on 30 November 2021.

Retrieved 30 November 2021. • ^ Yong C (26 November 2021). "Singapore bans travellers from 7 African countries; no cases of new Covid-19 variant here". The Straits Times. Singapore. Archived from the original on 26 November 2021. Retrieved 26 November 2021.

• ^ "Anvisa recomenda restrições de voo diante de nova variante de covid-19" [Anvisa recommends flight restrictions in view of the new covid-19 variant]. agenciabrasil.ebc.com.br. 26 November 2021. Archived from the original on 26 November 2021. Retrieved 27 November 2021. • ^ Kennedy M, Price RD. " 'It's Coming': NY Declares State of Emergency Ahead of Potential Omicron Spike". NBC New York. Archived from the original on 26 November 2021.

Retrieved 27 November 2021. • ^ "Switzerland announces new restrictions for Israelis after the discovery of Omicron". Globally 24. Archived from the original on 27 November 2021. Retrieved 27 November 2021. • ^ Winning A, Cocks T (26 November 2021).

"South Africa says travel bans over new variant unjustified". Reuters. Archived from the original on 26 November 2021. Retrieved 26 November 2021. • ^ Zwi A. "Travel bans aren't the answer to stopping new COVID variant Omicron". The Conversation. Archived from the original on 28 November 2021. Retrieved 28 November 2021. • ^ "EXCLUSIVE South Africa delays Corona omicron indonesia vaccine deliveries as inoculations slow". Reuters. 24 November 2021.

Archived from the original on 28 November 2021. Retrieved 28 November 2021. • ^ Kaitlan Collins and Kate Sullivan. "Biden says new Omicron variant is 'cause for concern, corona omicron indonesia a cause for panic' ". CNN. Archived from the original on 2 December 2021. Retrieved 1 December 2021. • ^ "New COVID-19 restrictions in effect for parts of Canada; some productions cancelled".

CTVNews. 20 December 2021. Archived from the original on 20 December 2021. Retrieved 20 December 2021. • corona omicron indonesia "B.C. enacts social gathering and event capacity limits as Omicron variant spreads". Global News. Archived from the original on 19 December 2021. Retrieved 18 December 2021. • ^ "B.C. limits indoor gatherings, cancels New Year's Eve events as Omicron picks up speed".

CBC News. 17 December 2021. Archived from the original on 20 December 2021. Retrieved 17 December 2021. • ^ "Quebec shutting down schools, bars, gyms tonight as COVID-19 cases soar". CTV News Montreal. 20 December 2021. Archived from the original on 20 December 2021.

Retrieved 20 December 2021. • ^ Meijer BH, van den Berg S (18 December 2021). "Netherlands to go into strict Christmas lockdown". Reuters. Archived from the original on 2 January 2022. Retrieved 2 January 2022. • ^ "As Omicron threatens a global surge, some countries shorten COVID-19 booster timelines".

Reuters. 20 December 2022. Archived from the original on 15 January 2022. Retrieved 15 January 2022. Further reading • WHO: Update on Omicron • Live Omicron Variant Location Map • Omicron variant: What have COVID vaccine makers said and are they working on new doses? • Callaway E, Ledford H (December 2021). "How bad is Omicron? What scientists know so far". Nature. 600 (7888): 197–199. Bibcode: 2021Natur.600.197C. doi: 10.1038/d41586-021-03614-z.

PMID 34857948. S2CID 244840636. External links • Corum J, Zimmer C (9 February 2021). "Coronavirus Variant Tracker". The New York Times. Archived from the original on 30 November 2021.

Retrieved 1 December 2021. Constantly Updated • Archived video: • Mohale F, Phaahla J, Oliveira T, Lessels R, Gottberg A, Moore P, Crisp N (25 November 2021). Health Department briefs media about a new so-called super-variant (Internet video live stream). South Africa: eNCA. Retrieved 27 November 2021. Archived at the Wayback Machine and Ghostarchive.

• Oliveira T, Kamwendo S (26 November 2021). Professor Tulio de Oliviera on the new COVID-19 variant (Internet video live stream). South Africa: SABC News. Archived from the original on 29 November 2021. Retrieved 27 November 2021. Archived at the Wayback Machine and Ghostarchive • Benin • Burkina Faso • Cape Verde • Equatorial Guinea • Gambia • Ghana • timeline • 2020 • March–July • August–December • 2021 • government response • impact • education • Guinea • Guinea-Bissau • Ivory Coast • timeline • Liberia • Mali • Niger • Nigeria • timeline • 2020 • February–June • July–December • January–June 2021 • government response • Saint Helena, Ascension and Tristan da Cunha • Senegal • Sierra Leone • Togo • Brunei • Cambodia • East Timor • Indonesia • timeline • 2020 • corona omicron indonesia • 2022 • social restrictions • Community Activities Restrictions Enforcement • Laos • Myanmar • Singapore • timeline • 2020 • 2021 • 2022 • circuit breaker response • vaccination • statistics • Thailand • timeline • vaccination • statistics • Vietnam • timeline • government response Malaysia • timeline • 2020 • 2021 • 2022 • government response • community quarantines • Luzon • evacuations • testing controversy • vaccination • Bangsamoro • Bicol Region • Cagayan Valley • Calabarzon • Caraga • Central Luzon • Central Visayas • Cordillera • Davao Region • Eastern Visayas • Ilocos Region • Metro Manila • Mimaropa • Northern Mindanao • Soccsksargen • Western Visayas • Zamboanga Peninsula • Overseas Filipinos • England • timeline • 2020 • January–June • July–December • 2021 • 2022 • London • local lockdown regulations • first tier regulations • Northern Ireland • timeline • 2020 • 2021 • 2022 • Scotland • timeline • 2020 • 2021 • 2022 • Wales • timeline • 2020 • 2021 • 2022 • Crown dependencies • Isle of Man • Jersey • Guernsey • Corona omicron indonesia territories • Akrotiri and Dhekelia • British Indian Ocean Territory • Gibraltar • Austria • Belgium • Bulgaria • Croatia • timeline • Cyprus • Northern Cyprus • Czech Republic • Denmark • Faroe Islands • Estonia • Finland • Åland • France • Guadeloupe corona omicron indonesia French Guiana • Réunion • Martinique • Mayotte • Normandy • Saint Martin • Germany • North Rhine-Westphalia • government response • Greece • Hungary • Ireland • timeline • 2020 • Corona omicron indonesia • July–December • 2021 • January–June • July–December • 2022 • economic impact • social impact • vaccination • Italy • lockdowns • timeline • Latvia • Lithuania • Luxembourg • Malta • timeline • Netherlands • Poland • Portugal • Romania • timeline • Slovakia • Slovenia • Spain • timeline • Asturias • Canary Islands • Ceuta • Community of Madrid • Melilla • Sweden • timeline • government response • Operation Gloria EFTA countries • timeline • economic impact • federal aid • vaccination • by province • military response • Atlantic Bubble • Alberta • timeline • British Columbia • Manitoba • New Brunswick • Newfoundland and Labrador • Northwest Territories • Nova Scotia • Nunavut • Ontario • timeline • 2020 • 2021 • 2022 • Ottawa • Peel Region • Toronto • York Region • Provincial government response • Vaccination • Prince Corona omicron indonesia Island • Quebec • Montreal • boroughs • timeline • Saskatchewan • timeline • Yukon Caribbean • Coalition for Epidemic Preparedness Innovations • Coronavirus Tech Handbook • COVID-19 Solidarity Response Fund • Covid Watch • EcoHealth Alliance • International Committee on Taxonomy of Viruses • Joint Committee on Vaccination and Immunisation • MusiCares COVID-19 Relief Fund • Pasteur Institute • in Cambodia • UN COVID-19 Supply Chain Task Force (WHO) • United Nations • resolutions • World Health Organization By location • Africa Centres for Disease Control and Prevention (African Union) • Ghana Infectious Disease Centre (Ghana) • Department of Health (Hong Kong) • Korea Disease Control and Prevention Agency (South Korea) • National Institute for Communicable Diseases (South Africa) • Taiwan Centers for Disease Control (Taiwan) Pandemic institutes • National COVID-19 Commission Advisory Board (Australia) • COVID-19 Immunity Task Force (Canada) • COVID-19 Supply Council (Canada) • PREPARE (European Union) • National Expert Group on Vaccine Administration for COVID-19 (India) • COVID-19 Response Acceleration Task Force (Indonesia) • National Public Health Emergency Team (Ireland) • Novel Coronavirus Expert Meeting (Japan) • Crisis Preparedness and Response Centre (Malaysia) • Defeat COVID-19 Ad Hoc Committee (Philippines) • Inter-Agency Task Force for the Management of Emerging Infectious Diseases (Philippines) • Central Epidemic Command Center (Taiwan) • Coronavirus Scientific Advisory Board (Turkey) • COVID-19 Genomics UK Consortium (United Kingdom) • Imperial College COVID-19 Response Team (United Kingdom) • Joint Biosecurity Centre (United Kingdom) • Vaccine Taskforce (United Kingdom) • COVID-19 Advisory Board (United States) • Great American Economic Revival Industry Groups (United States) • White House Coronavirus Task Force (United States) • White House COVID-19 Response Team (United States) • GACH (Uruguay) Relieve funds • Awang Bulgiba Awang Mahmud • Roberto Burioni • Chen Wei • Kizzmekia Corbett • Andrea Crisanti • Peter Daszak • Christian Drosten • Neil Ferguson • Dale Fisher • George F.

Gao • Azra Ghani • Sarah Gilbert • Guan Yi • Kentaro Iwata • Katalin Karikó • Matt Keeling • Trudie Lang • Li Lanjuan • W. Ian Lipkin • Ma Xiaowei • Shabir Madhi • Allison McGeer • Camilla Rothe • Shi Zhengli • Moncef Slaoui • Mike Tildesley • John Todd • Wang Chen • Wang Guangfa • Drew Weissman • Yuen Kwok-yung • Zeng Guang • Zhang Jixian • Zhang Yongzhen • Zhong Nanshan Officials • Cases, deaths, recoveries by country • Tests, cases, tests per capita, cases corona omicron indonesia capita by country • Tests, cases, tests per capita, cases per capita by country subdivision • WHO situation reports • cases • January 2020 • February 2020 • March 2020 • April 2020 • May 2020 • June 2020 • July 2020 • Corona omicron indonesia 2020 • September 2020 • October 2020 • November 2020 • December 2020 • January 2021 • February 2021 • April 2021 • May 2021 • June 2021 • July 2021 • deaths • World map by countries: confirmed per capita • China • Hospital beds by country • Lockdowns Africa • Algeria • Angola • Benin • Botswana • Burkina Faso • Burundi • Cameroon • Comoros • Egypt • Eswatini • Ethiopia • Ghana • cases chart • Ivory Coast • Kenya • Libya • Malawi • Mali • Mauritania • Mauritius • Morocco • Mozambique • Namibia • Nigera • cases chart • São Tomé and Príncipe • Senegal • Seychelles • Sierra Leone • South Africa • cases chart • South Sudan • Sudan • Tanzania • Togo • Tunisia • Uganda • Zambia • Zimbabwe • cases chart Americas • Argentina • Bolivia • Brazil • Canada • by province • vaccinations by province • Chile • by commune • Colombia • Costa Rica • cases chart • Cuba • Dominican Republic • Ecuador • El Salvador • Guatemala • Haiti • Honduras • Mexico • cases chart • Nicaragua • Panama • Paraguay • Peru • United States • by state • Uruguay • Venezuela Asia • Albania • Austria • corona omicron indonesia chart • Belarus • Belgium • cases chart • Bosnia and Herzegovina • Bulgaria • cases chart • Croatia • Cyprus • Czech Republic • Denmark • cases chart • Faroe Islands • Estonia • cases chart • Finland • France • cases chart • Germany • cases chart • Greece • Hungary • Iceland • cases chart • Ireland • cases chart • Italy • cases chart • statistics charts • vaccinations chart • Kosovo • Latvia • cases chart • Lithuania • cases chart • Luxembourg • Malta • Moldova • Monaco • Montenegro • Netherlands • North Macedonia • Norway • cases chart • Poland • cases chart • by voivodeship • Portugal • cases chart • Romania • cases chart • Russia • cases chart • by federal subject • North Asia • San Marino • Serbia • Slovakia • cases chart • by region • Slovenia • cases chart • Spain • cases chart • Sweden • cases chart • Switzerland • cases chart • Turkey • cases chart • Ukraine • Donetsk People's Republic • Luhansk People's Republic • United Kingdom • Scotland • Gibraltar • vaccinations chart • daily • by nation • Vatican City Oceania Hidden categories: • Webarchive template wayback links • CS1 errors: missing periodical • CS1 Danish-language sources (da) • CS1 Japanese-language sources (ja) • CS1 Brazilian Portuguese-language sources (pt) • CS1 Swedish-language sources (sv) • CS1 Norwegian-language sources (no) • CS1 maint: uses authors parameter • CS1 Portuguese-language sources (pt) • CS1 maint: url-status • CS1 German-language sources (de) • CS1 French-language sources (fr) • CS1 Indonesian-language sources (id) • CS1 Thai-language sources (th) • CS1 Estonian-language sources (et) • CS1 Hebrew-language sources (he) • CS1 Spanish-language sources (es) • CS1 Icelandic-language sources (is) • CS1 Italian-language sources (it) • CS1 Finnish-language sources (fi) • CS1 Chinese (Hong Kong)-language sources (zh) • CS1 Latvian-language sources (lv) • CS1 Romanian-language sources (ro) • CS1 Czech-language sources (cs) corona omicron indonesia CS1 European Spanish-language sources (es) • CS1 Turkish-language sources (tr) • CS1 Hungarian-language sources (hu) • CS1 Persian-language sources (fa) • CS1 Ukrainian-language sources (uk) • CS1 Macedonian-language sources (mk) • CS1 Vietnamese-language sources (vi) • CS1 Russian-language sources (ru) • CS1 Croatian-language sources (hr) • CS1 Dutch-language sources (nl) • Articles with short description • Short description is different from Wikidata • Wikipedia pages semi-protected against vandalism • Articles needing additional medical references from December 2021 • All articles needing additional references • Articles requiring reliable medical sources • Use South African English from December 2021 • All Wikipedia articles written in South African English • Use dmy dates from January 2022 • All articles lacking reliable references • Articles lacking reliable references from December 2021 • Wikipedia articles in need of updating from April 2022 • All Wikipedia articles in need of updating • Articles containing potentially dated statements from November 2021 • All articles containing potentially dated statements • AC with 0 elements • العربية • বাংলা • Banjar • Беларуская (тарашкевіца) • Bosanski • Català • Deutsch • Ελληνικά • Español • Euskara • فارسی • Français • 한국어 • हिन्दी • Bahasa Indonesia • Italiano • עברית • ქართული • ລາວ • Latina • Magyar • मराठी • მარგალური • Bahasa Melayu • Nederlands • 日本語 • Norsk bokmål • ଓଡ଼ିଆ • Oʻzbekcha/ўзбекча • Papiamentu • پښتو • Polski • Português • Română • Русский • Simple English • Slovenčina • Slovenščina • Српски / srpski • Svenska • Tagalog • தமிழ் • corona omicron indonesia • Türkçe • Українська • Tiếng Việt • 粵語 • 中文 Edit links • This corona omicron indonesia was last edited on 5 May 2022, at 03:28 (UTC).

• Text is available under the Creative Commons Attribution-ShareAlike License 3.0 ; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization. • Privacy policy • About Wikipedia • Disclaimers • Contact Wikipedia • Mobile view • Developers • Statistics • Cookie statement • •
"Berdasarkan bukti yang disajikan, mengindikasikan perubahan yang merugikan dalam epidemiologi Covid-19, TAG-VE telah menyarankan kepada WHO bahwa varian ini harus ditetapkan sebagai VOC, dan WHO telah menetapkan B.1.1.529 ke dalam VOC, dengan nama Omicron," tulis keterangan WHO.

Omicron adalah huruf ke-15 dalam alfabet Yunani. "Kita akan pastikan semua kantor karantina pelabuhan udara, laut dan darat bekerja dengan keras, kebijakan kita semua kedatangan internasional, semua kita tes PCR, kalau positif, akan di -genome sequencing ," kata Menkes Budi. Genome sequencing, atau pengurutan gen, adalah proses untuk mengetahui 'identitas' virus dari materi genetiknya.2019 2020 • January • responses • February • responses • March • responses • April • responses • May • responses • June • responses • July • responses • August • responses • September • responses • October • responses • November • responses • December • responses 2021 • January • responses • February • responses • March • responses • April • responses • May • responses • June • responses • July • responses • August • responses • September • responses • October • responses • November • responses • December • responses 2022 • January • responses • February • responses • March • responses • April • responses • May • responses • Disease testing • Breathalyzer • Development • Drug development • Drug repurposing • Public health mitigation Vaccines • History • Research • VITT • Deployment • Authorizations • Operation Warp Speed • Misinformation and hesitancy • US • Vaccine card • Vaccine passports Current vaccines • CoronaVac • Covaxin • Convidecia • Janssen • Medigen • Moderna • Novavax • Oxford–AstraZeneca • Pfizer–BioNTech • Sinopharm BIBP • Sputnik V • Arts and culture • Aviation • Cannabis • Cinema • films • Disney • Fashion • Financial markets • Food industry • Food security • Journalism • Music • Performing arts • Retail • Shipping • Television • US • sportscasting • programs • Tourism • Video games By country • Canada • India • Ireland • Malaysia • New Zealand • Russia • UK • US By sport • Association football • Baseball • Basketball • Combat sports • Cricket • Disc golf • Gaelic games • Gridirion football • Ice hockey • Motorsport • Rugby league • v • t • e CoronaVac, also known as the Sinovac COVID-19 vaccine, [3] is an whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech.

[4] [5] It was Phase III clinical trialled in Brazil, [6] Chile, [7] Indonesia, [8] the Philippines, [9] and Turkey [10] and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine.

[11] CoronaVac does not need to be frozen and both the final product and the raw material for formulating CoronaVac can be corona omicron indonesia refrigerated at 2–8 °C (36–46 °F), temperatures at which flu vaccines are kept. [12] A real-world study of tens of millions of Chileans who received CoronaVac found it 66% effective against symptomatic COVID-19, 88% against hospitalization, 90% against ICU admissions, and 86% against deaths.

[13] In Brazil, after 75% of the population in Serrana, São Paulo, received CoronaVac, preliminary results show deaths fell by 95%, hospitalizations by 86%, and symptomatic cases by 80%.

[14] [15] In Indonesia, real world data from 128,290 healthcare workers showed 94% protection against symptomatic infection by the vaccine, beating results in clinical trials. [16] Phase III results from Turkey published in The Lancet showed an efficacy of 84% based on 10,218 participants in the trials.

[17] [18] Phase III results from Brazil previously showed 50.7% efficacy at preventing symptomatic infections and 83.7% effective in preventing mild cases needing treatment. Efficacy against symptomatic infections increased to 62.3% with an interval of 21 days or more between the doses.

[19] CoronaVac is being used in vaccination campaigns in various countries in Asia, [20] corona omicron indonesia [22] South America, [23] [24] [25] Central America, [26] [27] [28] and Eastern Europe. [29] [30] [31] By April 2021, Sinovac had a production capacity of 2 billion doses a year.

corona omicron indonesia

{INSERTKEYS} [32] It is currently being manufactured at several facilities in China, [32] with planned overseas manufacture in Brazil in September 2021 [33] and eventually in Egypt [34] and Hungary. [35] On 1 June 2021, the World Health Organization (WHO) validated the vaccine for emergency use.

[36] [37] Sinovac has signed purchase agreements for 380 million doses from COVAX. [38] As of July 2021, CoronaVac was the most widely used COVID-19 vaccine in the world, with 943 million doses delivered. [39] As of 14 October 2021, CoronaVac is the COVID-19 vaccine with most doses administered worldwide.

[40] A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of Medicine, The Chinese University of Hong Kong (CU Medicine) showed that a third dose of Comirnaty vaccine given to those who received two doses of either Comirnaty or CoronaVac provides protective levels of measured antibodies against the Omicron variant of SARS-CoV-2.

Three doses of CoronaVac however did not provide adequate levels of protective antibodies by the same measure, [41] in direct contradiction to claims made by the vaccine manufacturer.

[42] [43] Contents • 1 Medical uses • 1.1 Effectiveness • 1.1.1 Variants • 1.1.2 In the elderly • 1.2 Specific populations • 2 Manufacturing • 3 History • 3.1 Clinical trials • 3.1.1 Phase I–II • 3.1.2 Phase III • 3.1.3 Children and adolescents trials • 3.1.4 Results of Phase III trials • 3.1.5 Variability in results • 3.1.6 Variants • 3.2 Authorizations • 4 Society and culture • 4.1 Economics • 4.1.1 Asia • 4.1.2 Africa • 4.1.3 Europe • 4.1.4 South America • 4.1.5 North America • 4.1.6 Oceania • 4.2 Controversies • 4.2.1 China state media propaganda • 4.2.2 Politicization • 4.2.3 Delays in releasing results • 5 References • 6 Further reading • 7 External links Medical uses The vaccine is given by intramuscular injection into the deltoid muscle.

The initial course consists of two doses. The World Health Organization (WHO) recommends an interval of 4 weeks between doses, with data from Chile suggesting that a longer interval provides more robust immunity. [44] Early evidence suggests that immunity wanes rapidly, so a booster dose after the initial course might be needed.

[45] [40] Effectiveness In Brazil, a study was conducted in Serrana, population 45,000, where authorities attempted to vaccinate the entire adult population with CoronaVac. [46] After 75% of the adult population received the vaccine, preliminary results show deaths fell by 95%, hospitalizations by 86% and symptomatic cases by 80%.

According to Ricardo Palacios, a director at São Paulo's Instituto Butantan, “The most important result was understanding that we can control the pandemic even without vaccinating the entire population.” [47] [48] In Brazil, a study was conducted in Serrana, population 45,000, where authorities attempted to vaccinate the entire adult population with CoronaVac.

[49] After 75% of the adult population received the vaccine, preliminary results show deaths fell by 95%, hospitalizations by 86% and symptomatic cases by 80%. According to Ricardo Palacios, a director at São Paulo's Instituto Butantan, “The most important result was understanding that we can control the pandemic even without vaccinating the entire population.” [50] [51] In July 2021, researchers from the Chilean Ministry of Health published a paper containing real-world data for their vaccination campaign.

The study was conducted between 2 February and 1 May 2021, consisting of 10.2 million people. The effectiveness of CoronaVac vaccine after the second dose was 66% (95% CI, 65– 67%) in preventing symptomatic disease, 88% ( 87– 88%) for hospitalization, 90% ( 89– 91%) for ICU admission, and 86% ( 85– 88%) in preventing COVID-19 related deaths. The effectiveness after the first dose was 16% (95% CI, 14– 17%) against symptomatic disease, 37% ( 35– 40%) against hospitalization, 45% ( 41– 48%) against ICU admission, and 46% ( 41– 50%) against deaths.

The study concluded that the vaccine was effective in preventing COVID-19. [13] In May 2021, real-world data from Indonesia showed the vaccine was highly effective, with 94% of inoculated health care workers protected against symptomatic infection by the vaccine, besting results of clinical trials.

[16] In this study of 128,290 health workers in Jakarta, [52] less than 1% of the vaccinated healthcare workers contracted symptomatic COVID-19, compared to more than 8% among the unvaccinated healthcare workers. The vaccine reduced the risk of hospitalization and death of the inoculated medical workers by 96% and 98% respectively.

[53] [54] Uruguay released real-world data based on 795,684 people who have received both doses of CoronaVac for more than 14 days as of 1 June 2021. In this group, 8,298 tested positive, 45 were admitted to the ICU, and 35 died of COVID-19.

This indicated 64.52% and 61.47% effectiveness in reducing COVID-19 cases for people aged 18–49 and 50 and older respectively. The vaccine was 94.95% and 92.18% effective in reducing ICU admissions, and 95.35% and 95.2% effective to prevent deaths. Among fully-vaccinated healthcare professionals, the vaccine was 66% effective in preventing cases, and 100% effective in preventing ICU admissions and deaths.

[55] Preliminary results from a test-negative case-control study from 19 January to 13 April 2021 in Manaus suggest that, after just one dose, the vaccine is 35% (95% CI, −7 to 61%) effective against asymptomatic infections and 50% (95% CI, 11– 71%) against symptomatic disease. The one-dose group consisted of 53,176 healthcare professionals. During the study, 66% of the samples were of the Gamma variant. The same study found paradoxically reduced effectiveness against symptomatic disease in another group that received two doses, an effect attributed by the authors to unmeasured confounding leading to downward bias in the efficacy estimate.

[56] In Chile, the effectiveness against symptomatic disease dropped from 67% between February–April 2021 to 58.5% in early July.

Because of this, on 11 August, Chile began giving an additional dose of the Oxford–AstraZeneca vaccine to people over 55 who were fully vaccinated with CoronaVac before 31 March.

[57] In October 2021, a large scale study in Chile with 2,017,878 participants reported that, with a CoronaVac booster, effectiveness against hospitalization increased from 84% to 88% and effectiveness against symptomatic disease increased from 56% to 80%.

The greatest increases were seen with a heterologous Oxford–AstraZeneca vaccine booster, resulting in 96% effectiveness against hospitalization and 93% against symptomatic disease. [58] A study by the University of Hong Kong in December 2021 found that a third dose of CoronaVac does not provide sufficient protection against the Omicron variant, [59] directly contradicting the vaccine manufacturer's claim [42] and a study by the Pontifical Catholic University of Chile that it does. [60] In April 2022, a Singapore study by infectious diseases experts from the National Centre for Infectious Diseases and the Ministry of Health found that CoronaVac recipients were 4.59 times more likely to have severe COVID-19 as well as 2.37 times more likely to be infected, compared to those who took the Pfizer-BioNTech vaccine.

[61] [62] Variants In the following tables, a vaccine is generally considered effective if the estimate is ≥50% with a >30% lower limit of the 95% confidence interval.

[63] Effectiveness is generally expected to slowly decrease over time. [64] Initial effectiveness by variant Doses Severity of illness Delta Gamma 1 Asymptomatic Not reported 16% ( 15– 17%) [65] Symptomatic 14% ( −60 to 55%) [A] Not reported Hospitalization Not reported 27% ( 25– 28%) [65] 2 Asymptomatic Not reported 54% ( 53– 55%) [65] Symptomatic 59% ( 16– 82%) [A] Not reported Moderate [B] 70% ( 43– 96%) [67] Not reported Hospitalization 100% [C] [67] 73% ( 72– 74%) [65] • ^ a b Efficacy from a study with 366 participants.

[66] • ^ Cases with imaging characteristics of pneumonia and also fever and respiratory symptoms. [66] • ^ A confidence interval was not provided, so it is not possible to know the accuracy of this measurement. In the elderly A test-negative case-control study from 17 January to 29 April 2021 in the state of São Paulo, during which 86% of the collected genotype isolates were of the Gamma variant, with 43,774 participants aged 70 years or older, found an effectiveness after two doses of 47% (95% CI, 39– 54%) against symptomatic disease, 56% (95% CI, 47– 63%) against hospitalization and 61% (95% CI, 49– 71%) against death.

After a single dose, the effectiveness was only 13% ( 4– 21%) against symptomatic disease, 17% ( 6– 27%) against hospitalization and 31% ( 18– 43%) against death, highlighting the importance of receiving the second dose. [68] The study also found that effectiveness against symptomatic disease decreased with increasing age: Initial effectiveness in old age after two doses (Brazil) [68] Severity of illness Age 70–74 Age 75–79 Age ≥80 Symptomatic 59% ( 44– 70%) 56% ( 43– 66%) 33% ( 17– 46%) Hospitalization 78% ( 63– 87%) 67% ( 52– 77%) 39% ( 21– 53%) Death 84% ( 59– 94%) 78% ( 59– 88%) 44% ( 20– 61%) Preliminary data from a large effectiveness study in Brazil with 61 million individuals from 18 January to 30 June 2021, when the Gamma variant was dominant in the country, indicate that effectiveness is markedly reduced in those aged 90 or older, attributable to immunosenescence: [65] Initial effectiveness by age (Brazil) [65] Doses Severity of illness Age <60 Age 60–69 Age 70–79 Age 80–89 Age ≥90 1 Asymptomatic 14% ( 12– 16%) 15% ( 13– 18%) 25% ( 23– 27%) 2% ( −3 to 6%) [i] −19% ( −31 to 9%) [i] Hospitalization 34% ( 27– 40%) 30% ( 26– 33%) 33% ( 30– 35%) 8% ( 2– 14%) −16% ( −31 to 3%) [i] Death 42% ( 26– 54%) 36% ( 30– 41%) 38% ( 35– 42%) 10% ( 3– 11%) −22% ( −41 to 6%) [i] 2 Asymptomatic 45% ( 43– 46%) 56% ( 54– 57%) 62% ( 61– 63%) 57% ( 55– 60%) 32% ( 24– 38%) Hospitalization 84% ( 81– 87%) 78% ( 76– 80%) 74% ( 73– 75%) 63% ( 60– 66%) 33% ( 23– 41%) Death 77% ( 67– 83%) 79% ( 77– 80%) 78% ( 77– 80%) 67% ( 64– 71%) 35% ( 24– 45%) • ^ a b c d The confidence interval includes zero, so it is possible that vaccination had no effect.

Specific populations On 21 October 2021, the WHO recommended a third dose as part of the initial course for older adults 3–6 months after the second dose and for immunocompromised individuals 1–3 months after the second dose because these groups mount a weaker immune response compared to healthy adults.

Where supplies are limited, the third dose for seniors should be given after achieving high coverage with two doses. [44] Manufacturing Brazilian version of CoronaVac, filled and finished by Instituto Butantan As an inactivated vaccine like the Sinopharm BIBP vaccine and Covaxin, CoronaVac uses a more traditional technology [69] [11] that is similar to the inactivated polio vaccine.

Initially, a sample of SARS-CoV-2 from China was used to grow large quantities of the virus using vero cells. From then on, the viruses are soaked in beta-propiolactone, which deactivates them by binding to their genes, while leaving other viral particles intact. The resulting inactivated viruses are then mixed with the adjuvant aluminium hydroxide. [4] [70] [18] CoronaVac does not need to be frozen, and both the vaccine and raw material for formulating the new doses could be transported and refrigerated at 2–8 °C (36–46 °F), temperatures at which flu vaccines are kept.

[12] CoronaVac could remain stable for up to three years in storage, which might offer some advantage in vaccine distribution to regions where cold chains are not developed. [71] In November 2020, Brazil's Instituto Butantan began building a facility to manufacture 100 million doses of CoronaVac a year, with a target completion date in September 2021.

[72] On 10 December, São Paulo Governor João Doria said that in the interim, prior to the local manufacture of CoronaVac, Instituto Butantan aimed to fill and finish 1 million doses of the vaccine per day.

[33] In April 2021, Sinovac said its third manufacturing plant for Coronavac was ready and had started manufacturing bulk vaccine ingredients, doubling its annual capacity to 2 billion doses. [32] In April 2021, Bio Farma of Indonesia had filled and finished 35 million doses of CoronaVac, but was facing some production delays because of diminished supply of bulk delivered CoronaVac from China.

[73] In May 2021, Malaysian company Pharmaniaga obtained local approval for its fill and finish CoronaVac. [74] In May 2021, Turkey was provided a license to produce CoronaVac. [75] In May 2021, Hungary announced an agreement to fill and finish CoronaVac, with the goal to eventually manufacture it locally in a new plant in Debrecen.

[35] In June 2021, Egypt announced that it will produce about 40 million doses by the end of the year. Distribution of the locally produced vaccine will begin by August and it will be used locally and sent to other African nations. [76] History Clinical trials For broader coverage of this topic, see COVID-19 vaccine.

Phase I–II In April 2020, CoronaVac began Phase I–II trials in China with 744 participants on adults over the age 18-59, and In May, CoronaVac began Phase I–II trials in China with 422 participants on elderly adults over the age 60 and above. [77] [78] Preliminary results indicate that neutralizing antibodies fell below the seropositive threshold 6 to 8 months after the first two doses, and that a third dose given 6 or more months after the second dose raised neutralizing antibody levels beyond that of an initial course consisting of 3 doses.

[79] In the Phase II trial completed in July 2020 published in The Lancet, CoronaVac showed seroconversion of neutralising antibodies for 109 (92%) of 118 participants in the 3 μg group, 117 (98%) of 119 in the 6 μg group, after the days 0 and 14 schedule; whereas at day 28 after the days 0 and 28 schedule, seroconversion was seen in 114 (97%) of 117 in the 3 μg group, 118 (100%) of 118 in the 6 μg group. [80] Phase II results for older adults published in The Lancet showed CoronaVac was safe and well tolerated in older adults, with neutralising antibody induced by a 3 μg dose similar to those of a 6 μg dose.

[81] Phase III In July 2020, Sinovac began Phase III trials to evaluate efficacy and safety on 9,000 volunteer healthcare professionals in Brazil, collaborating with Butantan Institute. [82] [83] On 19 October, São Paulo Governor João Doria said the first results of the clinical study conducted in Brazil proved that among the vaccines being tested in the country, CoronaVac is the safest, the one with the best and most promising immunization rates. [84] On 23 October, São Paulo increased the number of volunteers in the trial to 13,000.

[85] Brazil briefly paused the trials on 10 November after the suicide of a volunteer before resuming them the next day. The suicide was unrelated to the vaccine trial.

[86] [87] In August, a trial was started in Chile run by Pontifical Catholic University of Chile which was expected to include 3,000 volunteers between the ages of 18 and 65. [7] In August, Sinovac began trials in Indonesia with Bio Farma in Bandung involving 1,620 volunteers.

[8] In September, Turkey began trials with 13,000 volunteers on a two-dose 14-day interval. [88] The monitoring process took place at 25 centers in 12 cities across the country.

[89] The Governor of West Java Ridwan Kamil participating in phase 3 trial of the Sinovac COVID-19 vaccine in Indonesia. In October, Sinovac began trials in China involving 1,040 volunteers. [90] In April 2021, Sinovac began Phase II/III trials for the elderly aged 60–80 in the Philippines involving 352 volunteers.

[91] Children and adolescents trials In September 2020, Sinovac began Phase I–II trials in China on children and adolescents ages 3–17. [92] In May 2021, Sinovac began Phase IIb trials in China with 500 participants for children and adolescents 3–17 years old. [93] In June 2021, it was announced that the vaccine was safe and immunogenic in this age group.

[94] In July, Sinovac began Phase III trials in Chile with 14,000 participants for children and adolescents and expand from 6 months to 17 years old. [95] Results of Phase III trials Peer-reviewed Phase III results from Turkey showed an efficacy of 83.5% (95% CI, 65.4– 92.1%). The final efficacy rate was based on 41 infections, 32 of which had received a placebo. The vaccine prevented hospitalization and severe illness in 100% of cases, with all six people who were hospitalized in the placebo group.

The final results were based on 10,218 participants in the trials. [17] [18] Phase III results from Brazil submitted to Lancet showed 50.7% efficacy at preventing symptomatic infections, 83.7% effective in preventing mild cases needing treatment. Efficacy against symptomatic infections increased to 62.3% with an interval of 21 days or more between the doses. {/INSERTKEYS}

corona omicron indonesia

A total of 12,396 volunteers participated in the study between 21 July and 16 December 2020. All participants received at least one dose of the vaccine or placebo. Of this total, 9,823 participants received both doses. [19] Further detail published by Sinovac showed an efficacy 50.65% (95% CI, 35.66– 62.15%) against all symptomatic cases, 83.70% ( 57.99– 93.67%) against cases that require medical treatment, and 100.00% ( 56.37– 100.00%) against severe, hospitalized and fatal cases.

In the placebo group (N=4870), there were 168 COVID cases, 30 cases requiring medical attention, and 10 severe cases including one death. In the vaccine group (N=4953), there were 85 COVID cases, 5 cases requiring medical attention, and no severe cases or deaths. [96] On 1 April 2021, a preliminary report [97] from a phase III clinical trial in Chile [98] revealed that CoronaVac is safe and induces humoral and cell-mediated immunity in adults (18–59 years old) and the elderly (60 years or older) similar to previous phase Corona omicron indonesia trials conducted in China with the same age groups and immunization schedule consisting of two doses with a 14-day interval.

The side effects corona omicron indonesia mild and local, mainly limited to pain at the injection site, which was more common in adults. Seroconversion rates for adults 14–28 days after the second dose were 95.6% for the IgG specific against the S1-RBD ( receptor binding domain of the S1 subunit of the spike protein) and 96% for neutralizing anti-S1-RBD IgG.

For the elderly, seroconversion rates were 100% 14 days and 87.5% 28 days after the second dose for the S1-RBD specific IgG, 90% 14 days, and 100% 28 days after the second dose for neutralizing anti-S1-RBD IgG. As found in studies in animals, seroconversion rates for IgG specific against the N ( nucleocapsid) protein were weak for both groups, although CoronaVac contains significant amounts of the N protein.

corona omicron indonesia

A robust increase of T helper cells (CD4 +) secreting interferon gamma was detected 14 days after both doses in response to stimulation with peptides of the S protein and of other viral particles, but the response to S protein peptides was reduced corona omicron indonesia the elderly due to a natural reduction of activated CD4 + T cells in this age group, as found in studies of other vaccines.

Corona omicron indonesia immune response of cytotoxic T cell (CD8 +) was not as robust. The observed CD4 + T cell response is considered a balanced immune response capable of viral clearance and is similar to that observed in other COVID-19 vaccines, such as BNT162b1 and Convidecia.

Variability in results In early January 2021, Brazilian health officials announced that the vaccine had an efficacy of 78%. One week later, they revised this figure to 50.4%, stating that the revised figure now included "very mild" cases of COVID-19 among trial participants which were omitted in the earlier analysis.

[99] [100] Ricardo Palácios, Medical Director of Brazil's Instituto Butantan, said Sinovac's relatively low efficacy rate of 50% was due to more rigorous standards for what counted as an infection among trial participants. [101] The Institute split cases in six categories: asymptomatic, very mild, mild, two levels of moderate, and severe; the first two didn't require medical assistance.

[99] [100] Possible explanations for lower efficacy rate included: trial was largely made up of frontline health care workers who were more exposed to the virus; [100] two vaccine doses were given at shorter intervals (2 weeks); [100] [102] counting very mild cases; [100] [103] and the Gamma variant (lineage P.1), more transmissible and perhaps evaded immunity better, was circulating.

[103] According to Instituto Butantan director Dimas Covas, the Brazilian group was considered more vulnerable to infection and exposure to higher viral loads. In Turkish and Indonesian Phase III trials, the composition of volunteers was similar to that of the general population. [104] Variants On 10 March, Instituto Butantan Director Dimas Covas said CoronaVac was efficacious against three variants of COVID-19 in the country; Alpha (lineage B.1.1.7), Beta (lineage B.1.351), and lineage B.1.1.28 (identified in Brazil), from which Gamma and Zeta (lineages P.1 and P.2) descend.

[105] Preliminary results from a large study of health care workers suggest one dose of CoronaVac is still about 50% effective against symptomatic COVID-19 in Manaus. In April 2021, it was reported that over 75% of new cases were being caused by the highly transmissible Gamma variant. [106] In June, Thailand's Public Health Ministry stated the vaccine had 71%-91% efficacy against infection by the Alpha strain.

[107] In June 2021, Reuters reported that more than 350 Indonesian doctors and medical workers out of 5,000 in Kudus contracted the Delta strain despite being vaccinated with the CoronaVac, an infection rate of 7%. In response, Griffith University epidemiologist Dicky Budiman questioned the efficacy of CoronaVac against the variant but overall still recommended that people take the vaccine, expressing "confidence that to a certain degree Sinovac has effectiveness against the new variant".

He stated that the situation was due to various factors, including a "lack of proper protective gear and the overall situation in Indonesia". [108] The vast majority of those infected were protected from severe symptoms and recovered without hospitalization. [109] Authorizations See also: List of COVID-19 vaccine authorizations § CoronaVac The World Health Organization (WHO) validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use on 1 June 2021.

[110] [37] The recommendation was given with limited evidence at the time of approval for groups other than healthy adults. The WHO Strategic Advisory Group of Experts expressed high level of confidence in the efficacy of the vaccine for adults, moderate confidence in the efficacy for older adults and individuals with comorbidities, moderate confidence in its safety for adults and low confidence in its safety for the elderly and individuals with comorbidities.

[18] In late August 2020, China approved CoronaVac for emergency use to vaccinate high-risk groups such as medical staff. [111] In early February, China approved CoronaVac for general use.

[22] On 5 June 2021, China approved CoronaVac for emergency use with children and adolescents for 3–17 years old. [ citation needed] In January 2021, Bolivia authorized use of CoronaVac. [112] In April, Panama approved emergency use of Coronavac.

[113] On 4 May, the EMA's human medicines committee (CHMP) started a rolling review of CoronaVac. [114] In June, Bangladesh approved Coronavac for emergency use. [115] Society and culture Economics As of 7 July 2021, CoronaVac is the most widely used COVID-19 vaccine in the world, with 943 million doses delivered globally.

[39] In July, Sinovac signed advanced purchase agreements with GAVI to supply COVAX with 50 million doses in the third quarter of 2021 and up to a total of 380 million doses by the first corona omicron indonesia of 2022. [116] [117] Asia In January, Azerbaijan launched its vaccination campaign with CoronaVac. [118] It purchased 4 million doses from Turkey and 5 million doses from China. [119] In May, Armenia received 100,000 doses from China. [120] In February, Cambodia approved Coronavac for emergency use [121] and started vaccinations in March.

[122] By July, the country had received 10.5 million doses. [123] In October, Saudi Arabia signed an agreement to distribute CoronaVac to 7,000 healthcare workers, after conducting Phase III trials with the Saudi Arabian National Guard. [124] In November, Turkey signed a contract to buy 50 million doses of CoronaVac.

[125] Turkey approved emergency use on 13 January [126] and President Recep Tayyip Erdoğan received his first dose at Ankara City Hospital. [127] In February, Turkey signed a deal for another 50 million doses for a total of 100 million doses. [29] By March 10.7 million doses had been administered, and 852 of the 1.3 corona omicron indonesia people who had received both doses were later diagnosed with the disease.

53 were hospitalized, but none of those hospitalized were intubated or died. [128] In December, Corona omicron indonesia Kong ordered 7.5 million doses of CoronaVac.

[129] The vaccination campaign with CoronaVac began on 26 February. [130] By December 2020, Indonesia had signed agreements for 140 million doses of CoronaVac. [131] Indonesia approved emergency use authorization on 11 January [132] and President Joko Widodo received the first shot of the vaccine.

[20] By June, Indonesia had received 118.7 million bulk doses. [133] In January, Malaysia ordered 12 million doses [134] which was approved for emergency use in March. [135] Science, Technology and Innovation Minister Khairy Jamaluddin received the first dose as part of the vaccination campaign.

[136] In March, Kazakhstan ordered 3 million doses, [137] of which 500,000 doses arrived in June and has been approved for use by the Ministry of Health. [138] In May, Oman received its first batch of the vaccine. [139] In April, Pakistan granted emergency use authorization for CoronaVac [140] and received 14.5 million doses by July. [141] In January, the Philippines announced the country had secured 25 million doses.

[142] The vaccine was approved on 22 February but not for all health workers as it had lower efficacy when used with health workers compared to healthy corona omicron indonesia aged 18–59. The first 600,000 doses of CoronaVac arrived on 28 February, [143] and the country had received 7.5 million doses by June. [144] Singapore signed advance purchase agreements for CoronaVac. [145] In February, the first doses arrived [146] corona omicron indonesia in June it was approved for use under the Special Access Route.

[147] In May, Tajikistan's Ministry of Health announced it would receive 150,000 doses. [148] In February, Thailand approved emergency use [149] and started its vaccination program on corona omicron indonesia February.

[21] As of June, Thailand had received 10.5 million doses. [150] In May 2021, Georgia began vaccinations with CoronaVac, [151] for which it received 1 million doses by July. [152] In May 2021, Turkmenistan received a delivery of CoronaVac. [153] In May 2021, AKIPress reported Uzbekistan plans to use CoronaVac.

[154] In October 2021, Singapore included CoronaVac in its National Vaccination Programme for people aged 18 and over who are ineligible for mRNA vaccines due to allergies or serious adverse reactions after the first dose.

[155] Africa In March, Benin received 203,000 doses of CoronaVac [156] and started vaccinations on 29 March prioritizing healthcare workers, people over 60, and those with co-morbidities.

[157] In April, Botswana received 200,000 doses of CoronaVac as a donation and purchased an additional 200,000 doses [158] to be used in the vaccination program. [159] In March, Djibouti received 300,000 doses of CoronaVac. [160] In April, Egypt approved emergency use of CoronaVac. [161] In April, Guinea received 300,000 doses of CoronaVac which it had purchased.

[162] In April, Libya received 150,000 doses of CoronaVac from Turkey. [163] In April, Somalia received 200,000 doses of CoronaVac. [164] In July, South Africa approved CoronaVac for emergency use, and was expected to receive 2.5 million doses shortly. [165] In April, Togo received 200,000 doses of CoronaVac. [166] In March, Tunisia's Ministry of Health approved marketing authorization for CoronaVac [167] and the first 200,000 doses arrived on 25 March.

[168] In March, Zimbabwe approved emergency use [169] and the first 1 million doses arrived on 30 March. [170] Europe In March, Albania launched its vaccination campaign using mainly CoronaVac, [31] a week after securing 1 million doses from Turkey.

[171] By June, Northern Cyprus received 190,000 doses donated by Turkey. [172] In March, Bosnia received 30,000 doses donated by Turkey. [173] In June, North Macedonia received 30,000 doses donated by Turkey [172] and another 500,000 doses it purchased. [174] In March, Ukraine granted approval for use of CoronaVac. Ukrainian Pharmaceutical Company Lekhim has an agreement to deliver 5 million doses. [175] 1.7 million doses had been delivered by June.

[176] In April, Moldova purchased 400,000 doses of CoronaVac. [177] South America São Paulo State Secretary of Health Jean Gorinchteyn (left) and Instituto Butantan chairman Dimas Covas (right) holding single-dose prefilled syringes of CoronaVac, part of the fourth shipment of Sinovac-manufactured vaccine to arrive in Brazil In Brazil, São Paulo governor João Doria signed a $90 million contract with Sinovac in September to receive the initial 46 million doses of CoronaVac.

[178] The price for CoronaVac was announced to be US$10.3 (about R$59). [179] In January, Brazil announced it would obtain 100 million total doses. [180] On 17 January, Brazil's health regulatory agency Anvisa approved emergency use of CoronaVac. [181] In early February, Brazil said it intends to buy an additional 30 million doses on top of existing 100 million doses.

[23] A total of 39.7 million doses had been delivered by early April. [182] In October, Chile signed an agreement to purchase 20 million doses of CoronaVac [183] which was approved for emergency use on 20 January.

[184] By early March, the country had received 10 million doses of CoronaVac and had vaccinated 4.1 million people. [185] In February, Colombia had purchased 5 million doses and was in talks for an additional 5 million doses, [186] which had been approved for emergency use on 5 February. [187] In February, Ecuador signed a deal for 2 million doses which was approved for emergency use, [188] with the first 1 million doses arrived in early April. [189] [190] In March, Paraguay received a donation of 20,000 doses from Chile.

[191] Paraguay began vaccinations with CoronaVac on 10 March. [192] In January, Uruguay purchased 1.75 million doses, [193] of which the first 192,000 doses arrived on 25 February and vaccinations started on 1 March. [25] North America By June, Dominican Republic had received 7.8 million doses [194] of an order for 10 million doses.

[27] In March, El Salvador received 1 million doses of a total 2 million dose order for CoronaVac. The immunization campaign was initially focused on teachers, health professionals, firefighters, police, and military personnel. The first doses were provided to public school teachers beginning on March 30, with rollout expanding to private school teachers shortly after. Vaccination of the general public was planned for April 15, after the vaccination of the priority groups. [28] In February, Mexico approved emergency use of CoronaVac.

[195] The country has ordered 20 million doses, [196] of which 7 million had been received by May. [197] Oceania Corona omicron indonesia March, Fiji said it would be receiving a donation of CoronaVac. [198] Controversies China state media propaganda In January 2021, as part of a misinformation campaign, multiple Chinese state and CCP-affiliated media outlets, including CGTN and the Global Times, have touted CoronaVac and Chinese vaccines as "relatively safer due to their mature technology".

Pushing back against concerns of CoronaVac efficacy over the lack of transparency over releasing test results, China state media have raised doubts about the efficacy of the Pfizer–BioNTech vaccine, calling for an investigation into the deaths of elderly people in Norway and Germany after receiving the vaccine. According to Reuters, the reports made allegations of "deliberately downplaying the deaths” and “using propaganda power to promote the Pfizer vaccine and smearing Chinese vaccines".

[199] [200] According to a Ming Pao report published on 21 March 2022, of the 1,486 who died of COVID-19 after receiving at least one dose, 1,292 of them or 87%—had gotten the Sinovac vaccine.

[201] The Centre for Health Protection’s Chuang Shuk-kwan said that the Ming Pao report was inaccurate and has defended CorovaVac, saying “The issue is not about which jab offers more protection. The most important thing is whether you get vaccinated.” [202] Earlier in February 2022, health authorities refused to disclose data on which Covid-19 vaccine had been taken by Omicron patients, claiming the information “was not readily available.” [203] Hong Kong government data showed CoronaVac to be the preferred vaccine among those aged 70 and over, in part because some elderly care homes only offer this vaccine.

However, CoronaVac's limited effectiveness compared to the BioNTech vaccine, along with the zero-COVID strategy, have been regarded as factors behind Corona omicron indonesia Kong's spiking cases as of March 2022. [43] [204] Politicization CoronaVac has been championed by the governor of São Paulo, João Doria.

[205] A political showdown began in October 2020, when Bolsonaro vetoed a deal between the Brazilian health ministry and the São Paulo government for the purchase of 46 million doses of the vaccine. [206] After Instituto Butantan announced CoronaVac's efficacy rate, Bolsonaro mocked the vaccine's effectiveness against COVID-19. [207] In March 2021, the Paraná Pesquisas opinion polling institute found that the vaccines preferred by Brazilians are CoronaVac and the Oxford–AstraZeneca vaccine, chosen by 23.6% and 21.2% corona omicron indonesia Brazilians interviewed, respectively, against 11.3% of those who would prefer the Pfizer–BioNTech vaccine.

[208] During the pandemic parliamentary inquiry in Brazil, senators have expressed that corona omicron indonesia rhetoric has contributed to delaying access to vaccines in Brazil. [209] Delays in releasing results On 23 December 2020, researchers in Brazil said the vaccine was more than 50% effective, but withheld full results at Sinovac's request, raising questions about transparency as it was the third delay in releasing results from the trials. [210] Scientists said the lack of transparency risked damaging CoronaVac's credibility.

[199] References • ^ McGeever J, Fonseca P (17 January 2021). "Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin". Reuters.

Retrieved 17 January 2021. • ^ "Anvisa aprova por unanimidade uso emergencial das vacinas" [Anvisa unanimously approves the emergency use of vaccines] (in Portuguese). Federal government of Brazil. 17 January 2021. Retrieved 20 November 2021. • ^ Corum J, Zimmer C. "How the Sinovac Vaccine Works". The New York Times. ISSN 0362-4331. Retrieved 1 March 2021. • ^ a b Hotez, Peter J.; Bottazzi, Maria Elena (27 January 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines".

Annual Review of Medicine. 73 (1): 55–64. doi: 10.1146/annurev-med-042420-113212. ISSN 0066-4219. PMID 34637324. S2CID 238747462. Retrieved 14 April 2022. • ^ Parekh N (22 July 2020). "CoronaVac: A COVID-19 Vaccine Made From Inactivated SARS-CoV-2 Virus". Retrieved 25 July 2020. • ^ "New coronavirus vaccine trials corona omicron indonesia in Brazil". AP News. 21 July 2020. Retrieved 7 October 2020. • ^ a b "Chile initiates clinical study for COVID-19 vaccine".

Government of Chile. 4 August 2020. Archived from the original on 11 October 2020. Retrieved 9 April 2021. • ^ a b Bagus AR, Nasution R. Assegaf F (ed.). "248 volunteers have received Sinovac vaccine injections in Bandung". Antara News. Archived corona omicron indonesia the original on 30 September 2020. Retrieved 22 September 2020. • ^ "DOH eyes 5 hospitals for Sinovac vaccine Phase 3 clinical trial". PTV News. 16 September 2020.

Retrieved 7 October 2020. • ^ "Turkey begins phase three trials of Chinese Covid-19 vaccine". TRT World Corona omicron indonesia. 1 September 2020. Retrieved 7 October 2020. • ^ a b Zimmer C, Corum J, Wee SL.

"Coronavirus Vaccine Tracker". The New York Times. ISSN 0362-4331. Retrieved 9 April 2021. • ^ a b "CoronaVac: Doses will come from China on nine flights and can." AlKhaleej Today (in Arabic).

1 November 2020. Archived from the original on 16 December 2020. Retrieved 1 November 2020. • ^ a b Jara A, Undurraga EA, González C, Paredes F, Fontecilla T, Jara G, et al. (September 2021). "Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile". The New England Journal of Medicine. 385 corona omicron indonesia 875–884. doi: 10.1056/NEJMoa2107715. PMC 8279092. PMID 34233097. • ^ Savarese M (1 June 2021). "Sinovac vaccine restores a Brazilian city to near normal".

CTV News. Archived from the original on 1 June 2021. Retrieved 2 June 2021. • ^ Pearson S (31 May 2021).

"Brazil's Experiment to Vaccinate Town With Chinese CoronaVac Reduced Covid-19 Deaths by 95%". The Wall Street Journal. ISSN 0099-9660. Retrieved 2 June 2021. • ^ a b "China Sinovac Shot Seen Highly Effective corona omicron indonesia Real World Study". MSN. 12 May 2021. Retrieved 12 May 2021. • ^ a b Tanriover MD, Doğanay HL, Akova M, Güner HR, Azap A, Akhan S, et al. (8 July 2021). "Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey".

The Lancet. 398 (10296): 213–222. doi: 10.1016/S0140-6736(21)01429-X. ISSN 0140-6736. PMC 8266301. PMID 34246358. S2CID 235770533. • ^ a b c d Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine (PDF) (Presentation). World Health Organization.

29 April 2021. Retrieved 10 July 2021. • ^ a b Costa A (11 April 2021). "Estudo clínico que comprova maior eficácia da Coronavac é enviado para Lancet" [Clinical study proving greater efficacy of Coronavac is submitted to The Lancet].

CNN Brasil (in Portuguese). São Paulo. Retrieved 12 April 2021. • ^ a b Tarigan E, Milko V (13 January 2021). "Indonesia starts mass COVID vaccinations over vast territory". Associated Press. Retrieved 15 January 2021. • ^ a b "Thailand Kicks Off Covid-19 Vaccine Program With Sinovac Shots". Bloomberg.com. Retrieved 28 February 2021. • ^ a b "China approves Sinovac vaccines for general public use".

South China Morning Post. 6 February 2021. Retrieved 6 February 2021. • ^ a b Rochabrun M. "Brazil health ministry says plans to order 30 million more Coronavac doses". The Chronicle Herald. Archived from the original on 29 March 2021. Retrieved 26 February 2021.

• ^ Miranda NA (28 January 2021). "Chile receives two million-dose first delivery of Sinovac COVID-19 vaccine". Reuters. Retrieved 30 January 2021. • ^ a b "BNamericas - Uruguay prepares to launch COVID-19 vaccinat." BNamericas.com. Retrieved 1 March 2021.

• ^ "Venustiano Carranza next up for Covid vaccination in Mexico City". Mexico News Daily. 15 March 2021. Retrieved 16 March 2021. • ^ a b "Anticovid vaccines run out as Dominican Republic awaits arrival of more doses". Dominican Corona omicron indonesia. Archived from the original on 10 March 2021. Retrieved 10 March 2021. • ^ a b "Llegan a El Salvador un millón de dosis de la vacuna china CoronaVac contra el covid-19 de la farmacéutica Sinovac".

La Prensa Gráfica (in European Spanish). Retrieved 28 March 2021. • ^ a b "Turkey aims to vaccinate 60 percent of population: Minister – Turkey News".

Hürriyet Daily News. Retrieved 12 February 2021. • ^ "Vaccination with CoronaVac launched in Ukraine on April 13 – Health minister". www.unian.info. Retrieved 15 April 2021. • ^ a b Semini L. "Albania starts mass COVID vaccinations before tourist season". ABC News.

Archived from the original on 28 March 2021. Retrieved 28 March 2021. • ^ a b c Liu R (2 April 2021). "China Sinovac says it reached two billion doses annual capacity for COVID-19 vaccine". Reuters. Retrieved 2 April 2021. {{ cite news}}: CS1 maint: url-status ( link) • ^ a b Mano A, Simões E (10 December 2020). "Chinese vaccine draws demand across Latin America, say Brazilian officials". Reuters. Archived from the original on 10 December 2020.

Retrieved 10 December 2020. • ^ "Egypt to produce up to 80 million Sinovac vaccine doses annually". Arab News. 8 April 2021.

Retrieved 8 April 2021. • ^ a b "UPDATE 2-Hungarian vaccine plant to be fitted for production of Chinese Sinopharm shots -minister". Reuters. 31 May 2021. Retrieved 7 June 2021. • ^ Nebehay S (1 June 2021). "WHO approves Sinovac COVID vaccine, the second Chinese-made dose listed". Reuters. Geneva. Retrieved 1 June 2021.

• ^ a b "WHO recommendation Sinovac COVID-19 vaccine (Vero Cell [Inactivated]) – CoronaVac". World Health Organization (WHO).

1 May 2021. Retrieved 1 June 2021. • ^ "Chinese drugmakers agree to supply more than half a billion vaccines to COVAX". Reuters. 12 July 2021. Retrieved 13 July 2021. • ^ a b "Sinovac is world's most used vaccine, but how good is its Delta protection?".

South China Morning Post. 8 July 2021. Retrieved 29 July 2021. • ^ a b Mallapaty, Smriti (14 October 2021). "China's COVID vaccines have been crucial — now immunity is waning". Nature. 598 (7881): 398–399. Bibcode: 2021Natur.598.398M. doi: 10.1038/d41586-021-02796-w. PMID 34650240. S2CID 238990258. • ^ http://www.hku.hk: HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron • ^ a b "Two Sinovac shots not enough for omicron, but 3rd shows effect".

Nikkei Asia. 16 December 2021. Retrieved 8 January 2022. • ^ a b https://hongkongfp.com/2022/02/26/factwire-sinovac-limits-hong-kongs-protection-against-infection-from-omicron-analysis-suggests/ • ^ a b Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac (Guidance). World Health Organization. 21 October 2021. WHO/2019-nCoV/vaccines/SAGE_recommendation/Sinovac-CoronaVac/2021.2. • ^ "Chilean Sinovac trial leaders recommend third dose of COVID-19 vaccine".

Reuters. Santiago. 15 July 2021. Retrieved 19 July 2021. • ^ Pearson S, Magalhaes L (18 February 2021). "Brazil Turns Sleepy Sugarcane Town Into Global Covid-19 Experiment". The Wall Street Journal. ISSN 0099-9660. Retrieved 2 June 2021.

• ^ "Mass vaccination creates healthy oasis in Brazilian city". Reuters. 31 May 2021. Retrieved 2 June 2021. • ^ "Sinovac vaccine restores a Brazilian city to near normal". Associated Press. 1 June 2021. Archived from the original on 1 June 2021. Retrieved 2 June 2021. • ^ Pearson S, Magalhaes L (18 February 2021). "Brazil Turns Sleepy Sugarcane Town Into Global Covid-19 Experiment". The Wall Street Journal.

ISSN 0099-9660. Retrieved 2 June 2021. • ^ "Mass vaccination creates healthy oasis in Brazilian city". Reuters. 31 May 2021. Retrieved 2 June 2021. • ^ "Sinovac vaccine restores a Brazilian city to near normal". Associated Press. 1 June 2021. Archived from the original on 1 June 2021. Retrieved 2 June 2021. • ^ Bhwana PG (17 May 2021). "Indonesian Ministry Review Says Sinovac 98% Effective to Prevent Covid Deaths". Tempo. Retrieved 20 May 2021. • ^ "Indonesian Medics Find China Vaccine More Effective in Field".

The Australian. 12 May 2021. Retrieved 12 May 2021. • ^ "UPDATE VAKSINASI COVID-19: Efektivitas Vaksin SinoVac Terhadap Tenaga Kesehatan" (in Indonesian). 12 May 2021. • ^ "Segundo estudio de efectividad de vacunación anti SARS-CoV-2 en Uruguay al 8 de junio de 2021" (in Spanish). 8 June 2021. • ^ Hitchings MD, Ranzani OT, Torres MS, Oliveira SB, Almiron M, Said R, et al. (24 June 2021).

"Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study". medRxiv ( Corona omicron indonesia. Findings; Early at-least-one-dose analysis. doi: 10.1101/2021.04.07.21255081. S2CID 233171896.

• ^ "Chile to give COVID-19 vaccine boosters for those inoculated with Sinovac". Reuters. 5 August 2021. Retrieved 11 August 2021. • ^ "Chile realiza primer estudio a nivel mundial sobre uso de dosis de refuerzo en vacunas inactivadas: Aumenta efectividad en prevención y hospitalización por COVID-19" [Chile conducts the first study worldwide on inactivated vaccine boosters: increased effectiveness against disease and hospitalization due to COVID-19] (Press release) (in Spanish).

Ministry of Health of Chile. 7 October 2021. Retrieved 11 November 2021. • ^ " "HKUMed-CU Medicine joint study finds that third dose of Comirnaty has better protection from COVID-19 variant Omicron" ".

University of Hong Kong. Retrieved 24 December 2021. • ^ "Sinovac booster cose can activate cellular immunity against Omicron variant". Bernama. 1 January 2022. Retrieved 8 January 2022. • ^ "People who got Sinovac vaccine nearly 5 times more likely to develop severe COVID-19 than Pfizer: Singapore study". CNA. Retrieved 5 May 2022. • ^ "Singapore Says Virus Deaths Lowest Among Moderna Takers". Bloomberg.com. 10 January 2022. Retrieved 5 May 2022. • ^ Krause P, Fleming TR, Longini I, Henao-Restrepo AM, Peto R, Dean NE, et al.

(12 September 2020). "COVID-19 vaccine trials should seek worthwhile efficacy". The Lancet. 396 (10253): 741–743. doi: 10.1016/S0140-6736(20)31821-3. ISSN 0140-6736. PMC 7832749. PMID 32861315. WHO recommends that successful vaccines should show an estimated risk reduction of at least one-half, with sufficient precision to conclude that the true vaccine efficacy is greater than 30%. This means that the 95% CI for the trial result should exclude efficacy less than 30%.

Current US Food and Drug Administration guidance includes this lower limit of 30% as a criterion for vaccine licensure. • ^ Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. (May 2021). "Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection". Nature Medicine. 27 (7): 1205–1211. doi: 10.1038/s41591-021-01377-8. ISSN 1546-170X. PMID 34002089. S2CID 234769053. • ^ a b c d e f Cerqueira-Silva T, Oliveira VA, Pescarini J, Júnior JB, Machado TM, Ortiz RF, et al.

(25 August 2021). "The effectiveness of Vaxzevria and CoronaVac vaccines: A nationwide longitudinal retrospective study of 61 million Brazilians (VigiVac-COVID19)".

medRxiv ( Preprint). Results, table S2: 2021.08.21.21261501. doi: 10.1101/2021.08.21.21261501. S2CID 237292831. {{ cite journal}}: CS1 maint: location ( link) • ^ a b Li X, Huang Y, Wang W, Jing Q, Zhang C, Qin P, et al. (14 August 2021). "Efficacy of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: A test-negative case-control real-world study".

Emerging Microbes & Infections. 10 (1): 1751–1759. doi: 10.1080/22221751.2021.1969291. PMC 8425710. PMID 34396940. • ^ a b Kang M, Yi Y, Li Y, Sun L, Deng A, Hu T, et al. (5 August 2021). "Effectiveness of Inactivated COVID-19 Vaccines Against COVID-19 Pneumonia and Severe Illness Caused by the B.1.617.2 (Delta) Variant: Evidence from an Outbreak in Guangdong, China" ( Preprint).

SSRN 3895639. {{ cite journal}}: Cite journal requires -journal= ( help) • ^ a b Ranzani OT, Hitchings MD, Dorion M, D'Agostini TL, Paula RC, Paula OF, et al. (20 August 2021). "Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study".

BMJ. 374: n2015. doi: 10.1136/bmj.n2015. ISSN 1756-1833. PMC 8377801. PMID 34417194. • ^ Tan Y (16 December 2020). "Covid: What do we know about China's coronavirus vaccines?". BBC News. Retrieved 18 December 2020. • ^ Corum J, Zimmer C (26 April 2021).

"How the Sinovac Vaccine Works". The New York Times. ISSN 0362-4331. Retrieved 29 April 2021. • ^ Staff (7 September 2020). "China's Sinovac coronavirus vaccine candidate appears safe, slightly weaker in elderly". Reuters. Archived from the original on 7 October 2020. Retrieved 6 October 2020. • ^ "Sao Paulo starts building production plant for China's Sinovac vaccine – governor".

Financial Post. 9 November 2020. Archived from the original on 29 November 2020. Retrieved 9 Corona omicron indonesia 2020. • ^ "Indonesia's Bio Farma Urged to Boost Covid-19 Vaccine Production Capacity".

Antara (news agency). 21 April 2021. Retrieved 7 May 2021. • ^ " 'Fill and finish' Sinovac vaccine by Pharmaniaga approved". Free Malaysia Today. 23 April 2021. Retrieved 7 May 2021. • ^ "Sinovac allows its COVID-19 vaccine to be made in Turkey". Daily Sabah. 12 May 2021. Retrieved 12 May 2021. • ^ "Egypt to start local production of Sinovac vaccine mid-June- minister". Reuters. 7 June 2021. Retrieved 7 July 2021. • ^ Clinical trial number NCT04352608 for "Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)" at ClinicalTrials.gov • ^ Clinical trial number Corona omicron indonesia for "Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection (COVID-19)" at ClinicalTrials.gov • ^ Zeng G, Wu Q, Pan H, Li M, Yang J, Wang L, et al.

(7 December 2021). "Immunogenicity and safety of a third dose of CoronaVac, and corona omicron indonesia persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials". The Lancet Infectious Diseases.

22 (4): 483–495. doi: 10.1016/S1473-3099(21)00681-2. ISSN 1473-3099. PMC 8651254. PMID 34890537. • ^ Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, et al. (February 2021). "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial".

The Lancet. Infectious Diseases. 21 (2): 181–192. doi: 10.1016/S1473-3099(20)30843-4. PMC 7832443. PMID 33217362.

• ^ Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, et al. (June 2021). "Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial".

The Lancet. Infectious Diseases. 21 (6): 803–812. doi: 10.1016/S1473-3099(20)30987-7. PMC 7906628. PMID 33548194. • ^ Savarese M (21 July 2020). "New coronavirus vaccine trials start in Brazil".

Associated Press. Archived from the original on 13 August 2020. Retrieved 15 August 2020. • ^ Palacios R, Patiño EG, de Oliveira Piorelli R, Conde MT, Batista AP, Zeng G, et al. (October 2020). "Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial".

Trials. 21 (1): 853. doi: 10.1186/s13063-020-04775-4. PMC 7558252. PMID 33059771. • ^ "World's vaccine testing ground deems Chinese COVID candidate 'the safest, most promising' ". Fortune. Archived from the original on 31 October 2020. Retrieved 9 November 2020. • ^ "Doria says it guarantees purchase of 100 million doses of CoronaVac." AlKhaleej Today (in Arabic). 29 October 2020. Archived from the original on 1 November 2020. Retrieved 30 October 2020. • ^ "Brazil Clears Sinovac Trial to Resume Two Days After Halting It".

Bloomberg L.P. 11 November 2020. Archived from the original on 11 November 2020. Retrieved 11 November 2020. • ^ "Brazil's health regulator says China's Sinovac can resume Covid-19 vaccine trial after suspension". CNBC. 12 November 2020. Archived from the original on 13 November 2020. Retrieved 17 November 2020. • ^ Health Institutes of Turkey (8 October 2020). "Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated".

ClinicalTrials. Archived from the original on 20 October 2020. Retrieved 21 October 2020. • ^ "Chinese COVID-19 vaccine to be free, 1st doses to be delivered soon: Turkey's health minister". Daily Sabah. 23 November 2020. Archived from the original on 23 November 2020. Retrieved 23 November 2020. • ^ "Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults".

clinicaltrials.gov. United States National Library of Medicine. 4 November 2020. Retrieved 6 June 2021. {{ cite journal}}: CS1 maint: url-status ( link) • ^ "A Multi-center, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 Inactivated (Vero Cell) Vaccine in the Elderly 60–80 Years of Age, Coronovac ENCOV19 Study".

registry.healthresearch.ph. Philippine Health Research Registry. Retrieved 23 April 2021. • ^ Clinical trial number NCT04551547 for "A Randomized, Double-Blinded, Placebo-Controlled, Phase I/II Clinical Trial, to Evaluate the Safety and Immunogenicity of the SARS-CoV-2 Inactivated Vaccine (Vero Cell) in Healthy Population Aged 3–17 Years" at ClinicalTrials.gov • ^ "Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents".

clinicaltrials.gov. United States National Library of Medicine. 3 June 2021. Retrieved 5 June 2021. {{ cite journal}}: CS1 maint: url-status ( link) • ^ Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, Li M, Lian X, Jiao W, Wang L, Shu Q (28 June 2021).

"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial". The Lancet Infectious Diseases. 21 (12): 1645–1653. doi: 10.1016/S1473-3099(21)00319-4. ISSN 1473-3099. PMC 8238449. PMID 34197764. • ^ "Efficacy, Immunogenicity and Safety of COVID-19 Vaccine, Inactivated in Children and Adolescents". clinicaltrials.gov.

United States National Library of Medicine. 5 August 2021. Retrieved 5 August 2021. {{ cite journal}}: CS1 maint: url-status ( link) • ^ Palacios R, Batista AP, Albuquerque CS, Patiño EG, Santos JD, Tilli Reis Pessoa Conde M, et al. (14 April 2021). "Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study". SSRN. doi: 10.2139/ssrn.3822780. S2CID 234875399. Retrieved 9 May 2021. • ^ Bueno SM, Abarca K, González PA, Gálvez NM, Soto JA, Duarte LF, et al.

(1 April 2021). "Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy Chilean adults in corona omicron indonesia phase 3 clinical trial". corona omicron indonesia ( Preprint): 2021.03.31.21254494.

doi: 10.1101/2021.03.31.21254494. PMC 9016657. PMID 35441164. S2CID 232448335. • ^ Clinical trial number NCT04651790 for "Multicenter, Phase 3, Randomized Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against SARS-CoV-2 Infection in Adults." at ClinicalTrials.gov • ^ a b Leite J, Romani A (12 January 2021). "Overall Efficacy of Sinovac Vaccine in Brazil Just Above 50%".

BNN Bloomberg. • ^ a b c d e "Brazil finds Sinovac's vaccine efficacy well below earlier findings". BusinessDay. 12 January 2021. • ^ McGregor G (13 January 2021). "Why did the efficacy of China's top vaccine drop from 78% to 50%?". Fortune. Retrieved 14 January 2021. • ^ "expert reaction to reported results of the Sinovac COVID-19 vaccine from a trial by the Butantan Institute in Brazil".

Science Media Centre. 12 January 2021. Archived from the original on 14 June 2021. • ^ a b Mallapaty S (21 May 2021). "China's COVID vaccines are going global — but questions remain". Nature. • ^ Gielow I (7 January 2021). "Coronavac tem eficácia de 78% contra a Covid-19 em estudo no Brasil".

Folha de S.Paulo (in Brazilian Portuguese). Retrieved 7 January 2021. • ^ Cruz EP (10 March 2021). "Estudos mostram eficácia da CoronaVac contra três variantes do vírus".

Agência Brasil (in Brazilian Portuguese). Retrieved 18 March 2021. • ^ Moutinho S (April 2021). "Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil". Science. doi: 10.1126/science.abi9414.

• ^ "Sinovac jab 'up to 91% effective' after double dose". Bangkok Post. Retrieved 30 June 2021. • ^ Widianto S, Lamb K (18 June 2021). "Hundreds of vaccinated Indonesian health workers get COVID-19, dozens in hospital". Reuters. Archived from the original on 20 June 2021. Retrieved 20 June 2021. • ^ "Sinovac Vaccine Protects Health Workers From Severe Covid-19 in Delta-Hit Kudus".

Jakarta Globe. 20 June 2021. Retrieved 25 June 2021. • ^ "WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations". World Health Organization (WHO) (Press release). Retrieved 1 June 2021. • ^ Liu R, Kim M (29 August 2020). Nicolaci da Costa A (ed.). "Sinovac's coronavirus vaccine candidate approved for emergency use in China – source". Reuters. Archived from the original on 31 August 2020.

Retrieved 30 August 2020. • ^ "Bolívia autoriza uso de vacinas Sputnik V e CoronaVac contra covid-19". noticias.uol.com.br (in Brazilian Portuguese). Retrieved 7 January 2021. • ^ Moreno E (9 April 2021). "Panama approves use of China's Sinovac vaccine against COVID-19".

Reuters. Retrieved 10 April 2021. • ^ "EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated". EMA - European Medicines Agency. Archived from the original on 4 May 2021. Retrieved 4 May 2021. • ^ "Bangladesh approves Sinovac Covid-19 vaccine for emergency use".

Dhaka Tribune. 6 June 2021. Retrieved 6 June 2021. • ^ "Gavi signs agreements with Sinopharm and Sinovac for immediate supply to COVAX". www.gavi.org. Retrieved 13 July 2021. • ^ "Chinese drugmakers agree to supply more than half a billion vaccines to COVAX". Reuters. 12 July 2021. Retrieved 13 July 2021. • ^ Aliyev J (19 January 2021). "Azerbaijan kicks off COVID-19 vaccination". Anadolu Agency. Archived from the original on 18 January 2021.

• ^ "Azerbaijan Administers over 2 Million Doses of COVID-19 Vaccines". caspiannews.com. Retrieved 28 May 2021. • ^ "В Армению отправлена китайская вакцина от COVID-19". Общественное Радио Армении (in Russian). Retrieved 9 May 2021. • ^ "Cambodian PM okays two more Covid-19 vaccines - Sinovac and AstraZeneca - for emergency use".

The Star. Retrieved 19 March 2021. • ^ "Health Ministry to start rolling out Sinovac vaccine tomorrow - Khmer Times". 31 March 2021. Retrieved 31 March 2021. • ^ "Cambodia calls for 21-day interval between first and second doses for Sinopharm and Sinovac Covid-19 vaccines - Khmer Times".

14 July 2021. Retrieved 30 July 2021. • ^ "Virus vaccine waiting on Saudi 'green light' ". Arab News. 31 October 2020. Archived from the original on 16 December 2020. Retrieved 1 November 2020. • ^ "Turkey signs 50 million dose COVID-19 vaccine deal, health minister says".

Reuters. 25 November 2020. Archived from the original on 1 December 2020. Retrieved 27 November 2020. • ^ "Turkey grants emergency authorization to Sinovac's CoronaVac: Anadolu". Reuters. 13 January 2021. Retrieved 15 January 2021. • ^ "Turkish president gets COVID-19 vaccine". Anadolu Agency. 14 January 2021. Retrieved 20 January 2021.

• ^ "Few virus infections reported among vaccinated people in Turkey". Daily Sabah. 12 March 2021. Retrieved 12 March 2021. • ^ "Government announces latest development of COVID-19 vaccine procurement (Hong Kong Government Press Releases)".

Hong Kong Government. 12 December 2020. Archived from the original on 11 December 2020. • ^ "Hong Kong kicks off COVID-19 vaccinations with Sinovac jab". AP NEWS. 26 February corona omicron indonesia. Retrieved 7 March 2021. • ^ "Sinovac vaccine has no critical side effects, BPOM says".

The Jakarta Post. Retrieved 21 December 2020. • ^ Soeriaatmadja W (11 January 2021). "Indonesia grants emergency use approval to Sinovac's vaccine, local trials show 65% efficacy". The Straits Times. Retrieved 9 April 2021. • ^ "Indonesia receives 14 million Sinovac doses in 18th vaccine batch". The Jakarta Post. Archived from the original on 9 July 2021.

Retrieved 9 July 2021. • ^ Choong J (26 January 2021). "Health Ministry: Malaysia secures 18.4 million doses of Russian, Chinese Covid-19 vaccines". The Malay Mail. Retrieved 26 January 2021. • ^ "Malaysia's NPRA Approves AstraZeneca, Sinovac Covid-19 Vaccines".

CodeBlue. 2 March 2021. Retrieved 2 March 2021. • ^ Babulal V (18 March 2021). "KJ gets first dose of Sinovac vaccine [NSTTV]". New Straits Times. Retrieved 19 March 2021. • ^ "Китай отправит в Казахстан 3 миллиона доз вакцин от коронавируса".

Главные новости Казахстана - Tengrinews.kz (in Russian). 27 March 2021. Archived from the original on 27 March 2021. Retrieved 7 June 2021. • ^ "В Казахстан доставили первую партию китайской вакцины CoronaVac - Kazakhstan Today". www.kt.kz (in Russian). Retrieved 7 June 2021. • ^ "Oman receives Sinovac vaccines from China". Oman Observer. 17 May 2021. Archived from the original on 17 May 2021. Retrieved 17 May 2021. • ^ "DRAP allows emergency authorisation to fifth Covid-19 vaccine".

www.thenews.com.pk. Retrieved 9 April 2021. • ^ "Over 20 million doses of Covid-19 vaccines transported from China to Pakistan". Daily Times. 7 July 2021. Retrieved 7 July 2021. • ^ "Duque corona omicron indonesia deal sealed for 25M doses of Sinovac COVID-19 vaccine".

GMA News Online. Retrieved 10 January 2021. • ^ "Philippines receives COVID-19 vaccine after delays". AP NEWS. 28 February 2021. Retrieved 28 February 2021. • ^ Cabico GK. "1M more Sinovac COVID-19 jabs arrive in Philippines". Philstar.com. Retrieved 11 June 2021. • ^ Chen F (24 December 2020). "Brazil joins ranks of Chinese vaccine backers". Corona omicron indonesia Times Online. Retrieved 30 December 2020. • ^ "Singapore receives China's Sinovac vaccine corona omicron indonesia of approval".

The Star. 25 February 2021. Retrieved 26 February 2021. • ^ Goh T (2 June 2021). "MOH allows special access to Sinovac Covid-19 vaccine through private healthcare sector".

The Straits Times. Retrieved 3 June 2021. {{ cite news}}: CS1 maint: url-status ( link) • ^ "Vaccination against COVID-19 in Tajikistan: the role of joint efforts - P4H Network". p4h.world. Retrieved 3 June 2021. • ^ "Thailand gives emergency use authorisation for Sinovac's COVID-19 vaccine – official". Reuters. 22 February 2021. Retrieved 23 February 2021.

• ^ Bangkok Post Public Company Limited. "2 million more Corona omicron indonesia doses arrive in Thailand". Bangkok Post. Retrieved 24 June 2021. • ^ "Covid-19 vaccination with Sinovac to start on 24 May in Georgia". Agenda.ge. Retrieved 21 May 2021.

• ^ "One mln doses of Sinopharm, Sinovac now in Georgia - mass vaccination to start on July 5". Agenda.ge. Retrieved 3 July 2021. • ^ "В Туркменистан поступила крупная партия китайской вакцины "CoronaVac" - Здоровье". Туркменистан, интернет портал о культурной, деловой и развлекательной жизни в Туркменистане.

corona omicron indonesia

• ^ "Uzbekistan plans to obtain Sinovac coronavirus vaccine". akipress.com. Retrieved 14 May 2021. • ^ "Sinovac-CoronaVac included in the National Vaccination Programme". Government of Singapore. 23 October 2021. Retrieved 11 November 2021. • ^ "Lutte contre la Covid-19 : 203.000 doses de vaccins s dont 100.000 offertes par la Chine au Bénin". Concentrées d'informations sur le Bénin et le monde à votre service depuis 2009 (in French).

23 March 2021. Retrieved 25 March 2021. • ^ Ayosso A (29 March 2021). "Deux ministres vaccinés contre Covid-19". www.24haubenin.info (in French). Retrieved 30 March 2021. • ^ More K (26 April 2021). "China delivers vaccine". Daily News Botswana. Archived from the original on 27 April 2021.

• ^ "Botswana Could Be First African Country to Vaccinate Entire Adult Population". Voice of America. Retrieved 21 May 2021. • ^ "Djibouti Ministry of Health". Twitter. Archived from the original on 19 March 2021. Retrieved 30 March 2021.

• ^ "Egypt approves Sinovac COVID-19 vaccine for emergency use". gulfnews.com. Retrieved 27 April 2021. • ^ "Guinea receives purchase of 300,000 Sinovac COVID-19 vaccines". CNA. Retrieved 21 April 2021. • ^ Zaptia S (15 April 2021). "150,000 doses of Chinese Sinovac anti-Coronavirus vaccines arrive from Turkey".

Libya Herald. Retrieved 15 April 2021. • ^ "Somalia receives 200,000 Sinovac COVID-19 vaccine". hornobserver.com. 11 April 2021. Retrieved 11 April corona omicron indonesia. • ^ "South Africa approves China's Sinovac COVID-19 vaccine - health ministry". Reuters. 3 July 2021. Retrieved 3 July 2021. • ^ First T. "200,000 doses of SINOVAC vaccines received".

www.togofirst.com. Retrieved 27 April 2021. • ^ "Tunisia approva vaccino cinese Sinovac" (in Italian). Agenzia Nazionale Stampa Associata (in Italian). 5 March 2021.

Retrieved 7 March 2021. • ^ "La Tunisie réceptionne le don chinois de 200.000 doses de vaccins". Business News Tunisia. Archived from the original on 25 March 2021. • ^ Dzirutwe M (10 March 2021).

"Zimbabwe authorises Sputnik V, Sinovac coronavirus corona omicron indonesia for emergency use". Reuters. Retrieved 13 March 2021. {{ cite news}}: CS1 maint: url-status ( link) • ^ Zinyuke R.

"Zim receives 1 million Sinovac doses". The Herald. Archived from the original on 31 March 2021. Retrieved 30 March 2021. • ^ Reuters Staff (25 March 2021). "Albania gets 192,000 doses of Chinese Sinovac vaccine". Reuters. Retrieved 28 March 2021. • ^ a b "Turkey donates COVID-19 vaccines to North Macedonia". Daily Sabah. 9 June 2021. Archived from the original on 9 June 2021.

Retrieved 11 June 2021. • ^ Anadolu Agency (28 March 2021). "Turkey sends Chinese COVID-19 vaccines to Bosnia-Herzegovina". Daily Sabah. Retrieved 29 March 2021. • ^ Testorides K (27 June 2021). "North Macedonia gets 500,000 doses of Sinovac vaccines". Associated Press. Archived from the original on 27 June 2021. Retrieved 30 June 2021. • ^ Zinets N (9 March 2021). "Ukraine approves China's Sinovac COVID-19 vaccine".

Reuters. Retrieved 10 March corona omicron indonesia. • ^ "Ukrainians vaccinated with CoronaVac to receive international vaccination certificate – minister". covid.unian.info. Retrieved 3 June 2021. • ^ Tanas A (9 April 2021). "Moldova to buy 400,000 doses of Sinovac COVID-19 vaccine". Reuters. Retrieved 9 April 2021. • ^ Simoes E (30 September 2020). "Brazil's Sao Paulo signs agreement with Sinovac for COVID vaccine doses". Reuters. Archived from the original on 1 October 2020.

Retrieved 1 October 2020. • ^ Fonseca I (30 October 2020). "CoronaVac May Be Four Times More Costly Than Flu Vaccine". The Rio Times. Archived from the original on 3 November 2020. Retrieved 30 October 2020. • ^ "Em meio a críticas por atrasos, Pazuello diz que Brasil está preparado para iniciar vacinação em janeiro".

Folha de S.Paulo (in Brazilian Portuguese). 6 January 2021. Retrieved 7 January 2021. • ^ McGeever J, Fonseca P (17 January 2021). "Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin". Reuters. Retrieved 17 January 2021. • ^ Cardin A (12 April 2021). "1.5 million Coronavac doses delivered to Brazilian government by Butantan". The Rio Times. Retrieved 17 April 2021. • ^ "Government meets with Sinovac for first COVID-19 vaccine clinical trial in Chile". Government of Chile.

13 October 2020. Archived from the original on 17 October 2020. Retrieved 8 November 2020. • ^ AFP-Agence France Presse. "Chile Approves Chinese Coronavirus Vaccine". barrons.com. Retrieved 21 January 2021. • ^ "Fifth shipment with over two million Sinovac vaccines arrives to Chile".

Chile Reports. Archived from the original on 10 March 2021. Retrieved 12 March 2021. • ^ "Colombia extends health state of emergency, seeks more Sinovac vaccines". Reuters. Retrieved 26 February 2021. • ^ MENAFN. "Colombia declares emergency use of Sinovac vaccines". menafn.com. Retrieved 4 February 2021. • ^ "Ecuador signs agreement with Sinovac for 2 million COVID-19 vaccine: minister".

National Post. 25 February 2021. Retrieved 26 February 2021. • ^ "Ecuador recibe primeras 300.000 vacunas de Sinovac para ampliar inmunización". Primicias (in Mexican Spanish). Retrieved 11 April 2021. • ^ "A Ecuador llegaron 700 000 vacunas Sinovac contra el covid-19". El Comercio. Retrieved 11 April 2021. • ^ Valencia A (7 March 2021). "Chile donates 40,000 doses of Sinovac vaccine to Ecuador and Paraguay". Reuters. Retrieved 7 March 2021. {{ cite news}}: CS1 corona omicron indonesia url-status ( link) • ^ "CoronaVac, vacuna de alta eficacia".

Ministerio de Salud Publica Y Bienestar Social. Archived from the original on 10 March 2021. • ^ "Uruguay will receive first batches of Pfizer and Sinovac vaccines late February or early March: US$ 120 million investment". MercoPress. Retrieved 24 January 2021. • ^ Merit Designs Consulting Group. "With yesterday's batch China has shipped 7,818,000 doses". DominicanToday. Retrieved 24 June 2021.

• ^ "Mexico approves China's CanSino and Sinovac COVID-19 vaccines". Reuters. 11 February 2021. Retrieved 11 February 2021. • ^ Jorgic D (10 March 2021). "Mexico leans on China after Biden rules out vaccines sharing in short term". Reuters. Retrieved 10 March 2021.

{{ cite news}}: CS1 maint: url-status ( link) • ^ "Mexico breaks new COVID-19 vaccination record". Puerto Vallarta Corona omicron indonesia. 20 May 2021. Archived from the original on 25 May 2021. Retrieved 25 May 2021. • ^ "China to donate Sinovac Vaccine to Fiji". Fiji Broadcasting Corporation. Retrieved 22 March 2021. • ^ a b Pearson S, Magalhaes L (12 January 2021). "Chinese Covid-19 Vaccine Is Far Less Effective Than Initially Touted in Brazil".

The Wall Street Journal corona omicron indonesia. Retrieved 12 January 2021. • ^ "Chinese media criticise Pfizer COVID-19 vaccine, tout local shots". Reuters. 20 January 2021. Archived from the original on 5 February 2021.

Retrieved 9 February 2021 – via www.reuters.com. • ^ "Hong Kong's immunized who died of COVID mainly got Sinovac vaccine: Ming Pao". • ^ "Covid-19: Gov't defends efficacy of China-made Sinovac jab following report about death rate". 22 March 2022. • ^ "Hong Kong refuses to disclose data on Covid-19 patient vaccine types, despite concerns over Sinovac Omicron efficacy".

11 February 2022. • ^ "Hong Kong Covid crisis: Why is the death rate so high?". TheGuardian.com. 18 March 2022. • ^ Phillips T (10 November 2020). "Jair Bolsonaro claims 'victory' after suspension of Chinese vaccine trial".

The Guardian. Retrieved 18 January 2021. • ^ Baptista E (11 December 2020). "China-made coronavirus vaccine at heart of political showdown in Brazil". South China Morning Post. Retrieved 18 January 2021. • ^ Carvalho D (14 January 2021). " 'Is 50% Good?', Asks Bolsonaro, Mocking Coronavac's Effectiveness".

Folha de S.Paulo. Retrieved 18 January 2021. • ^ "Covid: 70% dos brasileiros não fazem questão de escolher vacina" [Covid: 70% of Brazilians do not make a point of choosing vaccine]. R7.com (in Portuguese).

3 March 2021. Retrieved 9 March 2021. • ^ Boadle A (18 May 2021). "Brazil senators say anti-China views hurt access to COVID-19 vaccines". Reuters. Retrieved 26 May 2021. • ^ Fonseca P (24 December 2020). "Brazil institute says CoronaVac efficacy above 50%, but delays full results". Reuters. Retrieved 25 December 2020. Further reading • Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac (PDF) (Report).

World Health Organization (WHO). May 2021. • "Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine" (PDF). World Health Organization (WHO). April 2021. • "COVID-19 Vaccine (Vero cell), Inactivated" (PDF). Sinovac. March 2021. External links • Clinical Research Protocol for CoronaVac Phase III Trials in Brazil • Clinical trial number NCT04551547 for "Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19" at ClinicalTrials.gov • Clinical trial number NCT04456595 for "Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals (PROFISCOV)" at ClinicalTrials.gov • Clinical trial number Corona omicron indonesia for "Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults (CoronaVac3CL)" at ClinicalTrials.gov • "How the Sinovac Vaccine Works".

The New York Times. • Anthrax • Brucellosis • Cholera # • Diphtheria # • Hib # • Leptospirosis • Lyme disease ‡ • Meningococcus # • MeNZB • NmVac4-A/C/Y/W-135 • Pertussis # • Plague • Pneumococcal # • PCV • PPSV • Q fever • Tetanus # • Tuberculosis • BCG # • Typhoid # • Ty21a • ViCPS • Typhus • combination: • DPT/DTwP/DTaP • Td/Tdap • research: • Clostridioides difficile • Group B streptococcal disease • Shigellosis Viral • Adenovirus • Ebola • rVSV-ZEBOV • Flu # • H1N1 ( Pandemrix) • H5N1 • LAIV • Hantavirus • Hepatitis A # • Hepatitis B # • Hepatitis E • HPV # • Cervarix • Gardasil • Japanese encephalitis # • Measles # • Mumps # • Mumpsvax • Polio # • Sabin • Salk • Rabies # • Rotavirus # • Rubella # • SARS-CoV-2 • Corbevax † • Bharat Biotech † • CanSino † • CoronaVac † • EpiVacCorona † • Janssen • Moderna • Novavax • Oxford–AstraZeneca • Pfizer–BioNTech • Sanofi–GSK † • Sinopharm BIBP † • Sputnik V † • Smallpox • Dryvax • Tick-borne encephalitis # • Varicella zoster • Chicken pox # • Shingles • Yellow fever # • combination: • Hepatitis A and B • MMR • MMRV • research: • Chikungunya • Cytomegalovirus • Dengue # • Epstein–Barr virus • Hepatitis Corona omicron indonesia • Herpes simplex • HIV • Respiratory syncytial virus • Zika Protozoan • Benin • Burkina Faso • Cape Verde • Equatorial Guinea • Gambia • Ghana • timeline • 2020 • March–July • August–December • 2021 • government response • impact • education • Guinea • Guinea-Bissau • Ivory Coast • timeline • Liberia • Mali • Niger • Corona omicron indonesia • timeline • 2020 • February–June • July–December • January–June 2021 • government response • Saint Helena, Ascension and Tristan da Cunha • Senegal • Sierra Leone • Togo • Brunei • Cambodia • East Timor corona omicron indonesia Indonesia • timeline • 2020 • 2021 • 2022 • social restrictions • Community Activities Restrictions Enforcement • Laos • Myanmar • Singapore • timeline • 2020 • 2021 • 2022 • circuit breaker response • vaccination • statistics • Thailand • timeline • vaccination • statistics • Vietnam • timeline • government response Malaysia • timeline • 2020 • 2021 • 2022 • government response • community corona omicron indonesia • Luzon • evacuations • testing controversy • vaccination • Bangsamoro • Bicol Region • Cagayan Valley • Calabarzon • Caraga corona omicron indonesia Central Luzon • Central Visayas • Cordillera • Davao Region • Eastern Visayas • Ilocos Region • Metro Manila • Mimaropa • Northern Mindanao • Soccsksargen • Western Visayas • Zamboanga Peninsula • Overseas Filipinos • England • timeline • 2020 • January–June • July–December • 2021 • 2022 • London • local lockdown regulations • first tier regulations • Northern Ireland • timeline • 2020 • 2021 • 2022 • Scotland • timeline • 2020 • 2021 • 2022 • Wales • timeline • 2020 • 2021 • 2022 • Crown dependencies • Isle of Man • Jersey • Guernsey • Overseas territories • Akrotiri and Dhekelia • British Indian Ocean Territory • Gibraltar • Austria • Belgium • Bulgaria • Croatia • timeline • Cyprus • Northern Cyprus • Czech Republic • Denmark • Faroe Islands • Estonia • Finland • Åland • France • Guadeloupe • French Guiana • Réunion • Martinique • Mayotte • Normandy • Saint Martin • Germany • North Rhine-Westphalia • government response • Greece • Hungary • Ireland • timeline • 2020 • January–June • July–December • 2021 • January–June • July–December • 2022 • economic impact • social impact • vaccination • Italy • lockdowns • timeline • Latvia • Lithuania • Luxembourg • Malta • timeline • Netherlands • Poland • Portugal • Romania • timeline • Slovakia • Slovenia • Spain • timeline • Asturias • Canary Islands • Ceuta • Community of Madrid • Melilla • Sweden • timeline • government response • Operation Gloria EFTA countries • timeline • economic impact • federal aid • vaccination • by province • military response • Atlantic Bubble • Alberta • timeline • British Columbia • Manitoba • New Brunswick • Newfoundland and Labrador • Northwest Territories • Nova Scotia • Nunavut • Ontario • timeline • 2020 • 2021 • 2022 • Ottawa • Peel Region • Toronto • York Region • Provincial government response • Vaccination • Prince Edward Island • Quebec • Montreal • boroughs • timeline • Saskatchewan • timeline • Yukon Caribbean • Coalition for Epidemic Preparedness Innovations • Coronavirus Tech Handbook • COVID-19 Solidarity Response Fund • Covid Watch • EcoHealth Alliance • International Committee on Taxonomy of Viruses • Joint Committee on Vaccination and Immunisation • MusiCares COVID-19 Relief Fund • Pasteur Institute • in Cambodia • UN COVID-19 Supply Chain Task Force (WHO) • United Nations • resolutions • World Health Organization By location • Africa Centres for Disease Control and Prevention (African Union) • Ghana Infectious Disease Centre (Ghana) • Department of Health (Hong Kong) • Korea Disease Control and Prevention Corona omicron indonesia (South Korea) • National Institute for Communicable Diseases (South Africa) • Taiwan Centers for Disease Control (Taiwan) Pandemic institutes • National COVID-19 Commission Advisory Board (Australia) • COVID-19 Immunity Task Force (Canada) • COVID-19 Supply Council (Canada) • PREPARE (European Union) • National Expert Group on Vaccine Administration for COVID-19 (India) • COVID-19 Response Acceleration Task Force (Indonesia) • National Public Health Emergency Team (Ireland) • Novel Coronavirus Expert Meeting (Japan) • Crisis Preparedness and Response Centre (Malaysia) • Defeat COVID-19 Ad Hoc Committee (Philippines) • Inter-Agency Task Force for the Management of Emerging Infectious Diseases (Philippines) • Central Epidemic Command Center (Taiwan) • Coronavirus Scientific Advisory Board (Turkey) • COVID-19 Genomics UK Consortium (United Kingdom) • Imperial College COVID-19 Response Team (United Kingdom) • Joint Biosecurity Centre (United Kingdom) • Vaccine Taskforce (United Kingdom) corona omicron indonesia COVID-19 Advisory Board (United States) • Great American Economic Revival Industry Groups (United States) • White House Coronavirus Task Force (United States) • White House COVID-19 Response Team (United States) • GACH (Uruguay) Relieve funds • Awang Bulgiba Awang Mahmud • Roberto Burioni • Chen Wei • Kizzmekia Corbett • Andrea Crisanti • Peter Daszak • Christian Drosten • Neil Ferguson • Dale Fisher • George F.

Gao • Azra Ghani • Sarah Gilbert • Guan Yi • Kentaro Iwata • Katalin Karikó • Matt Keeling • Trudie Lang • Li Lanjuan • W.

Ian Lipkin • Ma Xiaowei • Shabir Madhi • Allison McGeer • Camilla Rothe • Shi Zhengli • Moncef Slaoui • Mike Tildesley • John Todd • Wang Chen • Wang Guangfa • Drew Weissman • Yuen Kwok-yung • Zeng Guang • Zhang Jixian • Zhang Yongzhen • Zhong Nanshan Corona omicron indonesia • Cases, deaths, recoveries by country • Tests, cases, tests per capita, cases per capita by country • Tests, cases, tests per capita, cases per capita by country subdivision • WHO situation reports • cases • January 2020 • February 2020 • March 2020 • April 2020 • May 2020 • June 2020 • July 2020 • August 2020 • September 2020 • October 2020 • November 2020 • December 2020 • January 2021 • February 2021 • April 2021 • May 2021 corona omicron indonesia June 2021 • July 2021 • deaths • World map by countries: confirmed per capita • China • Hospital beds by country • Lockdowns Africa • Algeria • Angola corona omicron indonesia Benin • Botswana • Burkina Faso • Burundi • Cameroon • Comoros • Egypt • Eswatini • Ethiopia • Ghana • cases chart • Ivory Coast • Kenya • Libya • Malawi • Mali • Mauritania • Mauritius • Morocco • Mozambique • Namibia • Nigera • cases chart • São Tomé and Príncipe • Senegal • Seychelles • Sierra Leone • South Africa • cases chart • South Sudan • Sudan • Tanzania • Togo • Tunisia • Uganda • Zambia • Zimbabwe • cases chart Americas • Argentina • Bolivia • Brazil • Canada • by province • vaccinations by province • Chile • by commune • Colombia • Costa Rica • cases chart • Cuba • Dominican Republic • Ecuador • El Salvador • Guatemala • Haiti • Honduras • Mexico • cases chart • Nicaragua • Panama • Paraguay • Peru • United States • by state • Uruguay • Venezuela Asia • Albania • Austria • cases chart • Belarus • Belgium • cases chart • Bosnia and Herzegovina • Bulgaria • cases chart • Croatia • Cyprus • Czech Republic • Denmark • cases chart • Faroe Islands • Estonia • cases chart • Finland • France • cases chart • Germany • cases chart • Greece • Hungary • Iceland • cases chart • Ireland • cases chart • Italy • cases chart • statistics charts • vaccinations chart • Kosovo • Latvia • cases chart • Lithuania • cases chart • Luxembourg • Malta • Moldova • Monaco • Montenegro • Netherlands • North Macedonia • Norway • cases chart • Poland • cases chart • by voivodeship • Portugal • cases chart • Romania • cases chart • Russia • cases chart • by federal subject • North Asia • San Marino • Serbia • Slovakia • cases chart • by region • Slovenia • cases chart • Spain • cases chart • Sweden • cases chart • Switzerland • cases chart • Turkey • cases chart • Ukraine • Donetsk People's Republic corona omicron indonesia Luhansk People's Republic • United Kingdom • Scotland • Gibraltar • vaccinations chart • daily • by nation • Vatican City Oceania Hidden categories: • CS1 Portuguese-language sources (pt) • CS1 Arabic-language sources (ar) • CS1 European Spanish-language sources (es) • CS1 maint: url-status • CS1 Indonesian-language sources (id) • CS1 Spanish-language sources (es) • CS1 maint: location • CS1 errors: missing periodical • CS1 Brazilian Portuguese-language sources (pt) • CS1 Russian-language sources (ru) • CS1 French-language sources (fr) • CS1 Italian-language sources (it) • CS1 Mexican Spanish-language sources (es) • Articles with short description • Short description is different from Wikidata • Wikipedia extended-confirmed-protected pages • Use dmy dates from August 2021 • Drugs with non-standard legal status • Chemical articles without CAS registry number • Articles without EBI source • Chemical pages without ChemSpiderID • Articles without KEGG source • Articles without InChI source • Articles without UNII source • Articles containing unverified chemical infoboxes • Drugs that are a vaccine • Articles using infobox templates with no data rows • All articles with unsourced statements • Articles with unsourced statements from November 2021 • AC with 0 elements • Pages using the Graph extension • العربية • Azərbaycanca • Banjar • Català • Čeština • Deutsch • Español • فارسی • Français • Galego • 한국어 • Bahasa Indonesia • Italiano • ລາວ • Bahasa Melayu • 日本語 • Norsk bokmål • Oʻzbekcha/ўзбекча • Português • Русский • Српски / srpski • Svenska • Tagalog • ไทย • Türkçe • Українська • Tiếng Việt • 吴语 • 粵語 • 中文 Edit links • This page was last edited on 5 May 2022, at 07:26 (UTC).

• Text is available under the Creative Commons Attribution-ShareAlike License 3.0 ; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization. • Privacy policy • About Wikipedia • Disclaimers • Contact Wikipedia corona omicron indonesia Mobile view • Developers • Statistics • Cookie statement • •
Jakarta, 16 Desember 2021 Menteri Kesehatan Budi Gunadi Sadikin mengumumkan temuan kasus pertama COVID-19 varian omicron di Indonesia pada Kamis (16/12).

Kasus pertama omicron ini terdeteksi pada seorang petugas kebersihan berinisial N yang bekerja di RSDC Wisma Atlet Kemayoran, Jakarta. “Kementerian Kesehatan telah mendeteksi seorang pasien terkonfirmasi Omicron pada tanggal 15 Corona omicron indonesia, data-datanya sudah kita konfirmasikan ke GISAID dan telah dikonfirmasi kembali dari GISAID bahwa memang data ini data sequencing Omicron,” kata Menkes dalam keterangan pers perkembangan pandemi COVID-19.

Menkes merinci para petugas kebersihan Wisma Atlet diambil sampel rutin pada 8 Desember 2021. Hasil pemeriksaan keluar tanggal 10 Desember 2021 didapati 3 orang terkonfirmasi positif COVID-19. Ketiga sampel selanjutnya dikirim ke Balitbangkes untuk dilakukan Whole Genome Sequencing (WGS). Hasil pemeriksaan sampel keluar tanggal 15 Desember dan didapati 1 dari 3 sampel terkonfirmasi positif varian Omicron. “Ada 3 petugas kebersihan di RSDC Wisma Atlet yang positif PCR-nya, tapi yang terkonfirmasi positif Omicron adalah satu orang,” terang Menkes.

Seluruhnya kini telah menjalani karantina di Wisma Altet. Ketiga dalam kondiri sehat, tanpa ada gejala, tanpa batuk, dan tanpa demam. Dari hasil pemeriksaan PCR juga hasilnya telah negatif. Selain temuan kasus konfirmasi varian Omicron, Kementerian Kesehatan juga mengidentifikasi adanya 5 kasus probable Omicron. Kelimanya telah dikarantina dan sudah dilakukan pemeriksaan khusus yang sudah dikirimkan Balitbangkes. Hasilnya akan diketahui 3 hari mendatang untuk melihat apakah sampel tersebut positif omicron atau bukan.

“Dengan pemeriksaan khusus SGTF, kita mendeteksi 5 kasus probable omicron 2 kasus warga Indonesia yang baru balik dari Inggris dan AS, 3 lainnya WNA dari Tiongkok yang ke Manado yg sekarang dikarantina di Manado,” tutur Menkes. Menkes mengatakan bahwa penyebaran Omicron corona omicron indonesia sangat cepat.

Di Inggris misalnya dari 10 kasus/hari saat ini sudah mencapai 70.000 kasus/Hari. Jauh lebih tunggi dari puncak kasus di Indonesia pada bulan Juli di angka 50.000 kasus/hari. Terkait dengan temuan ini, Menkes Budi mengimbau masyarakat untuk tidak perlu panik dan tetap tenang. Yang terpenting segera melakukan vaksinasi COVID-19 terutama untuk kelompok rentan dan lansia serta tidak perlu bepergian ke luar negeri jika tidak mendesak, serta terus tegakkan protokol kesehatan 5M, dan memperkuat 3T.

“Kedatangan varian baru dari luar negeri yang kita identifikasi di karantina, menunjukkan bahwa sistem pertahanan kita atas kedatangan varian baru cukup baik, perlu kita perkuat. Jadi wajar kalau harus stay 10 hari corona omicron indonesia karantina.

Tujuannya bukan untuk mempersulit orang yang corona omicron indonesia, tapi melindungi seluruh masyarakat Indonesia” tutup Menkes Hotline Virus Corona 119 ext 9.

Berita ini disiarkan oleh Biro Komunikasi dan Pelayanan Masyarakat, Kementerian Kesehatan RI. Untuk informasi lebih lanjut dapat menghubungi nomor hotline Halo Kemenkes melalui nomor hotline 1500-567, SMS 081281562620, faksimili (021) 5223002, 52921669, dan alamat email kontak@kemkes.go.id (MF) Kepala Biro Komunikasi dan Pelayanan Masyarakat drg. Widyawati, MKM

Terjadi Penularan Lokal Corona Omicron, Ditemukan di Jakarta




2022 www.videocon.com